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The effects of high pressure on a selection of organic compounds have been 
studied. Crystallisation at high pressure has been successfully used to grow a single 
crystal of an elusive polymorph (form II) of mefenamic acid. Milling experiments 
revealed that form I can be converted to form II by milling at both ambient 
temperature and at -78 °C. Direct compression of powder samples of form I at 1.5 
GPa using methanol:ethanol as a pressure-transmitting medium resulted in the 
formation of a new high-pressure form III and this new form is recoverable to 
ambient pressure. Compression of powder samples of forms I and II using Fluorinert- 
FC77 as a pressure-transmitting medium resulted in a reversible phase transition to a 
new high-pressure form IV.
High-pressure crystallisation of N,N'-dimethylurea resulted in the formation 
of two new high-pressure polymorphs designated as forms III and IV. Crystal 
structures of these forms are reported here. Form III was also produced by 
compression of a powder samples of form I and decompression studies showed that it 
can be recovered to ambient pressure, but it was metastable compared to form I. 
Form II was produced through compression of form I using Fluorinert FC-77 as a 
pressure-transmitting medium. Form IV was produced by heating a mixture of form 
II and III to 150 °C at 1.75 GPa. Decompression of form IV resulted in formation of 
a new form, which was recoverable at ambient pressure. The experimental results 
have been compared with crystal structure prediction calculations.
High-pressure techniques have been used to study polymorphism of GSK 
developmental compounds A and B. New polymorphs for these compounds have 
been obtained at high pressure. Of particular importance are forms III and VI of 
compounds A and B, respectively, where recrystallisation at high pressure resulted in 
production of these forms and decompression studies have shown that they can be 
recovered to ambient pressure. From the compression studies performed on the 
powder samples of compound A, two new high-pressure forms designated as forms 
V and VI were obtained at 0.9 and 1.4 GPa, respectively. New polymorphs for these 
compounds were also produced from recrystallisation at ambient pressure.
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Polymorphism (from the Greek meaning “having multiple forms”) is a term 
used in many disciplines. According to the Oxford English Dictionary, the term first 
emerged in 1656 to express changes in fashion. In chemistry, polymorphism is the 
ability of a solid substance to crystallise with more than one crystal structure; these 
different crystalline forms are termed polymorphs. Polymorphs of a compound have 
the same chemical formulae, but different three dimensional arrangements and/or 
conformations of molecules within the unit cell. These different arrangements can 
have profound effects on the physical and chemical properties of the material. 
Examples include melting point, sublimation temperature, heat capacity, 
conductivity, solubility, density, dissolution rate, stability, hygroscopicity, and solid- 
state chemistry [1,2].
The term pseudo-polymorphism is sometimes applied to hydrates and solvates 
and is widely found in older literature. This notation has now been discouraged due 
to its rather confusing nature. The term allotrope is more commonly used when the 
substance under consideration is an element. The classic example of allotropy in 
nature is represented by carbon and three of its main allotropes, diamond, graphite 
and C6o (Buckminsterfullerene). Each of these forms display markedly different 
structures and properties (Figure 1.1). For example, graphite is a black, soft, 
electrically conducting and chemically reactive material. Diamond is optically 
transparent, hard, electrically insulating, and chemically rather inert. C6o is quite 
different from both and its structure comprises hexagons and pentagons of carbon 




Figure 1.1: Structures of (a) diamond, (b) graphite, and (c) C60
The first observation of polymorphism in organic materials is attributed to 
Friedrich Wohler and Justus Von Liebig in 1832 when they examined a boiling 
solution of benzamide. On cooling the benzamide initially crystallised as silky 
needles, but on standing these were slowly replaced by rhombic crystals [3].
1.1.1. Occurrence of polymorphism
Walter McCrone stated that " e v e r y  c o m p o u n d  h a s  d i f f e r e n t  p o l y m o r p h i c  
f o r m s ,  a n d  t h a t ,  i n  g e n e r a l ,  t h e  n u m b e r  o f  f o r m s  k n o w n  f o r  a  g i v e n  c o m p o u n d  i s  
p r o p o r t i o n e d  t o  t h e  t i m e  a n d  m o n e y  s p e n t  i n  r e s e a r c h  o n  t h a t  c o m p o u n d ' ' [4], 
Buerger and Bloom in 1937 stated that " p o l y m o r p h i s m  i s  a n  i n h e r e n t  p r o p e r t y  o f  t h e  
s o l i d  s t a t e  a n d  t h a t  i t  f a i l s  t o  a p p e a r  o n l y  u n d e r  s p e c i a l  c o n d i t i o n "  [5]. However, 
according to Bernstein [2] this statement should be used with caution because some 
very common materials, such as sucrose and naphthalene, which have been 
crystallised many times, have not been reported to be polymorphic.
Despite its potential implications, polymorphism is not always well 
understood. Crystallisation is determined by the complex interplay between kinetics 
and thermodynamics. Thermodynamics governs the order of stability of each form, 
whilst kinetic factors influence the appearance of thermodynamically less stable 
forms. The metastable form ultimately converts to the stable form, but in some cases
3
Chapter 1: Introduction
metastable forms are known to exhibit apparent stability for years, depending upon 
the environment surrounding the crystal (temperature, humidity, solvation, etc.).
Ostwald's rule of stages [6] is often applied in polymorphism involving 
molecular compounds. It states that, in general, it is not the most stable, but the least 
stable polymorph that crystallises first, which shows the dominance of kinetic factors 
upon crystallisation. With time, the metastable form is transformed to a more stable 
form (depending upon the thermodynamic energy difference between these forms). 
In terms of thermodynamics, there are two types of polymorphism [2], For a 
monotropic system, plots of the free energies of two polymorphs against temperature 
do not cross before the two polymorphs melt (Figure 1.2), i.e. any transition from 
one polymorph to another will be irreversible. For an enantiotropic system, plots of 
the free energy against temperature show a crossing point before the two melting 
points, and it is possible to convert reversibly between the two polymorphs on 
heating and cooling.
(a) (b)
Figure 1.2: Free energy/temperature diagram for monotropic (a) and enantiotropic (b) polymorphs [7],
1.1.2 Implications of polymorphism
The phenomenon of polymorphism in the crystallisation of compounds is of 
fundamental interest to experimental and theoretical chemists, and is also of crucial 
importance to industry for a wide range of materials that includes pharmaceuticals,
4
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pigments, explosives (energetic materials), food products and proteins [2], Examples 
of polymorphism for various classes of compounds are given in the following 
sections.
I.I.2.I. Pigments
The pigment and dye industry has been a significant commercial enterprise 
since the discovery of the dye indigo, which is the source of colour for the ubiquitous 
blue jeans [2]. One of the best examples of a pigment displaying polymorphism is 
copper phthalocyanine (Figure 1.3). At least five polymorphs are known, designated 
a, P, y, 3, e, and at least four more are claimed in the literature. All these forms 
exhibit different solubilities.
Figure 1.3: Molecular structure of copper phthalocyanine
These different polymorphs also have different shades of blue. The /Tforrn is 
used as the standard letter press printing ink, and the e-form is used as a colour filter 
for liquid crystal displays [2],
I.I.2.2. Energetic materials
Energetic materials are defined as those that generate large amounts of heat 
and generally a large amount of gas upon stimulus by heat, impact, shock, spark, etc 
[8], They can be broadly classified as explosives, propellants, gas generators, and 
pyrotechnics. Polymorphism can alter the sensitivity and performance of these
5
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energetic materials. For example, different polymorphs may have different densities 
that can affect the detonation velocity of an explosive. The widely used explosive 
HMX (1, 3, 5, 7-tetranitro-l, 3, 5, 7-tetrazocane) (Figure 1.4) can exist as four 
crystalline forms (the y-form is actually a hydrated form rather than a true 
polymorph) and the sensitivity to impact is in the order S> y > a> ft [8], RDX (1, 3, 
5-trinitrohexahydro-l, 3, 5-triazine) (Figure 1.4) is another example of a widely used 
military explosive which shows polymorphic behaviour. RDX exists as three 
crystalline forms; the a- and /i-forms can be obtained at ambient pressure, and the y- 
form can be obtained at high pressure [9].
Figure 1.4: Molecular structures of HMX (left) and RDX (right).
I.I.2.3. Amino acids and proteins
Glycine is the simplest amino acid and its polymorphism has been widely 
studied at both ambient and elevated pressures [10]. It has three polymorphs under 
ambient conditions (termed a, ft and y) and a further two at high pressure (termed S 
and e). ¿-glycine was produced by direct compression of /Tglycine, whilst e-glycine 
was produced by compression of y-glycine [10].
The most well known example of polymorphism in proteins is the complex 
polymorphism of lysozyme, a small enzyme that attacks the protective cell wall of 




1.1.3. Polymorphism in the pharmaceutical industry
Although new routes of administration for pharmaceutical active therapeutic 
agents are continuing to develop, solid dosage forms are still the fundamental and 
most preferred route of administration [11]. As with most compounds, the solid 
pharmaceutical agent can exist as an amorphous and/or crystalline form. The 
crystalline form is preferred because the crystals are relatively easy to isolate and 
minimise the risk of impurities [12]. The phenomenon of polymorphism (and solvate 
formation) in the pharmaceutical industry is particularly important for the following 
reasons:
Bio-availability and solubility: Polymorphs of a drug can exhibit different physical 
and chemical properties, and may have different solubilities and rates of dissolution
[13]. Many drugs rely on dissolution in the gastro-intestinal tract for their action. 
Hence if two polymorphs of the same drug compound have very different solubilities 
and rates of dissolution, then the bio-availabilities of the two forms may be very 
different with implications for delivery of the correct dosage to the patient.
Processibility and storage: Drug materials go through several stages of processing 
before being finally incorporated into dosage form. These may include 
crystallisation, milling, freeze drying, wet granulation, mixing with excipients, and 
tabletting. Different polymorphs may respond very differently to these processes and 
so polymorph selection and control is crucial [13]. The conditions under which 
polymorphs interconvert is of critical importance, particularly as pharmaceuticals 
may be exposed to a wide range of temperatures and relative humidities during 
storage. It is important to know if any phase transitions are possible in order to 
control the properties of drugs selectively and consistently.
Regulatory authorities: On account of the potential risks to patients, regulatory 
authorities such as the US Food and Drug Administration (FDA) now demand 
detailed information about drug polymorphs (polymorph types, reproducibility of 
manufacturing, and purity levels) before granting licenses for product distribution.
7
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Intellectual property: Different polymorphs of a drug compound can be patented, 
and so intellectual property can also become an issue for the pharmaceutical 
companies who develop and market new drug products. Challenges to patents on the 
basis of polymorphism are therefore becoming increasingly frequent and are very 
expensive [2].
For all these reasons, an understanding of the solid-state properties of a drug 
compound, including the identification of all possible forms and thorough 
characterisation of the observed forms, is of prime importance within the 
pharmaceutical industry. Establishing the polymorphic behaviour of a drug molecule 
early in development minimises the number of unsuitable candidates progressed and 
reduces the risk of encountering later issues that may have major financial impact
[14].
The most striking example of the impact of polymorphism in the 
pharmaceutical industry to date is represented by the case of Ritonavir. Ritonavir is a 
protease inhibitor used in the treatment of HIV and is currently marketed as Norvir
[15]. It was discovered in 1992 and brought to the market in 1996 as a semi-solid 
capsule by Abbott Laboratories. However, after about two years of production many 
final product lots failed a dissolution test. This was subsequently revealed as being 
due to the appearance of a new, much more stable and hence less soluble polymorph. 
This transformation of the polymorphic form caused major problems for processing 
and for the bioavailability of the drug in capsule form. A new formulation to 
accommodate the new form was designed and a controlled process was established to 
generate the initial form consistently. Abbott Laboratories lost an estimated $250 
million in sales because of the withdrawal of all of its batches from the market.
The case of ranitidine hydrochloride (Zantac), the largest selling anti-ulcer 
drug from GlaxoSmithKline (GSK), provides an example of the importance of 
polymorphism in patent litigation. Ranitidine hydrochloride exists in two 
polymorphic forms (I and II). In the mid-1990s, the patent on form I was about to 
expire and the patent on form II was still in force. Many pharmaceutical companies
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were interested in manufacturing and selling form I, but the problem of making form 
I is that it is always contaminated by form II. Novopharm, was repeatedly sued by 
GSK for manufacturing and selling mixtures of form I and form II. However, after 
several court cases and appeals, Novopharm was allowed to market its formulation 
and GSK lost large amounts of revenue.
Cefdinir is a broad-spectrum antibiotic which appears in 11 patents from 5 
pharmaceutical companies in which a total of 5 different polymorphs are described. 
The original inventor Fujisawa (now Astellas) extended the original patent covering 
a suspension with a new anhydrous formulation. Competitors in turn patented 
hydrates of the drug with varying water content [16],
The cases of Ritonavir, Ranitidine and Cefdinir emphasise the need for an 
effective and rapid means of identification, characterisation and mapping of drug 
polymorphs in the lengthy and expensive process of drug development. Nowadays 
pharmaceutical companies deploy substantial effort and resources in the screening of 
polymorphs and solvates of drugs, often in the early stages of development.
1.1.4. Polymorph screening
Physical form screening (or polymorph screening) includes systematic 
searches by applying a wide range of variables. The objectives of this screening 
process are to characterise the relationships between all forms, to identify the most 
thermodynamically stable form, and to optimise key physical properties, particularly 
solubility, dissolution rate and hygroscopicity. The key to successful product 
development is the early selection of the most appropriate solid-state form of the 
active ingredient to be used in the final product. Screening methodologies depend 
upon systematically fingerprinting samples, recrystallised under a wide range of 
conditions using spectroscopic, calorimetric and diffraction techniques [17], The 
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Figure 1.5: Flow sheet diagram for polymorph screening, outlining different steps
A wide range of variables can be employed and some examples are tabulated 
in Table 1.1
Thermal Anti Solvent Evaporation SlurryConversion Other Variables
Heating rate Anti-solvent type Rate of 
evaporation
Solvent type Mixing rate




















Tablet. 1 Different variables used in polymorph screening
In recent years considerable effort has been put into developing high- 
throughput, automated approaches to both salt and polymorph screening. The main 
aim is to develop methods that are capable of producing and identifying large 
numbers of samples in a relatively short period of time. Even after these exhaustive
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tests, a new polymorph may remain undetected for many years, or a sample of a new 
polymorph may be obtained once but never again, the phenomenon of so-called 
“disappearing polymorphs”. Dunitz and Bernstein have described several examples 
where this reproducibility has been shown to be very difficult to achieve and quoted 
examples where apparent loss of control of the crystallisation procedure results in an 
inability to obtain the desired form even though this form had previously been 
routinely obtained over long periods of time [18]. The example of benzocaine picrate 
was one where the original polymorph could be found again, but at a cost of cleaning 
the entire laboratory and waiting 8-12 days. Another example of the displacement of 
a metastable polymorph by a stable polymorph is xylitol, which showed the loss or 
disappearance of a metastable polymorph once the stable form was obtained. This 
metastable form has never been obtained again, in spite of exhaustive crystallisation 
attempts over the years.
Polymorphism remains one of the major challenges for both the 
pharmaceutical and academic sectors. The development of complementary methods 
for efficient polymorph and solvate formation, and more importantly the 
understanding of factors that result in different packing arrangements of organic 
molecule in the solid state would therefore be highly desirable. Within the 
pharmaceutical industry better control of polymorphism could ultimately improve the 
preparation and control of dosage form.
1.1.5. Crystal structure prediction
The prediction of crystal structures from nothing more than connectivity of 
atoms within a molecule has greatly improved in recent years. To date, several 
groups active in this field have performed four separate blind tests in the years 1999, 
2001, 2005 and 2009 [19-22], The aim of these blind tests was to evaluate how well 
currently available methods of crystal structure prediction perform when given only 
the molecular formula for an organic compound. The most recent fourth blind test 
has shown important improvements in the modelling methods and suggests that, at 
least for small rigid molecules [22], such calculations can be successfully applied to
11
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understand crystallisation and polymorphism of organic molecules. Calculations 
usually locate many more potential structures than are likely to be observed within a 
reasonable energy range and the energy differences between structures are typically 
in the order of 0.1-1 kJ mol"1. It is highly likely that some of the previously 
unobserved structures from these studies should be accessible through changes in 
growth conditions e.g. denser structure can be generated by high-pressure conditions. 
Due to the latest advances in methodology, CSP (crystal structure prediction) has 
potentially important applications in polymorph prediction within the pharmaceutical 
industry [23], although there remain significant challenges with the complexity and 
degree of conformational freedom associated with typical pharmaceutical molecules.
1.2. High-pressure research
1.2.1. General concept
The field of high-pressure research has attracted significant scientific interest 
over the last hundred years. P. W. Bridgman was a pioneer in high-pressure research 
and developed an opposed-anvil device for compressing solids up to pressures of 
100,000 atmospheres (ca. 10 GPa) [24], Bridgman made many improvements to his 
high-pressure apparatus over the years, and attempted the synthesis of diamond many 
times. In his volumetric experiments conducted up to 10 GPa, he carried out 
extensive investigations on the properties of matter, including a study of 
compressibility, electrical and thermal conductivity, tensile strength and viscosity of 
more than 100 different compounds [24]. Bridgman received a Nobel Prize in 1946 
for his pioneering work in this field. Since then researchers have continued to study a 
wide range of materials under conditions of high pressure.
In high-pressure research, several units of pressure are often used. The unit of 
gigapascals (GPa) will be employed in this work. The relationship between the three 
most common units are as follows:
9869.2 atm =10 kbar = 1 GPa
12
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Until recently, high-pressure research has mainly been focused within the 
Physics and Geosciences communities, where the use of pressure has been shown to 
be very effective for inducing phase transitions and substantial changes in electrical, 
optical, or magnetic properties in elements, ices, semiconductors, minerals, and 
ceramics. An entire volume of Reviews in Mineralogy & Geochemistry (volume 41) 
is dedicated to high-pressure and high-temperature crystal chemistry [25], The first 
part of this volume comprises numerous excellent reviews on the variation of 
structures with temperature and pressure. Minerals, framework structures, silicate 
structures, hydrous phases and molecular crystals are covered in part II of this 
volume. This volume also includes excellent reviews on experimental and analytical 
techniques for high-pressure crystallography. In the following section high-pressure 
research in molecular organic compounds is reviewed. Reviews on high-pressure 
work in other areas e.g. simple metals, condensed gases, and proteins etc. can also be 
found [25-27],
1.2.2. High-pressure studies of molecular organic compounds
The use of pressure as a variable for studying the structural chemistry of the 
organic solid state is relatively recent. In the last two decades, the number of 
publications dealing with the effects of pressure on molecular compounds has started 
to grow rapidly. This is due to several factors that include progress achieved in the 
design of diamond-anvil cells (e.g. larger apertures of high-pressure cells), the 
procedures used for data collection and reduction, and more reliable measurement of 
the intensities of reflections. Two-dimensional detectors, brighter laboratory sources 
of X-rays, and easier access to synchrotron radiation have also enabled in situ high- 
pressure studies of samples contained in diamond-anvil cell. The study of relatively 
weakly diffracting crystals with low (monoclinic and even triclinic) symmetry is also 
now possible. Some of these technical developments are summarised in reviews by 
Miletich et al. [28] and Katrusiak [29].
High-pressure studies on molecular organic compounds can be broadly 
divided into two main categories; direct compression of the solids, and high-pressure
13
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crystallisation from solution or from liquid. Studies can also be further categorised 
depending on the physical nature of the sample at ambient conditions i.e. gases, 
liquids and solids. High-pressure studies on samples that are gases at ambient 
pressure require more specialised loading and are not reported here.
I.2.2.I. Studies of the effect of pressure on solids immersed in hydrostatic 
liquids (compression studies).
Samples for compression studies are usually loaded as powders or single 
crystals. The evolution of structural changes can then be followed as a function of 
pressure. These studies are of fundamental importance and provide insight into the 
nature of intra- and inter-molecular interactions in molecular solids. Intermolecular 
interactions are strongly distance dependent and so pressure is a very useful tool for 
investigating these interactions. Compression of molecular crystals (to <10 GPa) 
affects the weaker, longer interactions between the constituent molecules (e.g. 
hydrogen bonds, C-H...7t interaction, and van der Waals interactions), but the 
conformations of molecules themselves can also be modified. Since organic 
molecules are usually not spherically symmetric, their orientation in the structure and 
the changes in the angles between the planes and axes of the molecules in the 
structure increase the number of possible variants of pressure-induced structural 
changes [30]. As a result, one can observe either a structural reconstruction (a phase 
transition), or a continuous anisotropic distortion within the limits of stability of the 
same phase.
Effect of hydrostatic pressure on organic crystals (usually in the range 0.1-10 
GPa) has been reviewed in the literature by Hemley & Dera [31] and Boldyreva [32, 
33], It is generally accepted that the effect of increasing pressure is comparable and 
correlated to that of decreasing temperature [27]. However, this is strictly true only 
for isotropic distortion in cubic systems and for crystal systems of lower symmetry 
the distortion is usually anisotropic. Paracetamol is one of the many examples that 
shows that the response can be qualitatively and quantitatively quite different [34],
14
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Systematic studies of the compressibility of various hydrogen bonded organic 
compounds have been described by Katrusiak [35-38], The compressibility of 
hydrogen bonds in these compounds depends on the type of intermolecular motif 
within the crystal structure. For example, the compressibility of the 0H...0 
hydrogen bonds, linking molecules into chains in the structures of 1,3- 
cyclohexanedione (Figure 1.6) is significantly less than for the 0H...0 bonds linking 
the molecules of dimedone (5,5-dimethyl-l,3-cyclopentanedione) into helices [36, 
37], Amino acids represent another class of hydrogen bonded organic compounds 
that have been studies in compression experiments. Comprehensive reviews on the 
effect of pressure on amino acids can be found in literature by Freire [39], Boldyreva 
[32] and Moggach et al. [10]. General phenomena that have been observed on 
compression of these compounds include the collapse of structural voids and changes 
in the conformations of molecules. Analysis of the structures of these compounds 
reveals the directions in which the structure is rigid and the directions in which it is 
more compressible. For structures in which molecules form hydrogen-bonded chains 
or two-dimensional layers, linear strain can be considered in relation to the 
orientation of hydrogen bonded chains and layers [30], For example, most of the 
amino acids are most rigid in the directions of the head-to-tail chains e.g. the 
structures of y-glycine and DL-serine are less compressible along the head-to-tail 
chains of the zwitterions than in the plane normal to these chains [40-42],
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Figure 1.6: Crystal packing diagrams of 1,3-cyclohexanedione viewed along a-axis (left) and 
dimedone viewed along c-axis (right).
From these and other examples it has been possible to make some 
generalisations about the effects of pressure on the structures of these molecular 
compounds. For example, many structures are more compressible in the direction 
normal to the molecular layers. However, there are also some exceptions e.g. a- 
glycine is about 1.2 times more compressible along the direction of the hydrogen 
bonds [41, 43], Other examples which shows this type of behaviour include 
benzoquinone [34] and dimedone [37],
Compression of an organic compound can also induce phase transitions and 
some examples have been recently reviewed by Moggach et al. [10] and Boldyreva 
[32, 44], Many of the pressure-induced polymorphic transitions are isosymmetric and 
the structures of the ambient-pressure and the high-pressure phases are often related, 
especially if the compression is performed on the single crystal. Such 
transformations are often reversible and give metastable forms although on occasions 
metastable forms can be recovered. The kinetic and thermodynamic aspects of these 
transitions are discussed in a recent review by Boldyreva [44]. The occurrence of 
phase transitions can also depend on the starting polymorph. An example is provided 
by glycine. The structure of a-glycine is stable at least up to 23 GPa [45], but /?- 
glycine undergoes a reversible single-crystal-to-single-crystal phase transition at 0.76
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GPa [43], whereas y-glycine transforms irreversibly into ¿-glycine at a pressure of 
ca. 3.5 GPa [41], and then converts into the C-form on decompression down to 0.6 
GPa. The phase transformation can also be sensitive to the choice of the pressure- 
transmitting liquid and an example is provided by a Co(III)-coordination compound 
([Co(NH3)5N02]l2), where no polymorphic transition was observed in fluorinated oil, 
but was observed in a methanol:ethanol:water mixture [46],
I.2.2.2. High-pressure crystallisation
High-pressure crystallisation techniques can further be divided into two 
categories, depending on the physical nature of the sample at ambient conditions.
Crystallisation of liquids at hieh pressure
Crystallisation of liquids by the application of pressure has been known as an 
alternative to crystallisation by cooling since the time of Bridgman [24], Liquid 
samples are generally straightforward to load and crystallisation can be induced by 
the application of pressure. The loading procedure involves placing a small drop of 
liquid on the edge of the gasket hole. The diamond-anvil cell is then rapidly 
assembled and the pressure is applied to induce crystallisation. This results in the 
formation of a polycrystalline solid. A single crystal is then grown by heating the 
sample, thereby reducing the number of crystallites, until a single crystal remains. 
The sample is then allowed to cool and this results in the growth of a single crystal 
that ideally fills the entire gasket hole. This single crystal can be studied by a range 
of techniques including single crystal X-ray diffraction.
Many examples of high-pressure studies of simple organic compounds that 
are liquid at ambient pressure have been published [47-60]. In most of these studies 
pressures in the range of 0.1-10.0 GPa have been used to investigate any structural 
changes. Almost all of the compounds studied have undergone one or more phase 
changes to give high-pressure polymorphs. On occasions, high-pressure forms have 
been found to be the same as the forms produced by crystallisation on cooling. 
Examples include 1,2-dichloromethane [47], carbon disulfide [48], 3-fluorophenol
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and 3-chlorophenol [49], More often, though, the high-pressure and the low- 
temperature polymorphs differ. Benzene [50-52], cyclohexane [53], acetone [54], 
simple alcohols [54-57], acetic acid [54], sulfuric acid [56], water [58], 1,2- 
diaminoethane [59], 2-chlorophenol, 2-fluorophenol and 4-fluorophenol [49] are just 
some examples of compounds that are liquid at ambient conditions and for which the 
high-pressure polymorphs are different from the forms obtained on cooling at 
ambient pressure.
Low-temperature and high-pressure polymorphs may differ in the 
conformations of the molecules as they pack together in the crystal structure. Formic 
acid [60] and propionic acid [61] are examples of monocarboxylic acids where low- 
temperature and high-pressure forms differ in the conformations adopted by 
molecules in their respective crystal structures. On many occasions, the main 
structural differences between high-pressure and low-temperature forms are related 
to the orientation of the molecules with respect to each other e.g. in acetic acid the 
hydrogen bonded molecular chains found in the high-pressure polymorph [54] at 0.2 
GPa are identical to those of the low-temperature phase [62], but the relative 
orientations of the chains are noticeable different.
Sometimes it is found that the low-temperature structure is disordered, but the 
high-pressure form is completely ordered e.g. 1, 3-cyclohexanedione (CHD) [36]. 
When subjected to pressure of ca. 0.1 GPa a crystal of CHD was observed to 
undergo a structural transformation which significantly changed the arrangement of 
the molecules and resulted in ordering of the methylene groups, but maintained the 
space group (P2\/c).
Compression without temperature variation can give forms different from 
those obtained by the combination of compression and temperature cycling [44], 
Katrusiak et al. have applied this technique to obtain high-pressure polymorphs for 
many halogenated compounds e.g. dichloromethane and dibromomethane [63].
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Crystallisation of solids at high pressure
It is clear from the above examples that that pressure-induced crystallisation 
of liquids is a very powerful method for accessing new polymorphs of these 
compounds. Solid samples with low melting points (typically < 323 K) can be gently 
heated until molten and then loaded into the DAC using the same procedure 
described in the previous section. For samples that crystallise rapidly, gentle heating 
of the cell components is required to ensure that the sample remains liquid. It is 
important to ensure that the crystallisation is achieved by the application of pressure 
rather than cooling at ambient pressure.
However, when we deal with larger organic molecules such as 
pharmaceuticals that typically have melting points significantly higher than ambient 
temperature, crystallisation from the melt is less applicable. The problem is made 
more difficult by the substantial increase in melting point induced in most substances 
by the application of pressure. Generally, chemical decomposition or some 
undesirable chemical reaction takes place before the pressure-elevated melting point 
is reached. Furthermore, there is often a substantial kinetic barrier to be overcome 
before the molecules can rearrange. A way to tackle these problems is by growing 
single crystals or polycrystalline powder from solution at high pressure. This 
removes the need for excessively high temperatures, and overcomes the barrier to 
molecular rearrangement in the solid, as the lattice energy is now overcome by the 
solvation energy. In this method, a diamond-anvil cell is first loaded with a solution 
of the compound and then is pressurised. This usually causes a decrease in the 
solubility of the compound and results in precipitation of the polycrystalline material, 
often as a high-pressure form. This powder can then be studied in situ by 
spectroscopic methods and by powder X-ray diffraction. Alternatively, by carefully 
cycling the temperature of the sample it is often possible to dissolve all but one of the 
crystallites, which on subsequent cooling grows to a large single crystal suitable for 




Crystallisation from solution at high pressure has been known for a long time 
and has been widely applied in hydrothermal growth of inorganic materials such as 
quartz [64], but its systematic application for organic compounds started only 
recently at the University of Edinburgh [65]. This technique is increasingly being 
used to explore polymorphism in molecular crystals at high pressure. Examples 
include a new polymorph of phenanthrene crystallised from dichloromethane 
solution at 0.35 GPa [66], a new polymorph of pyrene (form III) crystallised from 
dichloromethane solution at 0.3 and 0.7 GPa [67], and a new polymorph of 
acetamide crystallised from water at 0.8 GPa [68].
The high-pressure crystallisation technique also provides an opportunity to 
study crystallisation from different solvent systems. This has important implications 
for polymorph screening of pharmaceuticals where a range of solvents is used to 
discover new polymorphs. Furthermore, this technique also provides an opportunity 
for the formation of new solvates of these compounds. Paracetamol gives an example 
where high-pressure recrystallisation from solution has resulted in the formation of a 
new hydrate and a solvate. High-pressure recrystallisation of paracetamol from water 
at 1.1 GPa and methanol at 0.6 GPa gives a dihydrate and a 1:1 methanol solvate, 
respectively [69].
This technique has also been employed recently for high-pressure co­
crystallisation of solid compounds [70], Crystallisation of paracetamol and 
piperazine from ethanol at a pressure of 0.57 GPa produced an ethanol solvate of a 
2:1 co-crystal of paracetamokpiperazine. This contrasts with crystallisation from 
ethanol at ambient pressure for which only an unsolvated 2:1 co-crystal of 
paracetamokpiperazine has been obtained.
1.2.3. High-pressure studies of pharmaceuticals
One of the areas that has until recently been unexplored is the use of high 
pressure to study polymorphism in more complex organic compounds e.g. 
pharmaceuticals. The effect of pressure on the solid-state properties of
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pharmaceuticals is currently of great interest and there are many reasons for this. 
Firstly, many solid drugs are subjected to pressure during processing, e.g. milling (or 
mechanical grinding) and tabletting. Milling is used to reduce particle size and to 
ensure homogeneity of the formulation. Under these conditions the material can 
experience significant localised compression and shear stress, in addition to localised 
heating. Milling results not only in an increase in surface area, but can also lead to 
the formation of various defects in the crystals and this can lead ultimately to the 
disappearance of long range order and crystallinity, i.e. the material becomes 
amorphous. Examples include cephalexine, cephalotine, and clonidine [71]. 
Furthermore, milling and grinding can also induce phase transitions to different 
polymorphic forms. Phenylbutazone, sulfathiazole, caffeine, cimetidine represent a 
few of the many such examples that have been reported [72-74],
Tabletting is another process that involves the direct compression of the 
pharmaceutical substance with other excipients (e.g. starch, lactose, magnesium 
stearate). Tabletting generally produce pressures in the range 40-200 MPa (0.02-02 
GPa) and these are applied for relatively short times (typically <1 second). Some 
pharmaceutical substances have been shown to undergo changes in phase 
composition under these compression conditions. Some examples include 
indomethacin, carbamazepine dihydrate and chlorpropamide [71, 73], A study by 
Chan and Doelker showed that out of 32 selected pharmaceutical substances known 
to be polymorphic, 11 were transformed either completely or partially into other 
polymorphs during tabletting [75].
Recent advances in the field of high pressure have enabled high-pressure 
studies of pharmaceuticals. The high-pressure crystallisation technique is proving to 
be especially effective at producing new polymorphs and solvates of these 
compounds. High-pressure studies performed on some of the pharmaceuticals are 
summarised below.
Paracetamol: Paracetamol (acetaminophen) is one of the examples of a 
pharmaceutical which has been studied by high-pressure techniques. Its molecular
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structure is shown in Figure 1.7. It is a widely used analgesic and has been 
extensively studied using a range of techniques. Under ambient conditions the 
monoclinic form I is thermodynamically stable and a metastable orthorhombic form 
II has been prepared. An elusive third form (form III) has also been observed [76, 
77], and its crystal structure has recently been solved from X-ray powder diffraction 
data [78], In forms I and II, molecular packing in crystal structure is dominated by 
the formation of N-H...OH and 0-H...0=C hydrogen bonds that give rise to a layered 
2-D networks. In form I, the hydrogen-bonded layers are arranged parallel to the 
(010) planes: these give rise to polar layers, where all the molecules have the methyl 
group on the same side (Figure 1.8). In form II, methyl groups lie on the left- and 
right-hand sides of the molecules to form non-polar layers (Figure 1.8). Despite these 
structural differences, compression studies performed on forms I and II have shown 
that both polymorphs have very similar bulk compressibilities (i.e. the relative 
volume decrease as a function of pressure) leading to a ca. 20% decrease in volume 
from ambient pressure to 4.0 GPa [79]. Boldyreva et al. also demonstrated that the 
application of pressures in excess of 4 GPa to powdered samples of paracetamol 
resulted in conversion of form I into form II, but for kinetic reasons the conversion 
was incomplete and poorly reproducible. No conversion was observed in a single 
crystal. Such a transition would require reorientation of every other chain in a layer 
and hence the breaking/reforming of many intermolecular hydrogen bonds, leading 
to a high activation energy. The application of pressure alone was not sufficient to 
induce a phase transition to form II. As described earlier, recrystallisation from 
solution at high pressure is an alternative to overcome this problem. Direct 




Figure 1.7: Molecular structure of paracetamol.
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Figure 1.8: Hydrogen-bonded layers in (left) monoclinic paracetamol (form I) viewed along the ¿-axis 
and (right) orthorhombic paracetamol (form II) viewed along the c-axis.
Chloryroy amide: Chlorpropamide is a member of the sulfonylurea group of 
compounds, and is widely used as an oral antidiabetic agent [80]. Its molecular 
structure is shown in Figure 1.9. Seven polymorphs and a benzene solvate have been 
described in the literature [81], Form-A is known to be the thermodynamically stable 
form and is the commercially available one. Chlorpropamide can be considered as a 
model compound to study polymorphic transformations on tabletting [82], On 
tabletting, form-A has been reported to transform partially into another polymorph, 
form-C. Otsuka et al. have shown that when chlorpropamide is compacted at ca. 200 
MPa (0.2 GPa), form-A transformed to form-C [83]. Form-C is also known to be 
formed from form-A on heating up to ca. 115 °C [84], Wildfong et al. have 
described a method for quantitative determination of polymorphic composition of 
chlorpropamide in intact compacts by parallel-beam X-ray powder diffractometry
[85], They demonstrated that the minimum pressure for “A-to-C” is ca. 10.5 MPa 
(0.01 GPa). In a study by Boldyreva et al. the effect of hydrostatic pressure on form- 
A by Raman spectroscopy in a diamond anvil cell has been studied [86], In this 
study, no “A-to-C” transformation with increasing pressure was observed, but two 
other polymorphic transformations were claimed to occur at ca. 0.9 and 2.0 GPa. 
Since they used ethanol, as a pressure-transmitting medium in these experiments, the 
role of ethanol in these transformations could not excluded. Compression studies 
performed on powder samples of chlorpropamide have shown that in the absence of a 
pressure-transmitting liquid, no “A-to-C” polymorphic transformation was observed
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[86]. Therefore, the polymorphic transformation of form-A to form-C, which was 
reported during tabletting, is probably due to local heating effects. However, the 
pressure-induced phase transitions of form-A at 0.9 and 2.0 GPa may be solvent 
mediated. This was confirmed by high-pressure X-ray diffraction studies performed 
on samples of chlorpropamide compressed in the saturated ethanol solution [87].
O O
S NH C NH CH2 Et
O
Figure 1.9: Molecular structure of Chlorpropamide.
The example of chlorpropamide shows that the choice of pressure- 
transmitting medium may have an effect on the polymorphic transformations during 
compression. Indomethacin, a non-steroidal anti-inflammatory drug, gives another 
example where no phase transitions were observed on compressing dry intact 
powder, but occurred when an ethanol slurry was compressed [88].
Piracetam: Piracetam, a nootropic agent used to treat disorders of nervous system, is 
another drug that has been studied using high-pressure techniques [89, 90], High- 
pressure recrystallisation of aqueous and methanolic solutions of piracetam at 
pressures of 0.07-0.4 GPa resulted in the formation of a new high-pressure 
polymorph, form IV. Compression of form II resulted in a reversible, single to single 
crystal transition to a new polymorph, form V, between pressures of 0.45-0.7 GPa. 
Crystallisation from aqueous solution at pressure of 0.6 GPa resulted in the formation 
of a previously unreported dihydrate.
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1.3. General aims and outline of research
The aims of this work are as follows:
• To explore the extent to which high pressure can affect the polymorphic 
behaviour of different compounds with a particular emphasis on 
pharmaceutical compounds.
• To develop a high-pressure methodology for in situ crystallisation of 
pharmaceutical compounds.
• To identify high-pressure forms that are sufficiently metastable that they can 
be recovered to ambient pressure.
• To develop methodologies for polymorph/solvate screening at high pressure.
The principles of high-pressure techniques employed in this PhD and 
experimental procedures for sample preparation and structural characterisation are 
illustrated in Chapter 2. Chapter 3 describes the high-pressure studies of a non­
steroidal anti-inflammatory agent, mefenamic acid. The structure of new high- 
pressure polymorphs of N,N'-dimethylurea are presented in Chapter 4 alongside 
crystal structure prediction results. High-pressure and ambient-pressure studies of 
GSK developmental compound (Compound A) are described in Chapter 5. Chapter 6 
describes high-pressure studies performed on a second GSK compound (compound 
B). Conclusions and future directions are described in Chapter 7.
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Chapter 2: Experimental Techniques
2.1. The Merrill-Bassett diamond-anvil cell
The development of high-pressure apparatus continues to be a very active 
area of research. From the pioneering work by Bridgman until the 1960s, 
hydraulically driven anvils and piston-cylinder devices dominated high-pressure 
science [1], These devices were massive, and required specialised laboratories for 
operation. With the advent of the gasketed diamond-anvil cell in the mid 1960s, 
high-pressure research became less technically demanding and more accessible to 
non-specialised laboratories [2, 3]. The assembly of the gasketed diamond-anvil cell 
(DAC) is illustrated in the Figure 2.1.
Figure 2.1: Assembly of the gasketed diamond-anvil cell
The basic principle of the DAC is relatively simple. A sample is placed 
between two flat parallel diamond faces and the sample is subjected to conditions of 
high pressure when a force pushes the opposed anvils together. Due to the fact that 
diamond is transparent to a wide range of electromagnetic radiation, DACs have 
been utilised for both X-ray diffraction and spectroscopic studies.
Much of the work undertaken in this thesis was performed using a Merrill- 
Bassett DAC [4], A schematic representation is shown in Figure 2.2.
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Allen screw
Upper plate 
Backing seat with anvil
Tungsten gasket Backing seat with anvil 
Guide pin
Lower plate
Figure 2.2: Cross-section view of Merrill-Bassett diamond-anvil cell [4].
The choice of material, the preparation of the various cell components and 
their functions have been described in detail by Miletich et al. [5]. The DAC is ca. 5 
cm in diameter and comprises two gem-quality diamonds mounted on two beryllium 
backing discs. The backing discs are not only used to support the diamonds but also 
act as X-ray windows. These backing plates have confocal holes drilled through them 
to allow optical alignment of the diamonds and act as windows for electromagnetic 
radiation and sample viewing. The backing discs are held in a stainless steel casing 
by small screws to allow alignment of the diamond anvils. With the design of the 
DAC used at The University of Edinburgh the culet can be corrected for lateral but 
not for parallel alignment; parallelism can only be corrected during the mounting of 
the diamonds on the backing plates with glue. Diamond alignment is a crucial step in 
the cell preparation and misalignment is the most common reason for diamond 
failure. Type I diamonds were used for most of the experiments presented in this 
thesis, with the exception of experiments which involved Raman spectroscopic 
measurements, for which type II diamonds (low fluorescence) were used. The culet 
size of the diamonds that are used in the DAC play a big part in determining the 
pressure which can be reached. The diamond culets used in this work varied between 
400 and 600 pm.
Beryllium is a material often used for the backing plates. Due to its low 
atomic number, Be has a small absorption coefficient for X-rays (k < 0.7 A).
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B e ry llium  also has a high tensile strength and so can be used to reach pressures in 
excess o f 20 GPa. A lthough Be is transparent to X -rays, it is polycrysta lline and 
produces a powder pattern that contaminates the d iffraction pattern. Furthermore, Be 
is toxic, and so its handling requires care. C on ica lly  ground tungsten carbide (W C) 
backing discs can overcome this problem; however they provide little  support for the 
diamonds o f the type usually used in M errill-Basse tt cells. Boeh le r-A lm ax cut 
diamonds have recently become available [6], and these can be embedded in the W C  
backing plates, retain ing the typical 80° opening angle and provid ing support for the 
diamonds. F igure 2.3 shows two D A C  types w ith their backing disc design. D A C  
w ith W C  backing discs were also used in some experiments described in this thesis.
Diamond— ►
Be backing disc
Opening angle = 40°
Tungsten carbide backing disc
Figure 2.3: Backing seat and anvil design for {top) a beryllium backing seat with a modified brilliant- 
cut diamond anvil, (bottom) a WC backing seat with a conical Boehler-Almax diamond anvil.
The sample chamber was created by d r illin g  a hole o f 250 pm or 300 pm 
diameter through a pre-indented 250 pm th ick tungsten gasket by spark erosion. 
Th is gasket was then placed in between the two diamonds by align ing the hole w ith 
the d iam ond’ s thrust axis. Pressure is then applied by tightening the three A llen  
screws attached to the steel casing. A s  the diamonds are pushed together, the gasket
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extrudes outwards around the culets, sealing the sample chamber. In this 
arrangement, very high pressures can easily  be reached because the force is applied 
to a very sm all area. The pressure lim it o f the ce lls used in Edinburgh is about 12 
GPa, but can be substantially increased by reducing the size o f the gasket hole and 
the diamond culets. Th is  pressure range is modest compared to the pressure routinely 
employed in other areas o f research (e.g. pressure in the 100 G Pa range for study o f 
planetary interiors), but more than suffic ient fo r the high-pressure experiments 
presented in this thesis. In the case o f high-pressure crysta llisation experiments from 
solution, 12 G Pa  is w e ll in excess o f the w orking range, w h ich rarely exceeds 2 GPa.
2.2. Sample loading
2.2.1. Direct compression experiments
The compression studies reported in this thesis were conducted using 
materials as either a single crystal or po lycrysta lline  powder. Fo r both types o f 
experiment, the sample was loaded into the tungsten gasket chamber along w ith a 
ruby chip. Pressure was then applied gradually by tightening the screws o f the D A C .
M ost studies performed in this w ork have been performed under hydrostatic 
conditions. Fo r this reason samples under study were loaded into a D A C  together 
w ith  a hydrostatic medium  [7], The use o f a flu id  as a pressure-transmitting medium 
generally fu lf ils  this cond ition provided the flu id  does not so lid ify  in the pressure 
range under study. However, the selection o f an appropriate pressure-transmitting 
medium is crucia l, as non-hydrostatic media can cause several problems e.g. 
sign ificant broadening and shifts in d iffraction peaks may be observed. Such 
conditions can also promote or suppress phase transitions, and may also lead to 
crushing and amorphisation o f the sample. In addition, they can m odify the relative 
change o f ce ll parameters w ith pressure and can cause problems in determ ining 
pressure using ruby fluorescence on account o f broadening o f the R i line (Section 
2.3).
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In much o f the w ork presented in  this thesis, a 4:1 m ixture o f methanol: 
ethanol by volume was used. Th is has been shown to be hydrostatic up to pressures 
o f 10 G Pa  [7, 8]. However, a disadvantage o f th is m ixture is  that some samples may 
d isso lve in these alcohols. Fo r these compounds an alternative pressure-transmitting 
medium  is F luorinert-FC77, w h ich is a fluorinated hydrocarbon and has shown to be 
hydrostatic up to 1.2 G Pa  [9].
2.2.2. Pressure induced crystallisation
The technique o f pressure-induced crysta llisation from  the pure liqu id  or 
from  the melt for the generation o f new polymorphs was b rie fly  discussed in the 
introductory chapter. These techniques are particu larly  effective when the 
compounds under study have normal melting points that lie  below or close to room 
temperature. However, fo r more com plex compounds e.g. pharmaceuticals that have 
higher melting points, these techniques have been less successful. Th is is because 
thermal decomposition o f  such compounds usually occurs long before the pressure- 
elevated m elting temperature is reached. Furthermore, there is often a substantial 
k inetic barrier to be overcome before the molecules can rearrange.
To  overcome these problems a technique that invo lves recrystallisation from 
solution at high-pressure has been employed. Th is technique not on ly removes the 
need fo r excessive h igh temperatures to overcome the k inetic barrier to molecular 
rearrangement and also provides an opportunity to study high-pressure crystallisation 
from  different solvent systems. Th is has important im plications for polymorph 
screening o f pharmaceuticals where a range o f solvents is used to discover new 
polymorphs. P rev iously  at Edinburgh this technique has been successfully used to 
produce new polymorphs and solvates o f pharmaceutical compounds [10-12], A  
schematic procedure for the technique is summarised in F igure 2.4.
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2. Apply pressure to induce 
precipitation of polycrystalline 
material
3. Cycle the temperature to 
dissolve the polycrystalline 




Tungster1. Loading of 





Diamond Anvil cell chip 200 pm
Figure 2.4: Schematic procedure for high-pressure recrystallisation
C e ll loading and crystal growth are performed under an optical microscope. 
The procedure consists o f the fo llow ing: a small drop o f the solution w ith solvent o f 
cho ice was placed on the edge o f the gasket hole. The ce ll was then rapidly 
assembled and then pressurised by tightening the screws. Th is norm ally caused a 
decrease in the so lub ility  o f the compound, and usually resulted in the precipitation 
o f a po lycrysta lline material; this corresponds to the crysta llisation step. This powder 
cou ld  then be studied by X -ray  powder d iffraction and/or spectroscopic methods. For 
the single crystal studies, the single crystal was grown by heating the ce ll w ith a hot- 
air gun, thereby reducing the number o f crystallites, until a single crystal remains. A  
large single crystal cou ld then be grown from  this seed as the system was cooled, 
w hich idea lly  fille d  as much o f the gasket hole as possible. Detailed descriptions o f 
ind iv idua l recrystallisations are given in the particular chapter.
Several variables can be controlled prior to and during a high-pressure 
crysta llisation experiment and these are discussed in more detailed in the fo llow ing 
sections.
36
Chapter 2: Experimental Techniques
2.2.2.1. Choice of solvent
The choice o f solvent can be crucia l for high-pressure crystallisation. The 
solvent is chosen so that the compound o f interest has reasonable so lubility. 
S o lu b ility  not on ly  affects the pressure at which crysta llisation can be achieved, but 
also ensures that the resulting crystal is o f reasonable size for single crystal X -ray  
diffraction.
A n  important feature to be considered is the pressure at which the solvent 
crysta llises. Ideally it should crysta llise at reasonably high pressures > 0.5 GPa. This 
ensures a good w ork ing range fo r the high-pressure recrystallisation o f the solute. 
The solvents that were used in the experiments described in this thesis were 
methanol, ethanol, isopropyl a lcohol and methanol:ethanol m ixture (4:1).
Another requirement for the choice o f solvent is that it should not react w ith 
the solute under high-pressure conditions when the temperature is increased during 
heating. The poss ib ility  o f  a high-pressure reaction is an active area o f high-pressure 
research, but has not been explored in this w ork [13].
Another important consideration is the v iscosity  o f the solvent. It has been 
prev iously  reported by Jenner [13] that v iscosity is greatly affected by pressure; 
norm ally  it increases w ith increasing pressure. Th is may hinder the crystallisation 
process by preventing nucleation. One way o f dealing w ith this problem is by 
decreasing the pressure w ith in  the D A C  and this can sometimes induce 
crysta llisation. A lternative ly, in  the case o f a solvent w ith a low  freezing pressure, 
crysta llisation (freezing) o f the solvent w ith pressure can sometimes create 
nucleation points, thus resulting in  precip itation o f the solute.
2.2.2.2. Concentration
A  second important factor to be considered is the concentration o f the solute 
in the solvent system. Concentration plays a role in determ ining the size o f crystal 
that can be grown in D A C . Secondly, concentration may influence whether an
37
Chapter 2: Experimental Techniques
unsolvated or a solvated species is  crystallised. There are some examples in  the 
literature where concentration has played a part in this respect [14]. Concentration 
also affects the pressure at which precip itation occurs; the higher the concentration, 
the lower the pressure, provided so lub ility  decreases w ith increasing pressure. For 
this reason, in some experiments presented in  this thesis, the D A C  was loaded w ith 
the so lution o f the compound o f interest together w ith a few crystallites o f the 
compound. The pressure was then increased on ly  very s ligh tly  to form  a sealed 
system and the ce ll was then gently heated to disso lve a ll o f the crystallites. Th is is a 
cruc ia l step as a ll the seeds o f an ambient-pressure polymorph should be dissolved to 
avo id crysta llisation o f this polym orph at high pressure. The pressure inside the ce ll 
was then increased w hile the ce ll was s t ill warm; the ce ll was then allowed to cool to 
observe precip itation. The main advantage o f this procedure is that on coo ling a large 
single crysta l can often be recovered at ambient pressure.
2.3. Pressure measurement
The pressure w ith in the ce ll is usually measured using d iffraction or 
fluorescence [15]. The ruby fluorescence (C r3+ doped a -A LC E ) method was 
introduced in  1972 as a new way for ca librating the pressure in the D A C  [16]. Prior 
to this, pressure was determined by internal pressure markers such as sodium 
ch loride or s ilve r where the known equation o f state is applied to convert measured 
un it-ce ll volumes to pressure. Ruby fluorescence is characterised by an intense 
doublet, w ith a sharp band at approximately 694 nm [17]. Under compression the 
doublet shifts to higher wavelength, and this fluorescence shift has been calibrated up 
to 20 GPa.
A  sm all ch ip o f ruby was placed in the tungsten gasket together w ith the 
sample and a pressure-transmitting medium. Ruby fluorescence in this work was 
induced using the 632.8 nm line from  a He-Ne laser, and was dispersed and detected 
by a Job in -Yvon  Lab Ram  300 spectrometer w ith a typ ical precision in the 
measurements o f ± 0.05 GPa.
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2.4. R a m a n  spectroscopy
Raman spectroscopy has been less w ide ly  used than infrared spectroscopy 
(IR), but recent advances in instrument technologies have sim p lified  the equipment, 
and so Raman spectroscopy is now re lative ly straightforward and idea lly  suited for 
high-pressure studies using D A C s .
Raman spectroscopy invo lves sh ining an intense light source, e.g. a laser 
beam, on a sample and detecting the scattered light. When a beam o f monochromatic 
light interacts w ith the sample, photons can be absorbed or scattered by the material. 
The vast m ajority o f  the scattered photons have exactly the same wavelength as the 
incident photons and this is known as Ray le igh scattering. However a tiny proportion 
about (1 in 107) o f the scattered radiation is shifted to a different wavelength. This 
scattering is known as Raman scattering. The scattering o f the light is demonstrated 
in F igure 2.5.
Figure 2.5: Light scattered from a molecule has several components - the Rayleigh scattering (red) and 
the Stokes and anti-Stokes Raman scattering (green).
M ost o f the Raman scattered photons are shifted to a longer wavelength 
(Stokes shift), but a small proportion is shifted to shorter wavelengths (anti-Stokes 
shifts) [18]. A  s im p lif ied  energy diagram that illustrates this concept is given in 
F igure 2.6.
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Figure 2.6: Energy level diagram for Raman scattering; (a) Stokes Raman scattering (b) Anti-Stokes 
Raman scattering.
A  Raman spectrum is a plot o f the intensity o f Raman scattering as a function 
o f its frequency difference from  the incident radiation (usually in units o f wave 
numbers, cm '1). Th is difference is ca lled Raman shift and is independent o f the 
frequency o f the incident radiation. A lthough Infrared and Raman spectroscopy both 
measure the v ibrational energies o f the molecule, each method relies on different 
selection rules. Fo r a transition to be Raman active there must be change in 
po larisab ility. Th is  is best pictured as the ease w ith w hich the electron c loud is 
distorted i.e. polarised.
Raman spectroscopy is a very useful technique fo r detecting phase transitions 
in the crysta lline  state because the active vibrational modes o f molecules are 
dependent not on ly  on m olecular symmetry but also on site symmetry in the crystal. 
In particular, v ibrational bands below 100 cm"1 are sensitive to changes in 
interm olecu lar potential. Raman spectroscopy is very effective ly used in high- 
pressure studies; the appearance o f new bands and shifts in wavenumber w ith 
increasing pressure are p rim arily  due to changes in the environment, so lvation and 
intram olecular interactions. I f  a phase transformation occurs w ith pressure, new 
spectral features characteristic o f the new lattice may appear. Moreover, the position 
o f some o f the bands may change dram atically and a p lot o f wavenumber vs. pressure 
may exh ib it changes in gradient thus indicating a potential phase transition. Raman
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spectra presented in this thesis were collected using a LabRam  instrument equipped 
w ith  a 50 m W  He-Ne laser o f wavelength 632.8 nm. A n  excellent description o f the 
subject is covered in the text by Sm ith and Dent [18].
2.5. X-ray diffraction
2.5.1. High-pressure single crystal diffraction
X -ray  d iffraction is the most w ide ly  used and least ambiguous method for the 
determ ination o f positions o f atoms in molecules and solids. X -ray  d iffraction occurs 
when a beam o f X -rays interacts w ith electrons in a material and is e lastica lly 
scattered. D istance between atoms or ions are typ ica lly  in the order o f few A , which 
is comparable to X -ray  wavelength produce by bombardment o f metal by electrons 
(e.g. M o -K a  radiation, A = 0.71073 A ). In a crystal, regular arrays o f atoms results in 
the interference o f the scattered X -rays. A cco rd ing  to Bragg Equation, n2 = 2Jsin0, 
constructive interference occurs when reflected rays are completely in phase i.e. their 
path difference (2r/sin0) must be a whole number o f wavelengths (n2) where d is the 
separation between the planes and 2 is the wavelength o f the X -rays. Th is gives a 
characteristic pattern o f intensities. F igure 2.7 shows schematic diagram o f X-rays 
scattering from  a crystal lattice.
1‘
C
Figure 2.7: The Bragg construction for diffraction by two planes of atoms
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Intensities are d irectly  proportional to the square o f the amplitude o f the 
scattered radiation, but provide no know ledge about the phase o f the wave, g iv ing 
rise to the so-called phase problem. Th is is the one o f the fundamental challenges in 
X -ray  crysta llography, since both the amplitude and the phase o f the X -rays scattered 
by a crystal are required in order to obtain its molecular structure. The determination 
o f approximate phases can be achieved by the development o f the structural model 
by structure so lution (Patterson, direct methods). Calculated phases can then be 
combined w ith observed intensities. Fourier transformation is then used to create a 
better model (and as such a new set o f calculated phases). M iss ing  atoms can then be 
located by a difference Fourier synthesis. Structure refinement is then performed, 
where the aim  is to create the best agreement between observed and calculated 
amplitudes or intensities, leading to determination o f the crystal structure. A  
comprehensive description o f this subject is given in texts by W . M assa and C. 
G iacovazzo  [19, 20],
2.5.I.I. Synchrotron sources
The sm all size o f the pressure chamber and lim ited opening angle o f the 
D A C , typ ica lly  between 80-90°, gives rise to sign ificant problems in data collection. 
The m axim um  size o f the crystal loaded in  the D A C  is generally no larger than 100 x 
100 x  50 pm. Due to this sm all size, together w ith the absorption from the backing 
disc and diamonds anvils, the intensity o f the measured reflections is reduced, 
especia lly  at higher angles. Furthermore, the sm all opening angle o f the D A C , 
restricts the volum e o f reciprocal space that can be sampled during data collection. 
The completeness o f  data may be as low  as 20% for a tr ic lin ic  crystal system.
o
To overcome these problems, short wavelength X -rays (k < 0.6 A )  at 
synchrotron sources can be used. Synchrotron X -rays are generated by the 
acceleration o f electrons at re lativ istic velocities along circu lar paths o f very large 
radii, w h ich are often hundreds o f metres. These m oving electrons (charged particles) 
under the in fluence o f an accelerating fie ld  em it electromagnetic radiation. This
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radiation, w h ich is em itted tangentially from  the ring, has a continuous spectrum, 
from  which a single wavelength o f any value can be selected by monochromator.
W ith  conventional sources, experiments are lim ited  to specific wavelengths. 
Experim ents conducted using synchrotron radiation do not suffer from  this lim itation 
and for high-pressure experiments short wavelengths are norm ally used. Th is 
increases the completeness o f the data relative to laboratory sources by increasing the 
amount o f reciprocal space sampled, w h ile  the higher flu x  o f X -rays a llows shorter 
data co llection times for sm all samples.
2.5.1.2. Data collection
The m ajority o f experiments presented in this thesis were performed at 
Edinburgh on a B ruker-Non ius A P E X  2 C C D  diffractometer using M o -X q  radiation, 
X = 0.71073 A  at 293(2) K . Some w ork was done at the SR S  Daresbury Laboratory, 
Warrington, U K ,  on Stations 9.8 and 16.2 w ith a Bruker A P E X  2 C C D  
diffractometer at 293(2) K  using synchrotron radiation w ith X -ray  wavelengths o f 
between 0.65 A  and 0.85 A .
Data co llection  was performed according to an established procedure [21]. 
The D A C  was attached to a stainless steel "table" (usually w ith superglue or some 
other adhesive), w h ich has a vertical p in that can fit into the goniometer head. For the 
pressure ce ll to fit onto the goniometer, a short co llim ator was used to give enough 
clearance fo r the ce ll to be rotated w h ilst co llecting data (Figure 2.8).
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Figure 2.8: Experimental setup for collecting single crystal data from samples within a DAC.
2.5.1.3. Data processing
A l l  single-crystal data were processed according to the procedure described 
by Dawson et al. [21] w h ich are summarised here and described further in each 
chapter.
Processing o f high-pressure data from C C D  detector is non-trivial, because 
the images contain not on ly  sample reflections, but also intense diamond reflections 
and powder lines from  the backing seat and gasket material. Figure 2.9 shows a copy 
o f a S M A R T  C C D  frame contaminated by an intense diamond reflection and by 
bery llium  powder rings. The contamination o f the diffraction pattern makes the 
whole process o f indexing, integration and structure solution more challenging 
compared to ambient-pressure studies.
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Beryllium rings —   ► ■
Sarrjple reflection
Figure 2.9: Bruker Smart CCD data frame taken for high-pressure sample contained in a DAC.
A  thresholding algorithm  in the APEX 2 program was used to harvest sample 
reflections [22], In most cases, manual editing o f the data set was required to remove 
spots arising from  the D A C  (Figure 2.10) and was performed by using a reciprocal 
lattice v iewer (e.g. B rukerNon ius RLATT). Orientation matrices and unit cell 
parameters were obtained using the same program unless otherwise specified. Data 
integration and g lobal-ce ll refinement were performed using the program SAINT 
[23]. Dynam ic masks were applied during integration to ensure that intensity data 
were not harvested from  the regions o f the detector that are shaded by the body o f the 
D A C  and areas o f intense d iffraction from beryllium . The use o f dynam ic masks 
during the data integration has been shown to improve sign ifican tly  the results from 
such experiments.
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Figure 2.10: Pictures of diffraction spots taken from reciprocal space editor (BrukerNonius RLATT), 
unedited (left) and edited (right)
The quality o f the data can be improved by applying various corrections as 
described by Dawson et al. [21]. A n  analytical absorption correction was performed 
using the program SHADE [24]. Th is rejects reflections that lie  w ith in 2° o f the high- 
pressure ce ll opening angle (40°) and have poorly fitting profiles. In the next step, a 
multi-scan absorption correction was performed using the program SADABS [25], to 
correct for the differences in  path lengths o f X -rays through the crystals, which 
varied as the crystal orientation changed. The data were then merged using the 
program SORTAV [26] in the W in G X  [27] suite o f programs.
The structures reported in this thesis were solved by reciprocal-space 
methods (direct methods: SHELXS [28], Sir92 [29], Sir2002 [30]), as detailed in each 
chapter.
One o f the main problems w ith the high-pressure data is caused by the lim ited 
opening angle o f the D A C , which is generally between 80-90°. Th is restricts the 
volum e o f reciprocal space that can be accessed during data collection. Th is can be 
exacerbated by an unfortunate orientation o f the crystal inside D A C . The low  
resolution o f the data can cause further d ifficu lties. Fortunately they may be 
overcome using direct-space methods which have previously been used for solution
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of structures from powder diffraction data [31]. This particular area has developed 
significantly in the last few years, with the introduction of global optimisation 
methods for structure solution from powder samples. The success of these methods 
results from the fact that the problem of structure solution is reduced to determining 
only molecular position, orientation and internal conformation within the unit cell. 
However, these methods are only successful when the molecular contents of the 
crystal structure are known. Fortunately, for the high-pressure recrystallisation 
studies the main molecular contents are already known. These structure solution 
methods have successfully been used to solve structures from high-pressure single­
crystal data sets collected on a range of small molecule structures [32],
Once a solution has been obtained, structure refinement was performed using 
the program CRYSTALS [33], which will be described in each relevant section. 
Various strategies were used during refinement (e.g. the use of restraints to increase 
the data to parameter ratio).
2.5.2. X - r a y  p o w d e r  diffraction
Single crystal X-ray diffraction remains a benchmark technique. It provides 
direct information about covalent bond lengths, bond angles and molecular 
conformation and intermolecular interactions, such as hydrogen bonds. However, the 
technique requires sufficiently large crystals of good quality. When crystals of a 
suitable size/quality are not available for a single-crystal experiment, then powder 
diffraction can be a useful alternative.
The basic principle of X-ray powder diffraction is the same as single crystal 
X-ray diffraction, except that a small quantity of polycrystalline powder is used in 
the experiment. X-rays of known wavelength are passed through the powder, which 
consists of an essentially infinite number of tiny crystals, and this produces 
concentric rings for each reflection (Figure 2.11), with the radii determined by the 
Bragg equation. The resulting powder-pattern gives a number of sharp peaks of 
intensity versus diffraction angle (29). Each peak corresponds to one or more Bragg
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planes. Identifying the plane(s) associated with each peak and the peaks angular 
position in 2 <9 gives the unit cell. The intensities of the peaks give information on the 
positions of the various atoms in the unit cell, but this is rarely straightforward 
because the intensity for each peak may be due to a number of overlapping Bragg 
reflections. Therefore, it is difficult to assign intensity to each without knowing the 
location of the atoms in the first place. By grinding up the crystalline material into a 
fine powder with randomly oriented grains much of the 3D spatial information from 
the diffraction pattern has been lost. Only the single dimension of the scattering 
angle remains, and this makes the problem of indexing and obtaining any specific 
intensity measurements rather difficult.
Figure 2.11: Schematic diagram of powder diffraction
The main advantage of powder diffraction is that it is far easier to obtain a 
powder of a sample as opposed to a single crystal, as in some cases it is difficult to 
grow a suitable crystal for single crystal X-ray diffraction. In addition, powder X-tay 
diffraction experiments are much quicker to perform than single-crystal X-tay 
diffraction experiments, and the technique is therefore an excellent method for phase 
identification.
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X-ray powder diffraction is also proving a very powerful tool in high- 
pressure crystallography especially in identifying phase transitions caused by 
pressure. However, the sample volume in DAC suitable for X-ray powder diffraction 
studies is very small (<100 pm across). The resulting low signal-to-noise ratio makes 
it very difficult to obtain useful results with monochromatic angle-dispersive 
techniques, and the alternative white beam energy-dispersive techniques have limited 
resolution and generally give unreliable peak intensities. Due to these reasons, all 
high-pressure powder studies are performed exclusively with synchrotron X-ray 
source where the introduction of the image-plate two-dimensional detector allows 
angle-dispersive methods to be used with a greatly increased signal and improved 
powder averaging. The detailed description of the technique is given by Nelmes and 
McMahon [34, 35].
The high-pressure X-ray diffraction experiments described in thesis were 
performed on Station 9.5 HPT (k= 0.44397 A) at the SRS Daresbury Laboratory, 
Warrington, UK and on Beamline 115 (k- 0.444 A) at the Diamond Light Source, 
Oxfordshire. A focusing monochromator using Laue geometry was used to provide 
the monochromatic beam at the desired wavelength [36], This focused beam was 
used to probe the samples contained in a DAC. The scattered radiation was then 
collected on an image-plate area detector (Mar345). Any intense diffraction peaks 
due to diamonds were masked and the remaining two-dimensional pattern was then 
integrated to obtain a one dimensional powder-diffraction pattern with the help of 
FIT2D software for further processing [37]. The experimental set up on Station 9.5 is 
shown in Figure 2.12 and 2.13, with an example of a powder diffraction pattern 
detected on an image plate illustrated in Figure 2.14.
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Figure 2.12: Schematic of Station 9.5.
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Figure 2.13: Experimental arrangement at Station 9.5 HPT.
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Figure 2.14: Powder pattern obtained lfom Station 9.5 HPT using an image-plate.
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2.6. I n t e r p r e t a t i o n  o f  r e s u l t s
Throughout the course of this study, visualisation using graphics programs 
such as MERCURY [38], PLATON [39] and RPLUTO [40] were used to analyse 
results. These are particularly useful to rapidly compare ambient-pressure and high- 
pressure polymorphs, where packing and intermolecular interactions may be 
considerably different for each polymorph.
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C h a p t e r  3  
H i g h - P r e s s u r e  S t u d i e s  o f  M e f e n a m i c  a c i d
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C h a p t e r  3 :  H i g h - P r e s s u r e  S t u d i e s  o f  M e f e n a m i c  a c i d
3.1. B a c k g r o u n d
Mefenamic acid (2-{(2, 3-dimethyl phenyl)-amino} benzoic acid), is a well 
known fenamate derivative showing potent analgesic effect [1] and is marketed as 
Ponstel®. It belongs to the group of medicines called non-steroidal anti­
inflammatory drugs (NSAIDs), which are among the most frequently used medicinal 
drugs. They are utilised primarily as analgesics, anti-inflammatories and antipyretics, 
and their effects have been well studied [2], They work by blocking the action of the 
enzyme cyclo-oxygenase that is involved in the production of prostaglandins in the 
body [3]. Prostaglandins are produced in response to injury or certain diseases and 
cause pain, swelling and inflammation. As mefenamic acid (MA) blocks the 
production of prostaglandins, it is effective in relieving various types of pain and 
inflammation, e.g. for pain related to menstrual disorders. The neuroprotective 
effects and improvement of cognitive impairment in Alzheimer’s disease by the use 
of MA have recently been reported [4-6],
The molecular structure of MA with the numbering scheme used in this work 
is shown in Figure 3.1. It is structurally based on N-phenylanthranilic acid [7, 8], The 
melting point of MA is ca. 231 °C [9, 10].
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Figure 3.1: Mefenamic acid molecule, with numbering scheme used in this work.
MA is known to exist as two polymorphic forms, denoted as forms I and II, 
that are enantiotropically related. These polymorphs show different solubility and 
stability behaviour [11, 12], Form I is the most stable form under ambient conditions, 
but form II is the stable form above 160 °C [13], Gilpin and Zhou described an 
infrared method to study the thermal conversion of MA from form I to II [14], and 
observed that the rate of the conversion was dependent on the temperature. Form II 
rapidly transformed to form I in the presence of a solvent such as methanol and 
ethanol, even when its solubility is low [15]. The thermodynamic relationships 
involving the conversion between the two forms were studied by Anguiar and 
Zelmer [11]. They reported that the metastable form II of MA had a higher solubility 
than form I, but in the dissolution media form II was unstable and was completely 
converted to form I. The limiting step in the dissolution process was therefore 
attributed to the poor solubility of form I.
The crystal structure of form I was reported in 1976 [16], NMR spectroscopy 
[17] and crystallographic and theoretical studies [7] have shown that form I has some 
conformational similarities with related fenamate compounds e.g. flufenamic acid, 
niflumic acid and maclofenamic acid. Until recently there were two known methods 
to obtain the metastable form II. These are (i) heating of form I above the transition 
temperature and (ii) rapid cooling of a supersaturated solution in N,N-
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dimethylformamide [11,12], However, neither of these methods was able to produce 
single crystals suitable for X-ray analysis. Single crystal of form II were successfully 
obtained recently by a method that involved crystallisation in the presence of the 
structurally similar additive, flufenamic acid [18, 19], This allowed the crystal 
structure of form II to be determined for the first time. In a recent study by Lee et al. 
[20], the phenomenon of polymorphism in MA has been described as concomitant 
polymorphism, whereby the two forms nucleate and grow simultaneously under 
identical conditions. Solvent-mediated conversion back to form I means that form II 
is difficult to obtain.
One of the problems for the delivery of MA to patients is its poor water- 
solubility and absorption characteristics. Significant effort has therefore been made 
to improve the dissolution behaviour in order to enhance the drug’s bioavailability 
[9, 21, 22]. Form II exhibited higher solubility than form I in several solvent systems. 
The dissolution profile of form II showed initial super-saturation with respect to form 
I, but the solubility gradually decreased due to the transformation to form I. The 
dissolution profiles and solubilities of the two forms were examined in solvent 
mixtures of ethanol-water and ethyl acetate-ethanol by Romero et al. [9, 12], Both 
forms showed high dissolution rates in the less polar mixture. Moreover, form II 
showed higher dissolution rates and solubility than form I. Park et al. presented a 
technique for determining the solubility of both stable and metastable polymorphs 
[9]. They used MA as a model compound along with carbamazepine and glycine. 
They showed that it is possible to measure the solubility of metastable forms using a 
DSC technique. Kato et al. [23] investigated the transformation kinetics of MA from 
form II to I in three different solvents under high humidity conditions. They showed 
that form II transformed to form I under all storage conditions and the rate of 
transformation depended on the nature of solvent. The nucleation and growth 
processes were significantly accelerated in ethanol compared with water. 
Furthermore, addition of seed crystals of the stable form I also reduced both 
nucleation and growth processes and resulted in an accelerated phase transition. 
Various strategies have been employed to overcome the problems arising from the 
low solubility of MA. These include production of a MA complex with cyclodextrins
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and alkalonamids [24, 25]. Some complexes of MA with metal ions have also been 
reported [26, 27].
The compression behaviour of the two polymorphs has been studied in 
connection with the mechanical properties of the finished tablets, but very little 
attention has been paid to possible polymorphic transitions of the active ingredient 
under mechanical treatment [28], All polymorph screening has been performed at 
ambient pressure [29]. The aim of the current investigation was therefore to explore 
whether high-pressure methods could be used to obtain the elusive form II, or other 
new forms.
3.2. R e s u l t s  a n d  d i s c u s s i o n
3.2.1. D i r e c t  c o m p r e s s i o n  o f  a  single crystal o f  f o r m  I
High pressures for single-crystal X-ray diffraction studies were generated 
using a Merrill-Bassett diamond anvil cell (DAC) [30] equipped with 600 pm culet 
diamonds and a tungsten gasket. A single crystal of form I obtained from 
recrystallisation of a saturated solution of MA in THF (tetrahydrofuran) and a small 
ruby chip were loaded into the DAC. A methanol-ethanol (4:1) mixture was used as 
the pressure-transmitting medium [31]. The pressure applied to the sample was 
determined by the ruby fluorescence method [32] using a 632.8 nm excitation line 
from a He-Ne laser. The fluorescence was detected by a Jobin-Yvon LabRam 300. 
High-pressure data sets were collected using co-scans in 12 settings of 29 and cp with 
step size 0.3° for 1 second [33], Diffraction data were collected on a Bruker-Nonius 
APEX-II diffractometer with silicon-monochromated synchrotron radiation on 
Station 16.2SMX (h= 0.797 A) at the SRS, Daresbury Laboratories.
The first data-set was collected at ambient pressure. Indexing of the 
reflections confirmed the known triclinic form I of MA. Diffraction data were then 
collected in incremental steps of pressure up to 2.5 GPa. Data indexing from all the 
data sets were performed using the indexing programme CELL_NOW [34]. Lattice
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parameters at pressures up to 2.5 GPa are shown in Table 3.1. On raising the pressure 
to 3.0 GPa the crystal disintegrated.
Pressure ambient 0.18 GPa 0.49 GPa 0.90 GPa 1.67 GPa 2.50 GPa
Crystal
System
Triclinic Triclinic Triclinic Triclinic Triclinic Triclinic
Space
group
P-1 P-1 P-l P-l P-l P-l
a (A) 6.7582(14) 6.775(2) 6.7120(13) 6.6432(3) 6.5642(13) 6.5153(13)
6 (A) 7.3391(15) 7.288(2) 7.2369(14) 7.1516(6) 7.1406(14) 7.0188(14)
c (A) ■ 14.3127(29) 14.303(15) 14.0762(28) 13.7098(8) 13.4047(27) 13.1342(26)
«(°) 76.69(3) 76.72(5) 77.02(3) 77.724(6) 77.888(3) 78.38(26)
PC) 79.83(3) 79.11(5) 79.43(3) 78.962(4) 77.426(3) 77.11(3)
?C) 65.70(3) 65.55(2) 65.72(3) 65.606(6) 63.846(3) 62.82(3)
v (A-’) 626.94(31) 622.1(7) 604.1(31) 575.69(6) 545.78(2) 535.0(17)
z 2 2 2 2 2 2
T (K) 293(2) 293(2) 293(2) 293(2) 293(2) 293(2)
Table 3.1: Lattice parameters for form I with increasing pressure up to 2.50 GPa.
All data sets up to 2.50 GPa were processed according to the procedure 
described in chapter 2. As a result of the limitations caused by shading from the steel 
body of the diamond-anvil cell, high-pressure data-sets are frequently incomplete 
compared with data-sets recorded at ambient pressure. These factors combined to 
make structural refinement particularly challenging and in this case resulted in poor 
structural refinement with high /̂-factors. Therefore, only lattice parameters are 
reported here. Figure 3.2 shows the variation of unit cell volume with increasing 
pressure. There was a ca. 14 % decrease in the unit cell volume over the studied 
pressure range. Within the limits of experimental errors, the volume decreases 
smoothly over this pressure range, indicating that there is no phase transition 
associated with direct compression of the single crystal.
58
Chapter 3: High-Pressure Studies of Mefenamic acid
P ressu re  (G P a )
Figure 3.2: variation of unit cell volume of form I with pressure.
The observation that at 3.0 GPa the crystal disintegrated to give a 
polycrystalline powder, suggests reconstructive phase transition at this pressure. 
These observations prompted a study by recrystallisation from solution at high 
pressure.
3.2.2. Crystallisation f r o m  solution at h i g h  p r e s s u r e
A ca. 1M solution of mefenamic acid was prepared in ethanol. The solution 
was then loaded along with a few crystallites of form I at 293(2) K into a DAC. A 
small piece of ruby was also added in order to allow the determination of the 
pressure by laser fluorescence spectroscopy [32], The pressure was increased to a 
minimum in order to form a sealed system and the cell was then gently heated to 
dissolve all of the solid material. Pressure was then applied by tightening the screws 
of the DAC to induce precipitation. Crystallisation was achieved at ca. 0.6 GPa. The 
pressure was then reduced to 0.3 GPa in order to facilitate growth of a single crystal. 
The temperature was then cycled near 353 K in order to dissolve all but one of the 
crystallites. On slow cooling to 298 K a single crystal grew. Diffraction data were 
then collected on a Bruker APEX II CCD diffractometer by using co-scans in 12 
settings of 28 and cp with step size 0.3° for 30 s. Data indexing was performed using 
the indexing programme CELL_NOW [34], This gave a triclinic unit cell with lattice
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parameters shown in Table 3.2. These lattice parameters were consistent with those 
of form II [18].
High-pressure
crystallisation
MA (form II) 
(from ref 18)
Crystal System Triclinic Triclinic
Space group P-1 P-l
a (A) 7.7900(15) 7.6969
b (A) 9.1890(18) 9.1234
c( A) 9.4120(19) 9.4535
a(°) 106.751(10) 107.113
PC) 92.287(12) 91.791





Table 3.2: Lattice parameters for form II of MA.
Data processing was performed according to the procedure described by 
Dawson et al. (2004) [35] and detailed in chapter 2. Integration of data sets and 
global cell refinement were carried out using the program SAINT [36], in which 
‘dynamic masks’ were used in order to prevent integration of areas of the detector 
shaded by the body of the DAC. An analytical correction for the absorption by the 
DAC component was then applied using SHADE [37] and an absorption correction 
for the crystal was applied using SADABS [38]. Known coordinates were taken from 
the literature [16]. Refinement was then performed using CRYSTALS [39]. All non­
hydrogen atoms were refined isotropically and hydrogen atoms were placed in 
calculated positions. A completeness of only ca. 40 % was obtained for this dataset 
and this led to a rather high R-factor of 9.5 %. Nevertheless, this was sufficient to 
identify the main structural features of form II and make a comparison between the 
polymorphs. Full structural refinements details are shown in Appendix A. 
Crystallographic data in CIF format are available on the attached CD.
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3.2.2.1. Decompression studies
On progressive decompression from 0.3 GPa at 293 K to ambient pressure, 
no colour change or destruction of the crystal was observed. This tiny crystal was 
then removed from gasket, placed on the goniometer and was successfully indexed as 
form II. However, owing to poor quality and the damage done during unloading from 
the gasket it was not possible to obtain sufficiently good data for full structure 
refinements. The crystal was also used as a seed in order to attempt the growth of 
single crystals of form II at ambient pressure, but this resulted in the production of 
form I instead. This suggests that presence of form I seeds in solution may dominate 
the crystallisation process.
In order to demonstrate reproducibility, repeated crystallisation at high 
pressure always resulted in form H These results are of great significance as they 
demonstrate that form II can be prepared reproducibly at high pressure and recovered 
successfully to ambient pressure. Furthermore, unlike in the study by Lee et al., [18] 
no additives were required. This may suggest that the form II is the more 
thermodynamically stable form at high pressure, mirroring the behaviour of 
paracetamol [40],
3.2.3. C o m p a r i s o n  of the crystal structures o f  f o r m s  I a n d  II
Crystallographic data for forms I and II are summarised in Table 4.3. The 
structures of forms I and II have been previously described by McConnell et al., [16] 
and Lee et al., [18] respectively .
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parameter MA II (high-pressure 
crystallisation)3




Chemical formula c15hi5no2 c15hi5no2 c15hI5no2
Formula weight 241.29 241.29 241.29
Crystal system PA PA PA
Space group Triclinic Triclinic Triclinic
a (A) 7.7900(15) 7.6969 14.556
b( A) 9.1890(18) 9.1234 6.811
c (A) 9.4120(19) 9.4535 7.657
«0 106.751(10) 107.113 119.57
no 92.287(12) 91.791 103.93
vO 101.377(11) 101.481 91.30v (AJ) 629.1(2) 618.89 631.766
z 2 2 2
T (K) 298(2) 150 298
R( F0) 0.095 0.052 0.045
Rw (Ft) 0.095 0.134
Programme used CRYSTALS SHELXTL MULTAN
a this study E. H. Lee et al. [18]c McConnell et al. [16]
Table 3.3: Comparison of cell parameters for forms I and II.
The molecular structure of MA with numbering scheme used in this work is 
shown in Figure 3.3. The conformation of the molecule in the crystal structure can be 
described by three torsional angles (see Figure 3.3): 6\ (01-C7-C6-C1) i.e. twisting 
of the carboxylic group with respect to C6-C7 axis; 62 (C1-N1-C8-C13) i.e. twisting 
of the second phenyl group with respect to the N1-C8 axis; and #3 (C6-C1-N1-C8)
i.e. twisting of bridging group relative to the C1-N2 axis. These torsional angles are 
shown by arrows in Figure 3.3 and are calculated by using the program MERCURY 
[41].
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H 3c
15
1 1 9 2 4
1 0 3
Figure 3.3: Mefenamic acid molecule, with numbering scheme used in this work. Definition of 
torsional angles: 0, is the angle involving 01-C7-C6-C1, ftisthe angle involving C1-N1-C8-C13 and 
03 is the angle involving C6-C1 -N1-C8.
3.2.3.I. Description of crystal structure of form I
The crystal packing diagram of form I is shown in Figure 3.4. There are two 
molecules in the unit cell. The phenyl ring bearing the carboxyl group is coplanar 
with the carboxyl- and bridging amino-groups. This coplanar conformation is 
stabilised by the resonance interaction and internal hydrogen bond between the 
amino- and carboxyl-groups [7], The distance between the atoms (N1...01) involved 
in this interaction is ca. 2.63 A (Figure 3.5). The molecules pack as dimer units 
through an intermolecular hydrogen bond involving the carboxylic acid group (0 2 -
H...0 1 ) with an 0 2 . . .0 1 distance of 2.65 A. Hydrogen bonding in form I can be 
best described with the aid of graph-set analysis. The graph-set notations are 
assigned by the method described by Bernstein et al. [42], and can be obtained from 
PLUTO [43] and MERCURY [41]. The description of the hydrogen-bond pattern in 
form II according to the graph-set notation at the first level graph set is Ah = 
S(6)R22(8) where S and R motifs represents internal and external hydrogen bonds, 
respectively. The values for the three torsional angles 6\, 02 and 6(3 are shown in 
Table 3.4.
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Figure 3.4: Crystal packing diagram of form I viewed down the c-axis.
Figure 3.5: Dimer unit in form I.
3.2.3.2. Description of crystal structure of form II
The crystal packing diagram of form II is shown in Figure 3.6. Similar to 
form I the phenyl ring bearing the carboxyl-group is coplanar with the carboxylic 
acid group. There are two molecules in the unit cell which pack as dimer units by 
making two hydrogen bonds involving the carboxylic acid group. The distance 
between 02...01 is ca. 2.65 A, similar to that found in form I. An internal hydrogen 
bond with an N1...01 distance of ca. 2.68 A is also found in fotm II.
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Figure 3.6: Crystal packing diagram of form II (left) and dimer packing unit of MA molecule as they 
pack in crystal structure of form II (right).
The comparison of space-filling diagrams (Figure 3.7) of forms I and II 
indicates more efficient packing of MA molecules in form II. The difference in the 
crystal packing between forms I and II arises from the torsional angle 6b (Table 3.4), 
where the values has changed significantly from -119.99° to -85.19°, whilst the 
deviation in the other two torsional angles, (6\ and 63) are very small. Due to changes 
in 62, the carboxylic acid group and the amino group are no longer coplanar in form 
II and as a result the length of the intramolecular hydrogen bond (N1...01) increases 
slightly from 2.63 A to 2.67 A.
Figure 3.7: Space-filling diagrams for forms I (lett) and II (right).
65
Chapter 3: High-Pressure Studies of Mefenamic acid




Table 3.4: Comparison of torsional angles between forms I and II of MA.
3.2.4. V a r i a b l e  t e m p e r a t u r e  X - r a y  p o w d e r  diffraction
Variable temperature X-ray powder diffraction (XPPD) experiments were 
performed using an Anton Parr TTK450 heating and cooling stage (Figure 3.8) over 
the temperature range from 20 °C to 210 °C. About 1 g MA sample was presented as 
a flat pressed powder in a sample stage. XRPD data were collected on a Bruker AXS 
D8 diffractometer (operating at 40 kV, 40 mA), using Cu-Xa radiation (A, = 1.5418 
Â) with a position sensitive detector (PSD). Diffraction data were collected in the 
range 26 = 2-30° with a step size of 0.02°.
Figure 3.8: Anton Parr TTK450 heating and cooling stage used for variable temperature XRPD.
The purpose of these experiments was to confirm that form II is the high- 
temperature form and to identify the transition temperature. Figure 3.9 shows the 
powder diffraction patterns of MA obtained at elevated temperature, starting from 50 
°C up to 210 °C. The powder pattern at 50 °C represents pure form I, and 
characteristic Bragg peaks of form I were observed at 26 values of 6.3, 21.3 and 
26.3°. All peaks were consistent with the calculated powder pattern obtained from 
the crystal structure of form I. With increasing temperature up to 160 °C no changes 
except movement of peaks to lower 26 value were observed. All patterns up to 160
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°C were indexed as form I. At 170 °C a number of new peaks appeared in the pattern 
indicating transition to a new phase. These new peaks were observed at 20 values of 
11.8, 17.9, 23.8 and 25.6° and are characteristic of form II. Therefore the powder 
pattern at 170 °C represents a mixture of forms I and II. With increasing temperature, 
form I peaks gradually disappeared and the sample completely converted to form II. 
The pattern at 190 °C could be indexed as form II and represents pure form II. 
Further increase in temperature up to the melting point showed no further phase 
transitions. Optical observation showed a colour change from white to green-yellow 
on conversion to form II.
Figure 3.9: X-ray powder diffraction patterns of MA collected at temperature ranges 50 °C to 210 °C 
(X= 1.5418 Â).
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3.2.5. D r y  g r i n d i n g  a n d  milling e x p e r i m e n t s
Milling of MA was carried out in a Retsch MM301 Ball Mill, as shown in 
Figure 3.10. In a typical experiment, ca. 0.5 g of sample was loaded into the milling 
vessel along with a steel ball (mass ca. 30 g and diameter ca. 20 mm). The vessel 
was then shaken at 5 Hz for up to 15 min. XRPD and IR techniques were used to 
analyse powder samples after milling. XRPD data were collected on a Bruker D8 
diffractometer using Cu-Xa radiation (k = 1.5418 A) at 40 kV and 40 mA. Each 
sample was analysed between 26 = 2-40° with a step size of 0.02°. Experimental 
powder patterns were compared to simulated powder patterns obtained from crystal 
structure. IR absorption spectra were collected in the ranges of 200-3500 cm'1. 
Samples were analysed at periods of 0, 3, 6, 9, 12 and 15 min of milling.
Figure 3.10: Retsch MM301 ball mill.
Figure 3.11 shows the X-ray powder diffraction patterns of MA obtained 
after different times of milling. Milling was initially performed in the absence ot any 
solvent or liquid. The starting form was form I, represented by bottom pattern in 
Figure 3.11. No changes were observed in the pattern after 3 min of milling. In the 
pattern obtained after 6 min of milling, new peaks at values of 26 = 12.1, 17.3 and 
24.1 appeared. These peaks were attributable to form II and therefore this pattern 
represents a mixture of forms I and II. After 15 mins of milling, all of the sample had 
been converted to form II. It was also noticeable from the patterns that there was an 
increase in background intensity, and that the peaks became broader with increasing
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time of milling. These changes can be attributed to both possible size reduction and 
partial amorphisation of the sample as grinding progressed. Thus, not only was the 
phase transition observed by milling but a decrease in crystallinity was also achieved, 
which may account for the increase in the dissolution rate of MA [28],
2-theta (°)
Figure 3.11: X-ray powder diffraction patterns of MA collected after different times of dry milling (k 
= 1.5418 A).
X-ray powder diffraction results are supported by IR spectroscopic 
measurements. Figure 3.12 shows the IR spectrum recorded as a KBr disc ol a MA 
powder sample. The spectrum agrees with that previously published for form I [12]. 
An important spectral feature that can be used to distinguish between polymorphs of 
MA is the N-H stretching band that occurs in the range 3300-3350 cm'1.
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Wave number (cm'1)
Figure 3.12: IR absorption spectra for form I of MA.
Figure 3.13 shows IR spectra recorded after different periods of milling, in 
the range 3250-3400 cm"1. The band at 3312 cm"1 arises from the amino-group that 
forms an intramolecular hydrogen bond with the carboxyl-group (Figure 3.1) 
associated with form I. During milling, the intensity of this band decreases and a 
band at 3353 cm' 1 begins to grow. This new band is significantly less broad than the 
initial band at 3312 cm1. Both of these observations can be interpreted by the 
transformation of form I to II. In form I, the N-H bond is involved in a relatively 
strong interaction with the carbonyl group (N...0 distance is 2.63 A). In form II, this 
distance increases to 2.67 A, indicating a weaker interaction. This results in the N-H 
bond becoming stronger and hence shifting to higher energy. These spectral changes 
are consistent with the quantum mechanical calculations performed on the structure 
of MA [21,44],
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wavenumbers, cm' 1
Figure 3.13: Comparison of IR absorption spectra (3250-3400 cm1) of MA recorded over short 
periods of milling.
In the milling process, not only are shear and stress forces applied, but a 
heating of the mill assembly (typically up to ca. 50 °C) occurs. This is a relatively 
modest temperature rise, and would be insufficient to transform form I to form II 
(transition temperature is ca. 170 °C). However, it is also necessary to consider the 
effect of local heating when the steel ball impacts on the wall of the mill. Hence the 
question arises as to whether the transformation induced by milling is caused by 
pressure or temperature. To answer this, an experiment was performed in which the 
sample was milled in the presence of an excess of dry ice at a temperature of -78 °C. 
The results showed that under these conditions, form I did indeed transform to form 
H, indicating that it is a localised pressure increase that may be responsible for the 
transformation. Of course, this pressure is significantly lower than the hydrostatic 
pressure experienced in the diamond-anvil cell, but this may reflect the fact that the 
pressure experienced during ball-milling will be highly non-hydrostatic. Such 
phenomena are well documented in other systems, e.g. ammonium nitrate undergoes
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a phase transition subjected to non-hydrostatic pressure, but no transition is observed 
when pressure is applied hydrostatically [45],
Milling of form I was also performed in the presence of a small amount (ca. 
1 ml) of solvent. Different solvents (listed in Table 3.5) were used. In all cases 
except one, no transitions were observed. A partial transformation was observed for 
Fluorinert-FC77. This can be explained by the fact that form II is metastable with 
respect to form I and readily reverts to form I in contact with solvents in which it has 
some solubility. However, MA is only sparingly soluble in Fluorinert-FC77 and so 
the back transformation is very slow.
Solvent used Results after 15 minutes of milling
Methanol No transition to form II
Ethanol No transition to form II
THF No transition to form II
Water No transition to form II
DMF No transition to form II
Fluorinert-FC77 Partial transition to form II
Methanol: ethanol (4:1) No transition to form II
Isopropyl alcohol No transition to form II
DMSO No transition to form II
Acetone No transition to form II
Acetonitrile No transition to form II
Table 3.5: Results from wet milling of MA with different solvents.
3.2.6. H i g h - p r e s s u r e  X - r a v  p o w d e r  diffraction e x p e r i m e n t s
High-pressure X-ray powder diffraction experiments were performed using a 
Merrill-Bassett diamond-anvil cell (half-opening angle 40°) [30]. A pre-indented 
tungsten gasket of thickness 250 urn with a 300 pm diameter hole was used. To 
improve the uniformity of polycrystalline material, the powder was ground using a 
mortar and pestle prior to loading into the cell. The powder was loaded with a small 
ruby chip to measure pressure using the ruby fluorescence technique. The piessure- 
transmitting medium used in these experiments was either a methanol.ethanol (4.1) 
mixture or Fluorinert-FC77. Pressure was increased in small steps and after each
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pressure adjustment the DAC was allowed to stand as such for 2-3 hours. This also 
allowed any slow phase transitions to occur.
Powder diffraction patterns were collected with synchrotron X-ray radiation 
using Station 9.5HPT (k= 0.4439 A) at the SRS, Daresbury Laboratory. To improve 
the uniformity of the cones of diffracted radiation, the sample was continuously 
rastered over a range of +100 pm transverse to the incident X-ray beam in order to 
illuminate as many individual crystallites as possible. The scattered radiation was 
then collected on an image-plate area detector (Mar345). Any intense diffraction 
peaks due to diamonds were masked and the remaining two-dimensional pattern was 
then integrated to obtain a one dimensional powder diffraction pattern with using 
FIT2D software [46]. Data were initially processed by Datlab and Powder cell [47] 
and then further analysed by Le Bail methods using GSAS [48] with an EXPGUI [49] 
interface to refine unit cell parameters.
3.2.6.I. Powder compression using methanol:ethanol (4:1) as a pressure- 
transmitting medium
Figure 3.14 shows the powder diffraction patterns of MA collected at 
pressures between ambient and 2.8 GPa. Methanol:ethanol (4:1) mixture was used as 
the pressure-transmitting medium. The pattern recorded at ambient pressure was 
indexed as form I. On increasing the pressure to 1.1 GPa no significant changes were 
observed in the powder patterns except for the movement of peaks towards higher 29 
values. All the powder patterns up to 1.1 GPa could be indexed as form I, and the 
lattice parameters are shown in Table 3.6.
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2 theta (°)
Figure 3.14: X-ray powder diffraction patterns of MA collected at pressure up to 2.8 GPa (A = 0.4439 
A).
Pressure Ambient 0.45 GPa 1.1 GPa
Crystal System Triclinic Triclinic Triclinic
Space group P-l P-l P-l
a( A) 14.5668(9) 14.2918(15) 14.1320(11)
b( A) 6.8138(6) 6.7251(7) 6.6688(5)
c (A) 7.6476(5) 7.5770(6) 7.5152(5)
«(°) 119.405(4) 119.551(5) 119.528(5)
PC) 103.905(5) 104.602(6) 105.149(5)
7 0 91.505(7) 91.469(8) 91.513(8)a \V(AJ) 632.49(8) 603.26(10) 584.61(8)
z 2 2 2
T/K 298(2) 298(2) 298(2)
Table 3.6: Lattice parameters obtained from powder patterns up to 1.1 GPa.
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In the next step the pressure was raised to 1.5 GPa. At this pressure new 
peaks were observed to grow in the pattern e.g. at ca. 6.2, 6.5 and 9.8° (shown by 
arrows in Figure 3.14), indicating a transition to a new form. The pattern at this 
pressure may represent a mixed phase as most of the peaks attributable to form I are 
still present in this pattern. Furthermore, it proved impossible to index this pattern 
suggesting a partial phase transition to a new form. The pressure was then increased 
further to 1.8 GPa. The powder pattern simplified somewhat and more new peaks 
emerged in the pattern. No further changes except shifting of peaks towards higher 
29 value were observed on raising the pressure to 2.8 GPa. Comparison with the 
calculated diffraction patterns of form I and form II or a mixture of these forms 
showed no similarity, suggesting that a new form (designated as form III) has been 
generated at 1.5 GPa. Further support for this hypothesis is provided by the 
appearance of the 2D-diffraction images (Figure 3.15). The image recorded at 1.5 
GPa is noticeably more textured than at 1.1 GPa, indicating the appearance of larger 
crystallites. Such an observation is often characteristic of a solvent-mediated phase 
transition in which one form dissolves and recrystallises into another form. This is 
entirely possible since MA has a significant solubility in the methanokethanol 
mixture.
CADocuxoenti aid Sattmgs\Paconi_resl2\Desktop\Pulium_May07tmef_003.mai3450
Figure 3.15: 2-D diffraction images of MA at 1.1 GPa (left) & 1.5 GPa (right).
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There was some suspicion that the transition to the new form was incomplete 
as several peaks attributed to form I persisted. For this reason the pressure was 
cycled several times between 0.8 and 2.2 GPa. Figure 3.16 shows the comparison 
between patterns before and after this pressure cycling. It is evident from the results 
that the pattern has changed quite significantly, especially the low angle peak at 
ca. 1.8°, attributed to form I, which has completely disappeared. Moreover, 
broadening of the peaks was also observed with this pressure cycling. The pattern at 
2.2 GPa after this cycling may represent the pure form III. However, all indexing 
attempts proved unsuccessful. The pressure was then increased to 3.2 GPa, but no 
significant changes were observed in the pattern.
Figure 3.16: X-ray powder diffraction patterns of MA collected before and after pressure cycling (A. 
0.4439 A).
In the next step the pressure was gradually reduced to ambient pressure. 
Figure 3.17 shows the powder patterns recorded after gradually releasing the 
pressure down to ambient pressure. There were no significant changes observed in
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the powder patterns except for the movement of peaks towards lower 26 values with 
the telease of pressure, indicating that the new high-pressure form (form III) 
persisted on decompression.
2-theta (°)
Figure 3.17: X-ray powder diffraction patterns of MA collected at pressure range 3.2 GPa to ambient- 
pressure (X = 0.4439 A).
High-pressure Raman studies were also performed on the powder sample of 
form I, but due to significant fluorescence, the spectra obtained were weak and peaks 
were not prominent. It was very difficult to identify any phase changes in the Raman 
spectra.
3.2.6.2. Powder compression using Fluorinert-FC75 as a pressure-transmitting 
medium
To avoid solvent-mediated effects on possible phase transitions it was 
decided to perform compression studies on powder samples of MA in the presence of 
a pressure-transmitting medium in which MA has a low solubility. Fluorinert-FC77, 
a fluorinated hydrocarbon, was selected for this purpose. For powder-compression
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experiments in Fluorinert, the DAC was loaded with finely ground powder of either 
form I or form II in separate experiments.
Direct compression of powder sample of form I
Figure 3.18 shows the powder patterns for form I collected in increasing 
pressure steps between ambient and 2.7 GPa. Fluorinert-FC77 was used as the 
pressure-transmitting medium in this case. The pattern recorded at ambient pressure 
was indexed as form I. On increasing the pressure to 0.3 GPa, no significant changes 
were observed except for the movement of peaks towards higher 26 values. The 
powder pattern at 0.3 GPa could be indexed as form I. The pressure was then 
increased to 0.75 GPa, and new peaks were observed to grow at 2 6 values of ca. 2.2, 
10.5 and 10.7°, indicating a transition to a new form. Indexing attempts for this new 
form were unsuccessful. However, the powder pattern at 0.75 GPa may represent a 
mixed phase as all the peaks attributed to form I were still present. The new phase 
was designated as form IV. The pressure was then gradually increased to 2.7 GPa, 
but no significant changes were observed except for the movement of peaks towards 
higher 26 values. However, broadening of the peaks with increasing pressure 
occurred on account of non-hydrostatic conditions associated with the pressure- 
transmitting medium.
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2-theta (°)
Figure 3.18: X-ray powder diffraction patterns of MA form I in Fluorinert-FC77 collected at pressures 
up to 2.7 GPa. The upper pattern represents the powder pattern obtained after reducing the pressure to 
ambient.
In the next step, the pressure was reduced to ambient. The powder pattern 
collected at ambient pressure (Figure 3.18) showed that the sample had transformed 
back to form I, indicating that the phase transition to form IV at 0.75 GPa was 
reversible.
Direct compression of powder samyle of form II
Direct compression studies using Fluorinert-FC77 were also performed on the 
powder samples of form II. A DAC was loaded with powder samples of form II 
along with a ruby chip. Figure 3.19 shows the powder patterns for form II collected 
at increasing pressure steps between ambient and 2.8 GPa. The powder pattern at 
ambient pressure was successfully indexed as form II indicating no solvent mediated 
transition to form I. On increasing the pressure to 0.30 GPa and then to 0.57 GPa, no 
significant changes were observed. All the powder patterns up to 0.57 GPa could be 
indexed as form II.
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2-theta (°)
Figure 3.19: X-ray powder diffraction patterns of MA form II in Fluorinert-FC77 collected at 
pressures up to 2.8 GPa. The upper pattern represents the powder pattern obtained after gradually 
reducing the pressure to ambient.
At 0.75 GPa, new peaks appeared in the powder pattern at 2 6 values of ca.
2.2, 10.5 and 10.7°, indicating a transition to a new phase. This new phase was 
identified as form IV, by comparison with the results of compression of form I in 
Fluorinert-FC77. All indexing attempts were unsuccessful. However, the powder 
pattern at 0.75 GPa may also represent a mixed phase as all the peaks attributed to 
form II were still present. The pressure was then gradually increased to 2.8 GPa, but 
no significant changes were observed except for the movement of peaks towards 
higher 26 values. However, broadening of the peaks with increasing pressure 
occurred on account of non-hydrostatic conditions associated with the pressure- 
transmitting medium.
In the next step, the pressure was reduced to ambient. The powder pattern 
collected at ambient pressure (Figure 3.19) showed that the sample had transformed 
back to form II, indicating that the phase transition to form IV at 0.75 GPa was 
reversible.
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3.3. C o n c l u s i o n s  a n d  f u t u r e  d i r e c t i o n s
The transfoimations between the polymorphs of mefenamic acid are 







Compression of powder 
sample in MeOH:EtOH at 




powder sample in 
Fluorinert-FC77 at 
0.9 GPa Decompression to ambient 
pressure
Form IV
Scheme 3.1: Transformations between polymorphs of MA.
High-pressure crystallisation of a solution of mefenamic acid in ethanol 
contained in a diamcnd-anvil cell at a pressure of 0.6 GPa resulted in the 
reproducible formation of elusive form II. These results are of great significance as 
they demonstrate that form II can be obtained reproducibly at high pressure and 
recovered successfully to ambient pressure. Furthermore, no additives were required 
like in the study by Lee et al., [18]. This may suggest that the form II is more 
thermodynamically stable form at high pressure. Furthermore, dry and cold milling 
results have shown that form II can also be produced by milling of form I, and that 
the pressure rather than temperature may be responsible for this transition. Milling of
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pharmaceutical materials is an area that merits further explanation, particularly in 
relation to the possible effects of localised pressure.
Direct compression studies have shown that by compressing a single crystal 
of form I, no phase transition was observed up to 2.5 GPa. The pressure was then 
raised to 3.0 GPa. At this pressure, the crystal disintegrated, perhaps suggesting a 
reconstructive phase transition. Compression of powder samples of form I at 1.5 GPa 
in methanohethanol mixture resulted in formation of a new form (form III). This is 
consistent with the observation that the phase transition may be solvent mediated i.e. 
the finely divided powder has higher surface area than the single crystal and so 
kinetics of dissolution and precipitation will be faster. The results also showed that 
the solubility of MA in pressure-transmitting fluid plays a significant role. Support 
for this was provided by the appearance of a textured powder pattern after the phase 
transition. This behaviour is often characteristic of a solvent-mediated phase 
transition in which one form dissolves and then recrystallises as a high-pressure 
form. This process may be enhanced by partial amorphisation of the powder sample 
as indicated by the broadening of powder pattern peaks. This amorphisation can 
result in an increase in the solubility of MA in the methanohethanol mixture and so 
the kinetics of dissolution and precipitation may be faster. It was not possible to 
obtain lattice parameters for form III, owing to limited resolution, preferred 
orientation, and problems with texture. Decompression studies showed that form III 
can be recovered to ambient pressure and so future structural studies should peihaps 
focus on this aspect. It proved impossible to compress form II whilst using a 
methanohethanol mixture because of solvent-mediated conversion of form II to I. To 
reduce the effect of solubility, Fluorinert-FC77 was also used as piessure- 
transmitting medium. This allowed compression of powder samples of both forms I 
and II. The results from these experiments were different from the compression of 
form I in methanohethanol mixture. In this case a new polymorph, designated as 
form IV, was obtained at 0.75 GPa by compressing forms I and II. However the 
transition to form IV was incomplete. High-pressure crystallisation is a potential 
route to obtain this form and would be an area for future exploration. The high-
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pressure recrystallisation attempts at relative low pressure in this study always 
resulted in the formation of form II.
3.4. R e f e r e n c e s
1. R. J. Flower, Pharmacol. Rev., 1974, 26, 33-67.
2. V. Dokorou, M. A. Demertzis and D. Kovala-Demertzi, Pharmakeutike.,
2008, 21, 1-9.
3. S. Avram, D. M. Duda-Seiman, I. Svab, S. Mancas, C. Duda-Seiman and D. 
F. Mihailescu, Curr. Comput. Aided Drug Des., 2009, 5, 1-12.
4. F. A. Aly, S. A. Al-Tamimi and A. A. Alwarthan, Anal. Chim. Acta, 2000, 
416, 87-96.
5. P. C. Ioannou, N. V. Rusakova, D. A. Andrikopoulou, K. M. Glynou and G. 
M. Tzompanaki, Analyst., 1998,123, 2839-2843.
6. Y. Joo, H. S. Kim, R. S. Woo, C. H. Park, K. Y. Shin, J. P. Lee, K. A. Chang,
S. Kim and Y. H. Suh, Mol. Pharmacol, 2006, 69, 76-84.
7. V. Dhanaraj and M. Viiayan, Acta Crystallogr., Sect. B: Struct. Sei., 1988, 44
(Pt 4), 406-412.
8. A. O. Surov, I. V. Terekhova, A. Bauer-Brandl and G. L. Perlovich, Cryst. 
Growth Des, 2009, 9, 3265-3272.
9. K. Park, J. M. B. Evans and A. S. Myerson, Cryst. Growth Des., 2003, 3, 
991-995.
10. L. D. Hughes, D. S. Palmer, F. Nigsch and J. B. O. Mitchell, J. Chem. Inf. 
Model., 2008, 48, 220-232.
11. A. J. Aguiar and J. E. Zelmer, J. Pharm. Sei., 1969, 58, 983-987.
12. S. Romero, B. Escalera and P. Bustamante, Int. J. Pharm., 1999,178, 193- 
2 0 2 .
13. K. Urakami, Y. Shono, A. Higashi, K. Umemoto and M. Godo, Bull. Chem. 
Soc. Jpn., 2002, 75, 1241-1245.
14. R. K. Gilpin and W. Zhou, V ib . Spectrosc., 2005, 37, 53-59.
15. S. Cesur and S. Gokbel, Cryst. Res. Technol., 2008, 43, 720-728.
16. J. F. McConnell and F. Z. Company, Cryst. Struct. Commun., 1976, 5, 861- 
864.
17. S. L. A. Munro and D. J. Craik, Magn. Reson. Chem., 1994, 32, 335-342.
18. E. H. Lee, S. R. Byrn and M. T. Carvajal, Pharm. Res., 2006, 23, 2375-2380.
19. S. Byrn and E. Lee, Abstracts of Papers, 235th ACS National Meeting, New 
Orleans, LA, United States, April 6-10, 2008, IEC-059.
20. I. S. Lee, A. Y. Lee and A. S. Myerson, Pharm. Res., 2008, 25, 960-968.
21. N. Mizuno, D. Shinkuma and T. Hamaguchi, Yakugaku Zasshi, 2003,123, 
477-493.
22. A. Adam, L. Schrimpl and P. C. Schmidt, Drug Dev. Ind. Pharm., 2000, 26, 
477-487.
23. F. Kato, M. Otsuka and Y. Matsuda, Int. J. Pharm., 2006, 321, 18-26.
83
Chapter 3: High-Pressure Studies of Mefenamic acid
24. M. M. Pop, K. Goubitz, G. Borodi, M. Bogdan, D. J. A. De Ridder, R. 
Peschar and H. Schenk, Acta Crystallogr., Sect. B: Struct. Sci., 2002 B58 
1036-1043.
25. L. Fang, S. Numajiri, D. Kobayashi, H. Ueda, K. Nakayama, H. Miyamae 
and Y. Morimoto, J. Pharm. Sci., 2004, 93, 144-154.
26. A. Topacli and S. Ide, J. Pharm. Biomed. Anal, 1999, 21, 975-982.
27. V. Dokorou, Z. Ciunik, U. Russo and D. Kovala-Demertzi, J. Organomet. 
Chem., 2001, 630, 205-214.
28. T. Iwasaki, M. Takahara, R. Sonoda and S. Watano, Part. Part. Syst. 
Charact., 2007, 24, 236-241.
29. A. J. Alvarez, A. Singh and A. S. Myerson, Cryst. Growth Des., 2009, 9, 
4181-4188.
30. L. Merrill and W. A. Bassett, Rev. Sci. Instrum., 1974, 45, 290-294.
31. G. J. Piermarini, S. Block and J. D. Barnett, J. Appl. Phys., 1973, 44, 5377- 
5382.
32. G. J. Piermarini, S. Block, J. D. Barnett and R. A. Forman , J. Appl. Phys., 
1975,46, 2774-2780.
33. S. A. Moggach, D. R. Allan, S. Parsons, L. Sawyer and J. E. Warren, J. 
Synchrotron Radiat., 2005,12, 598-607.
34. G. M. Sheldrick, CELL_NOW, University of Gottingen, Germany, 2002.
35. A. Dawson, D. R. Allan, S. Parsons and M. Ruf, J. Appl. Crystallogr., 2004,
37,410-416.
36. B. AXS, SAINT, Bruker-AXS, Madison, Wisconsin, USA, 2003.
37. S. Parsons, SHADE, University of Edinburgh, Scotland, UK, 2004.
38. G. M. Sheldrick, SADABS, University of Gottingen, Germany, 2006.
39. P. W. Betteridge, J. R. Carruthers, R. I. Cooper, K. Prout and D. J. Watkin, J. 
Appl. Crystallogr., 2003, 36, 1487.
40. F. P. A. Fabbiani, D. R. Allan, W. I. F. David, S. A. Moggach, S. Parsons and
C. R. Pulham, CrystEngComm, 2004, 6, 504-511.
41. C. F. Macrae, P. R. Edgington, P. McCabe, E. Pidcock, G. P. Shields, R.
Taylor, M. Towler and J. van de Streek, J. Appl. Crystallogr., 2006, 39, 453- 
457.
42. J. Bernstein, R. E. Davis, L. Shimoni and N. L. Chang, Angew. Chem., Int.
Ed. Engl., 1995, 34, 1555-1573.
43. W. D. S. Motherwell, G. P. Shields and F. H. Allen, Acta Crystallogr., Sect. 
B: Struct. Sci., 1999, B55, 1044-1056.
44. V. Dhanaraj andM. Vijayan, Acta Crystallogr., Sect. B: Struct. Sci., 1988,
B44, 406-412.
45. D. M. Adams and S. K. Sharma, J. Chem. Soc., Faraday Trans. 2, 1976, 72,
2069-2074.
46. A. P. Hammersley, S. O. Svensson, M. H. and, A. N. Fitch and D.
Hausermann, High Pressure Res., 1996,14, 235-248.
47. W. Kraus and G. Nolze, Powder Cell, Berlin, Germany.
48. A. C. Larson and R. B. V. Dreele, General Structure Analysis System (GSAS),
Los Alamos National Laboratory, 2000.
49. B. H. Toby, J. Appl. Crystallogr., 2001, 34, 210-213.
84
Chapter 4. High Pressure Studies of N,N'-dimethylurea
C h a p t e r  4  
H i g h - P r e s s u r e  S t u d i e s  o f  N . N f- d i m e t h v l u r e a
85
Chapter 4: High-Pressure Studies of N,N'-dimethylurea
C h a p t e r  4:  H i g h - P r e s s u r e  S t u d i e s  o f  N . N ' - d i m e t h v l u r e a  
( D M U )
4.1. B a c k g r o u n d
Urea, (NH2)2CO, and related compounds have been the subject of extensive 
theoretical and experimental studies in the past four decades, mainly because of their 
interesting physical and chemical properties [1-5]. Urea is one of the most common 
and renowned chemical and biological compounds. It is the main nitrogen-containing 
end product of animal metabolism and is widely used in industry, mainly for the 
production of fertilisers, pharmaceuticals, and urea-formaldehyde plastics. Its crystal 
structure at ambient conditions, form I, consists of ribbons of molecules in which 
each carbonyl oxygen atom accepts four N-H...0 hydrogen bonds [6, 7]. The overall 
structure that results from the optimisation of these bonds is relatively open [8]. Urea 
shows rich high-pressure behaviour, and at least four polymorphs exist at elevated 
pressures. In 1916, Bridgman discovered that urea transforms to form II above 373 K 
and 0.60 GPa, and to form III at 293 K above 0.48 GPa [9, 10], Neutron powder 
diffraction studies of deuterated urea (ND2)2CO identified form IV (stable between 
2.80-7.20 GPa) and form V (stable above 7.20 GPa) [11, 12], Most recently, single 
crystals of forms I, II and IV were grown in situ in a diamond-anvil cell (DAC), and 
their structures were determined by X-ray diffraction [13].
The work described in this chapter has focused on the high-pressure 
behaviour of N,N'-dimethylurea (DMU) also known as 1,3-dimethylurea, which 
represents one of the simplest examples of a disubstituted urea. DMU exists as a 
white crystalline powder with a melting point in the range 101-105 °C and a density 
of about 1.14 g/cm3 at ambient temperature. DMU is widely used in a variety of 
scientific and industrial processes, e.g. as an intermediate in many phaimaceutical 
preparations [14], in membrane transport within red blood cells [15], and as a 
stabiliser in hydrated lubricating oil [16], It has shown some protective effect against
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streptozotocin-induced diabetes in mice, but has not been studied as a drug in 
humans [17].
The molecular structure of DMU with the numbering scheme used in this 




Figure 4.1: Molecular structure of N, N'-dimethylurea
Until recently, DMU was known to exist in only one crystalline modification 
denoted as form I. The crystal structure of this form was determined by Perez-Folch 
et al. in 1997 and was assigned the space group Cc [18]. This crystal structure was 
unexpected for it indicated a polar lattice, in contrast to that of urea (Figure 4.2). The 
authors also attempted a refinement in the space group Fdd2, but dismissed it on the 
basis that it led to larger thermal parameters and higher /̂-factors. Various 
crystallisation techniques were applied in an effort to obtain a polymorph with 
packing more like that observed in urea, but these were all unsuccessful [18]. The 
space group of DMU was subsequently reassigned to Fdd2 by Marsh during a survey 
of the crystal structure database [19].
87
Chapter 4: High-Pressure Studies of N,N'-dimethylurea
Figure 4.2: Crystal packing diagram viewed down the a-axis for form I urea (left) and form I DMU 
(right). Note that molecules stack via hydrogen bonding along the c-axis to create one-dimensional 
chains; for form I urea, neighbouring chains pack in opposite directions, giving rise to a nonpolar 
lattice, whilst DMU form I shows single chains oriented in only one direction.
More recently, another polymorph of DMU has been obtained at ambient 
pressure (denoted as form II) by Martins et al. [20]. Form II is an orthorhombic form 
with P2\2\2 space group, and was obtained accidentally from the slow crystallisation 
(more than 6 months) of a solution of DMU in phosphoric acid. Crystals of this 
phase were subsequently identified in samples of DMU purchased directly from 
Sigma-Aldrich. Figure 4.3 shows the comparison of X-ray powder patterns simulated 
from the crystal structures of form I (blue) and form II (red).
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Figure 4.3: Comparison of simulated X-ray powder pattern for form I and II of DMU. These patterns 
were calculated using the program MERCURY [21] (A. = 1.541 A).
The molecules in the crystal structure of form II pack in a slightly more 
efficient arrangement, and so the density of form II at room temperature exceeds that 
of form I by about 2 %. As a consequence, the authors suggested that this polymorph 
could be obtained by high-pressure techniques [20]. Furthermore, first order energy 
calculations performed on both forms suggested that form II is more stable below 
100 K and form I is more stable above 100 K [20], Based on these calculations along 
with computed thermodynamical values, the authors also suggested that form II 
should be considered a readily accessible polymorph. The aim of the current 
investigation was therefore to explore whether high-pressure methods could be used 
to obtain form II or other new forms. The results also stimulated crystal structure 
prediction (CSP) calculations on DMU performed separately at the University of 
Cambridge by Dr Graeme Day and the experimental and computational results are 
compared in this chapter.
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4.2. E x p e r i m e n t a l
4.2.1. M a t e r i a l
N,N'-dimethylurea was purchased from Sigma Aldrich, UK and used as 
received. The supplied form was studied by collecting X-ray powder diffraction 
patterns and comparing them with the patterns calculated from the single crystal 
structure. Analytical grade solvents were used for the recrystallisation experiments.
All high-pressure experiments were carried out using Merrill-Bassett 
diamond-anvil cell (DAC) (half-opening angle 40°) [22], equipped with a pre­
indented tungsten gasket of thickness 250 qm and a 300 pm diameter hole. For high- 
pressure crystallisation experiments, diamond-anvil cells using tungsten carbide 
backing disc [23] were used.
4.2.2. M e t h o d s
4.2.2.1. Variable temperature X-ray powder diffraction
Variable temperature X-ray powder diffraction (XRPD) experiments were 
performed using an Anton Parr TTK450 heating and cooling stage over the 
temperature ranges 20 -100 °C. XRPD data were collected on a Bruker AXS D8 
diffractometer, using Cu-Ka radiation (k = 1.5418 A at 40 kV and 40 mA), equipped 
with a PSD detector. Each sample was analysed between 26 = 2-40 with a step size 
of ca. 0.02°. Experimental powder patterns were compared to simulated powder 
patterns obtained from the single crystal structures of forms I and II of DMU.
4.2.2.2. Milling experiments
Milling of DMU form I was carried out in a Retsch MM301 Ball Mill. 0.5 g 
of sample was loaded into the milling vessel along with a steel ball (mass ca. 30 g 
and diameter ca. 20 mm). Milling was performed at rate of 5 Hz. XRPD was used to 
analyse powder samples obtained after different peiiods of millinD.
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4.2.2.3. High-pressure crystallisation from solution
About 1M solution of DMU was prepared in a methanohethanol (4:1) 
mixture. The solution was then loaded along with a few crystallites of DMU at 293 K 
into a DAC. A small piece of ruby was also added in order to allow the determination 
of the pressure by laser fluorescence spectroscopy as described in chapter 2 [24], The 
pressure was increased to a minimum to form a sealed system and the cell was then 
subjected to gentle heating to dissolve all of the solid material. The pressure was then 
applied by tightening the screws of the DAC to induce precipitation. Crystallisation 
was achieved at ca. 0.7 GPa. The temperature was then cycled near 353 K in order to 
dissolve all but one of the crystallites. On slow cooling to 293 K a single crystal 
grew, which filled almost 50% of the gasket hole. The pressure within the gasket 
hole was determined to be ca. 0.7 GPa.
In another loading of the DAC with the same solution, a similar procedure 
was used to grow a single crystal at high pressure, but this time the pressure was 
increased to ca. 1.1 GPa before crystallisation occurred. The temperature was then 
cycled near 353 K at this pressure to dissolve all of the crystallites except one; this 
was allowed to grow by slow cooling to 293 K and filled almost all of the gasket 
hole.
4.2.2.4. Single crystal X-rav diffraction
Diffraction data were collected on a Broker APEX CCD diffractometer at 
293(2) K using Mo-Ka radiation (X = 0.71073). Data collection and processing was 
performed according to procedures described by Dawson et al. [25]. Integrations 
were performed using the program SAINT [26], and absoiption collections used the 
programs SHADE [27] and SADABS [28], In the case of single crystal grown at 0.7 
GPa, diffraction data were collected with the diamond-anvil cell in two orientations 
(glued on the goniometer head by two different sides of the cell) to improve data 
completeness. Both data-sets were treated separately up to the absorption correction 
step. The two unmerged reflection data sets were then scaled and merged in SORTAV
[29],
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4.2.2.5. X-ray powder diffraction at high pressure
High-pressure powder diffraction experiments were carried out using a 
Merrill-Bassett diamond-anvil cell (half-opening angle 40°) [22], A pre-indented 
tungsten gasket of thickness 250 pm with a 300 pm diameter hole was used. To 
improve the uniformity of polycrystalline material, the powder was ground using a 
mortar and pestle prior to loading into the cell. The powder was loaded with a small 
ruby chip to measure pressure by the line shift in ruby fluorescence. The pressure- 
transmitting medium used in these experiments was either Fluorinert-FC77 or a 
methanokethanol (4:1) mixture.
Powder diffraction patterns were collected with synchrotron X-ray radiation 
using Station 9.5HPT (X= 0.444 A) at the SRS, Daresbury Laboratory and Beamline 
115 (k= 0.485 A) at the Diamond Light Source, Oxfordshire. To improve the 
uniformity of the cones of diffracted radiation, the sample was continuously rastered 
over a range of+ 100 pm transverse to the incident X-ray beam in order to illuminate 
as many individual crystallites as possible. The scattered radiation was then collected 
on an image-plate area detector (Mar345). Any intense diffraction peaks due to 
diamonds were masked and the remaining two-dimensional pattern was then 
integrated to obtain a one dimensional powder-diffraction pattern with the help of 
FIT 2D software [30],
4.3. R e s u l t s  a n d  d i s c u s s i o n
4.3.1. V a r i a b l e  t e m p e r a t u r e  X - r a y  p o w d e r  diffraction
X-ray powder diffraction studies were performed in the range 20-100 C in 
order to explore the effect of temperature on the polymorphism of DMU. The sample 
received from the supplier was identified as a mixtuie of foims I and II, and 
represented by the lower powder pattern in Figure 4.4. To improve the quality of the 
powder and to reduce the effects of preferred orientation the powder was lightly 
ground with a mortar and pestle. After this treatment, the X-ray powder pattern
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showed only the presence of form I, indicating that a phase transition had occurred 
on grinding. The ease of this transition suggests that form II is metastable with 
respect to form I undei these conditions in which localised shear forces and elevated 
temperatures may arise. Similar results were obtained by mechanical milling in the 
absence of any solvent. Figure 4.5 shows that the mixture of forms I and II rapidly 
transformed to form I after only 1 min of milling. For this reason, variable 
temperature experiments used the supplied powder with no prior grinding. The 
powder pattern at 30 °C represents a mixture of forms I and II. On raising the 
temperature to 40 °C, the powder pattern still showed a mixture of forms I and II, but 
the intensity of peaks due to form II had decreased and the intensity of peaks due to 
form I had increased. With further increase in temperature up to 50 °C all the peaks 
attributed to form II disappeared. The pattern at this temperature therefore represents 
pure form I. No further changes in the patterns were observed up to the melting point 
at 105 °C. After melting and subsequent cooling to 293 K the sample crystallised as 
form I.
Figure 4.4: X-ray powder diffraction patterns of DMU recorded at temperature range 30°-100°C (X - 
1.541 A).
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Figure 4.5: X-ray powder diffraction patterns of DMU recorded after different times of milling. The 0 
min pattern represents the untreated sample and shows the presence of form II (k= 1.541 A).
4.3.2. P o l y m o r p h  s c r e e n i n g  at a m b i e n t  p re s su r e
In order to screen for other possible polymorphs of DMU under ambient 
pressure, polymorph screening was performed using automated screening 
instruments at GSK, Stevenage, UK. Slurries of DMU were prepared in 48 different 
solvents and solvent mixtures. The list of solvents and respective concentrations of 
solute is given in Appendix B. Solutions were stirred and heated to 60 °C for ca. 24 h 
before being cooled to ambient temperature. Solutions were then filtered and the 
solid materials were analysed by XRPD. Half of the filtrates from all the solvent 
systems were maintained at ambient temperature for solvent evaporation and the 
other half were maintained at 0 °C until crystallisation had occoured. Any solid 
material obtained was analysed by XRPD. All the recrystallised samples from slurry, 
evaporation and cooling experiments were identified as form I. Recrystallisations 
from saturated solutions in a variety of solvents were also performed at high and low 
cooling rates, but all attempts resulted in form I. As the sample obtained from Sigma- 
Aldrich contained a mixture of form I and II, Sigma-Aldrich was also consulted to 
obtain the preparative scheme for their synthesis of DMU, but due to proprietary
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reasons they were unwilling to give any information. Rather interestingly a second 
sample obtained from this supplier contained only form I, suggesting that form II is 
rather elusive and can be produced only under a very specific set of conditions.
4.3.3. Crystallisation f r o m  solution at h i g h  pressu r e
4.3.3.1. High-pressure crystallisation at 0.7 GPa (form III)
For the high-pressure crystallisation experiments, a ca. 1M saturated solution 
of DMU was prepared in methanol:ethanol (4:1) mixture. The solution was loaded 
along with the ruby chip into a diamond-anvil cell and pressure was applied to 
induce crystallisation at 0.7 GPa. All of the crystallites except one were dissolved by 
gentle heating. On cooling, a single crystal grew slowly to fill almost all of the gasket 
hole (Figure 4.6). Single crystal X-ray diffraction data were then collected. The data 
were indexed to give a monoclinic unit cell with lattice parameters shown in Table
4.1.
Figure 4.6: Optical image of single crystal of DMU (form III) in a diamond-anvil cell at 0.7 GPa.












Dc (g cm'3) 1.24
P (GPa) 0.70(5)
T(K) 298(2)
Table 4.1: Unit cell parameters for crystal grown at 0.7 GPa (form III).
To improve the degree of completeness, diffraction data were collected with 
the diamond-anvil cell in two orientations. Both data sets were treated separately up 
to the absorption correction step. The two unmerged reflection files were then scaled 
and merged in SORTAV [29] in the manner described in experimental section.
Data processing was performed according to the procedure described in 
chapter 2, up to the absorption correction step. The structure was solved in P2/c 
using direct methods (SIR 97) [31]. Full-matrix least-squares structuie refinement 
was then performed using CRYSTALS [32], Hydrogen atoms were placed in 
calculated positions and allowed to ride on their parent atom. Full structural 
refinement details are tabulated in Appendix A. Crystallographic data in CIF format 
are available on the attached CD. This high-pressure polymorph of DMU was 
designated as form III.
4.3.3.2. High-pressure crystallisation «t 1.1 GPa (form IV)
A second high-pressure form (designated as form IV) was also obtained from 
the same 1M solution as above (section 4.3.3.1), but this time the pressure was 
increased in a single step up to 1.1 GPa to give a polycrystalline solid. It proved 
difficult to grow a single crystal by gentle heating and cooling cycles at this pressure
Chapter 4: High-Pressure Studies of N.N'-dimethylurea
and so the pressure was decreased to 0.9 GPa. On warming to ca. 393 K all of the 
crystallites dissolved except for one, which was allowed to grow by slow cooling to 
293 K. On cooling the crystal grew to almost fill the gasket hole (Figure 4.7). After 
cci. 5 minute another small single crystal also started to grow. These two crystals are 
shown in Figure 4.7.
Figure 4.7: Optical image of two single crystals of DMU (form IV) in a diamond-anvil cell at 0.9 GPa
Single crystal X-ray diffraction data from both crystals were then collected. 
Data indexing was performed using the indexing programme CELL_NOW [33]. This 
gave a new orthorhombic unit cell with lattice parameters shown in Table 4.2. 
Reflections from both single crystals were integrated and treated separately up to the 
absorption correction step. The two unmerged reflection files were then scaled and 
merged in SORTAV [29] in the manner described in the experimental section. After 
this procedure, a data completeness of 61% was achieved. Data processing was 
performed according to the procedure described by Dawson et al. (2004) [34] and 
detailed in chapter 2. The structure was solved in space group Pbcn using direct 
methods (SIR) [31]. Data were refined using the same refinement strategy employed 
for the structure obtained at 0.7 GPa. Hydrogen atoms were placed in calculated 
positions and allowed to ride on their parent atoms. Full structural refinement details 
are tabulated in Appendix A. Crystallographic data in CIF format are available on the 
attached CD.
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Dc (g cm"’) 1.36
P (GPa) 0.90(5)
T(K) 298(2)
Table 4.2: Unit cell parameters for the crystal grown at 0.9 GPa (form IV).
4.3.4. D e s c r i p t i o n  o f  crystal structures
Crystallographic data for the two new high-pressure polymorphs along with 
two ambient forms of DMU are summarised in Table 4.3. In the case of form II, both 
low-temperature (150 K) and ambient-temperature cell parameters are reported. The 
structures of forms I and II have been previously described by Marsh et al., [19] and 
Martins et al., respectively [20].
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aForm I bForm II bForm II Form III Form IV
CSD reference 
code NIJHUJ01 - - - -
Crystal system Orthorhombic Orthorhombic Orthorhombic Monoclinic Orthorhombic
Space group Fdd2 P2{2{2 P2{2i2 P2lc Pbcn
a (A) 11.4 5.2202(15) 4.9790(10) 5.0888(10) 4.3175(13)
b (A) 20.186 10.769(3) 10.769(2) 4.5563(3) 8.488(6)
c(A) 4.594 4.5952(3) 4.5764(9) 10.2891(7) 11.752(4)
an 90.00 90.00 90.00 98.081(10) 90.00
V (Ah 1051.42 258.325(13) 245.518(12) 236.20(5) 430.7(4)
Z 8 2 2 2 4
Dr (g cm'h 1.14 1.17 1.19 1.24 1.36
P (GPa) 0.0 0.0 0.0 0.70(5) 0.90(5)
T(K) 298(2) 298(2) 150(2) 298(2) 298(2)
Table 4.3: Comparison of cell parameters of all four known polymorphs of DMU by different studies. 
In case of form II both 150 K and ambient temperature cell-parameters are presented.
In the crystal structure of all four polymorphs, DMU molecules adopt the Z- 
Z' conformation (Figure 4.8). The structures of all the polymorphs except form I 
show similar features compared to previously published structures of some N, N - 
disubstituted symmetric and asymmetric ureas [35-37]. In all of these structures the 
DMU molecule always adopts the Z-Z' conformation. However, the formation of 
chains in the crystal structure is only present in the symmetrically substituted 
molecules and all of them show alternate hydrogen bonds from one row to the 
immediate neighbouring row. In the case of form I, the structure does not show this 
alternate hydrogen bonding scheme; neighbouring chains adopt the same orientation 
that runs along the c-axis of unit cell resulting in the polar structure. The crystal 
structures of all four forms are described in the following section.
HqC„
O







Figure 4.8: Two conform,.ions of DMU molecule,; one with .wo methyl groups on .he same side 
with C=0 (Z-Z') (left) and second with methyl groups on opposite direction (E Z) (ri0ht).
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4.3.4.1. Crystal structure of form T
The crystal packing and space-filling diagrams are shown in Figure 4.9. 
Theie aie eight DMU molecules in the unit cell and all the non-hydrogen atoms are 
coplanar. DMU molecules are arranged in a head-to-tail fashion making bifurcated 
hydrogen bonds along the c-axis. Both nitrogen atoms of one molecule are hydrogen 
bonded to the oxygen atom of a neighbouring molecule, which combine to form one 
dimensional chains with an intermolecular distance of ca. 4.6 A. The angle between 
the molecular planes of neighbouring chains is 70.2°. The hydrogen bond angles are 
ca. 145° because the same oxygen atom from the C=0 group is hydrogen bonded to 
two parallel N-H groups.
Figure 4.9: Crystal packing diagram of DMU form I (left) viewed down the ¿-axis and space-fill ing 
diagram (right).
4.3.4.2. Crystal structure of form II
The crystal packing and space-filling diagrams of form II are shown in Figure 
4.10. The DMU molecules are planar and maintain the Z-Z' conformation. It is also 
evident from the structure that the similar strong inteiactions obseived in toim I ate
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found in foim II, resulting in the same lepeating structural unit i.e. chains of 
bifurcated hydrogen bond linked in a head-to-tail fashion with neighbouring chains 
repeating along the c-axis. However, in form II neighbouring chains adopt alternating 
orientations leading to a non-polar lattice that is characteristic of symmetrically 
disubstituted ureas in general and of urea form I itself [5]. The density of form II at 
room temperature exceeds that of form I by ca. 2%. Moreover, this form becomes 
significantly denser (5 %) at low temperature (150 K), which may be attributed to the 
structural flexibility along the a-axis direction, the cohesion along which is largely 
dominated by van der Waals’ interactions. This observation supports the suggestion 
that form II might be accessible via crystallisation at pressure.
Figure 4.10: Crystal packing diagram of DMU form II (left) viewed down the ¿-axis and space lill 
diagram (right).
4.3.4.3. Crystal structure of form III
The crystal packing and space-filling diagrams of the high-pressure form III 
are shown in Figure 4.11. There are two DMU molecules in the unit cell. These 
molecules are arranged in a head-to-tail fashion linked by bifuicated hydiocen bonds 
along the ¿-axis: nitrogen atoms of one molecule are hydrogen bonded to the oxygen 
atom of a neighbouring molecule, which combine to foim one dimensional 
with an intermolecular distance of ca. 4.56 A. These infinite hydiogen bonded chair 
adopt alternating orientations leading to a non-polar lattice. The diffeience betwee
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form III and the ambient-pressure forms arises from the direction of these repeating 
units. In form III, DMU molecules repeat along the ¿-axis of the unit cell instead of 
along the c-axis. The space-filling diagram (Figure 4.11) shows efficient packing of 
DMU molecules in the form of layers. The calculated density of form III at 0.7 GPa 
is 1.24 g cm'3.
/ / / /
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Figure 4.11: Crystal structure of DMU form III grown at 0.7 GPa viewed down the ¿-axis; the packing 
diagram shows an alternative arrangement of DMU chains (left) and the space-filling diagram 
showing packing of DMU in the form of layers (right).
4.3.4.4. Crystal structure of form IV
Crystal packing diagrams of form IV obtained at 0.9 GPa are shown in Figure 
4.12. All the non-hydrogen atoms are coplanar and maintain the Z-Z confoimation. 
There are four molecules in the unit cell. As in the form III stmcture, molecules pack 
as infinite chains. These infinite hydrogen-bonded chains of DMU molecules run 
parallel to the b-axis. The neighbouring chains of DMU molecules adopt alternating 
orientations, leading to a non-polar lattice. The structure of form IV is dominated by 
a two dimensional hydrogen-bonded network, where each DMU molecule accepts 
and donates two hydrogen bonds. Each molecule shows bifurcated hydrogen bonding 
with neighbouring molecules, bu, in this case a hydrogen bond is formed between an 
oxygen atom of one molecule with two nitrogen atoms of two adjacent molecules, 
resulting a zig-zag arrangement of chains as shown in Figure 4.12(c). These 
infinite hydrogen-bonded chains of DMU molecules run parallel to t e w. 
intermolecular distance between DMU molecules in adjacent chai
Chapter 4: High-Pressure Studies of N,N'-dimethylurea
(c)
Figure 4.12: Crystal structure of DMU form IV grown at 1.1 GPa viewed down the b-axis, (a) Packing 
diagrams of crystal structure shows an alternative arrangement of DMU chains, (b) the space-filling 
diagram showing efficient packing of DMU and (c) hydrogen bonding network showing each DMU 
molecule forming hydrogen bonds with two neighbouring molecules.
4.3.4.5. Hydrogen bonding (graph-set analysis)
The hydrogen bonding in DMU can be best described with the aid of graph 
set analysis. Graph-set analysis is a very useful tool to reduce complicated networks 
to combinations of simple patterns. The graph-set notations am assigned by the 
method described by Bernstein et al. [38] and obtained by PLUTO [39] and 
MERCURY [21].
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Forms I, II and III show similar types of hydrogen bonding to form infinite 
chains of DMU molecules. As described in section 4.3.3 the difference between the 
packing of DMU molecules in these polymorphs arises from the relative orientation 
of these chains in their respective crystal structure. Since there is no hydrogen bond 
between the neighbouring chains, all these polymorphs can be represented by the 
same graph-set notation. The description of the hydrogen-bond pattern in these forms 
according to the graph-set notation at the first level graph set is N\ = C(4)R'2(6) . 
Graph-set motifs for these two modifications are illustrated in Figure 4.13.
Figure 4.13: Hydrogen-bonding arrangements together with graph-set assignments of the structure ot 
form II of DMU. Since forms I, II and III all shows similar arrangements of DMU molecules only the 
form II structure is shown. Atoms highlighted in blue show the ring motil whilst atoms in red show 
the chain motif of DMU molecules.
The crystal structure of form IV is dominated by the hydrogen-bonding 
pattern, which is different from all of the other forms. The desciiption of the 
hydrogen-bonding patterns for form IV according to graph-set notation at a first level 
graph set is M = C(4)C12(6)R34(14)R56(22). Graph-set motifs for these four
modifications are illustrated in Figure 4.14.
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Figure 4.14: Hydrogen bonding pattern, with graph-set assignments, of the structure of form IV. 
Atoms highlighted in blue and yellow shows two different ring motifs whilst atoms in red and green 
show two chain motifs of DMU molecules.
Analysis of the local environment around a central molecule is also a useful 
tool to illustrate the packing of molecules in a crystal structure. Figures 4.15a and
0 f4.15b show local environments of the centroids within a sphere of radius 6.5 A tor 
forms I and II, respectively. Centroids shown in pink and green correspond to 
molecules related to the central molecule via 2-fold screw rotation and glide 
symmetry, respectively. There are four and eight molecules associated with 2-fold 
screw rotations in forms f and II, respectively. Centroids shown in red correspond to 
DMU molecules related by translation symmetry. In the case of form I, each 
molecule has two nearest neighbours below 5 A and eight fuithei neighbouis at 
distances in the range 5 - 6.5 A. In form II, there are four nearest neighbours below 5 
A and eight neighbours at distances in the range 5 -6.5 A. This illustrates the better 
packing of DMU molecules in form II. The distance between the molecules involved 
in hydrogen bonding (D...A = 2.86 A) is the same in both forms I and II and so the
105
Chapter 4: High-Pressure Studies of N,N’-dimethylurea




• - -9 ° 7\ i  // -■ ** C/5"7







Figure 4.15: The environment of a DMU molecule (centroid) in the crystal structures of (a) form I (b) 
form II (distance in A).
The local environment of DMU molecules within a sphere radius of 6.5 A for 
forms III and IV are compared in Figure 4.16. The centroids shown in red and green 
correspond to the DMU molecules related by translation and glide symmetry, 
respectively. There are four nearest neighbours from the middle centroid at distances 
in the range 4-5 A in both forms III and IV. However, two and four molecules lie 
within the range of 5-6.5 A in forms III and IV, respectively. This highlights the 
close packing of DMU molecules in form IV.
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(a) (b)
Figure 4.16: The environment of a DMU molecule (centroid) in the crystal structures of (a) form III 
(b) form IV (distances in Â).
4.3.5. H i g h - p r e s s u r e  p o w d e r  diffraction e x p e r i m e n t s
4.3.5.I. High-pressure crystallisation from melt
Form III was also obtained by in situ crystallisation from the melt at high 
pressure. In this experiment, a DAC was loaded with finely ground powder of form I 
with no pressure transmitting medium and the pressure was then increased to 0.6 ± 
0.05 GPa. At this pressure, the DAC was heated to melt the sample and on cooling a 
polycrystalline powder was formed. The powder diffraction pattern obtained from 
this sample along with the calculated pattern from single crystal data of form III 
(grown at 0.7 GPa) is shown in Figure 4.17. Compared to the calculated pattern, the 
peaks in the experimental pattern were at lower 29 values, which is consistent with 
the lower pressure at which these measurements were made. The peaks were also 
noticeably broadened on account of the non-hydrostatic nature of the expeiiments.
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Figure 4.17: Comparison of X-ray powder diffraction patterns of DMU recorded at 0.6 GPa after 
recrystallisation from the melt (blue) with the simulated powder pattern of form III (red) calculated 
from single crystal data at 0.7 GPa (X = 0.44397 Â).
4.3.5.2. Powder compression using methanolrethanol (4:1) as pressure- 
transmitting medium
Figure 4.18 shows powder diffraction patterns of DMU collected at pressures 
between ambient and 0.38 GPa. Methanol:ethanol (4:1) mixture was used as the 
pressure-transmitting medium. The pattern recorded at ambient pressure was indexed 
as form I. On increasing the pressure to 0.16 GPa, all peaks attributable to form I 
completely disappeared and a new pattern was observed which could be indexed as 
form III (lattice parameters are shown in Table 4.4). On further compression to 0.25 
GPa and then to 0.38 GPa, no significant changes were observed in the powder 
patterns except for the movement of peaks towards higher 29 values.
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F igure 4 .1 8 : X -ray  p ow d er diffraction  patterns o f  D M U  with m ethanohethanol (4 :1) as pressure- 
transm itting m ed iu m . P ow d er diffraction patterns w ere co llected  with synchrotron X -ray radiation (X 
=  0 .4 8 5  Â ) u sin g  B ea m lin e  115 at the D iam ond L ight Source, Oxfordshire.
Pressure 0.0  GPa 0.16 GPa 0.20 GPa 0.25 GPa 0.38 Gpa 0.0 GPaa 0.0 GPa"









Fdd2 P2/c P2/c P2/c P2/c P2lc Fdd2
a (À) 11.4023(10) 5.2116(8) 5.1998(6) 5.1925(6) 5.1469(6) 5.3098(11) 11.4015(19)
6 (A) 20.1516(14) 4.5794(4) 4.5771(25) 4.5762(29) 4.5741(4) 4.5764(7) 20.1762(29)
c (Â) 4.5695(4) 10.4268(12) 10.4095(12) 10.4011(11) 10.3684(12) 10.4404(18) 4.5700(5)
f t O 90 97.304(7) 97.430(4) 97.494(5) 97.657(12) 96.974(20) 90
V (A J) 1049.94(14) 246.82(5) 245.67(4) 245.04(4) 241.92(5) 251.82(8) 1051.28(25)
V /m olecule
(A3)
131.24(3) 123.41(2) 122.83(5) 122.52(2) 120.96(3) 125.91(4) 131.41(3)
z 8 2 2 2 2 2 8
T (K ) 293(2) 293(2) 293(2) 293(2) 293(2) 293(2) 293(2)
T ab le 4 .4 : L attice  param eters for D M U  at d ifferent pressures (using M eO H /EtO H  as pressure- 
transm itting m ed iu m ). a Pressure w as released  to am bient. b Powder pattern was co llec ted  after 36  
hours at a m b ien t pressure.
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In the next step the pressure was reduced to ambient, but the sample chamber 
o f the D A C  remained sealed. The powder pattern collected at ambient pressure 
(F igu ie  4.18) showed no changes except for the movement o f peaks towards lower 
2d values, ind icating that form III can be recovered at ambient pressure. The D A C  
was then left to stand for ca. 36 hours. The powder pattern collected after 36 hours 
showed that the sample had completely transformed to form I. This shows that form I 
is more stable than fo im  III at ambient conditions. Figure 4.19 shows the comparison 
o f the 2D -d iffraction  images recorded at ambient pressure before and after 36 hours. 
The image recorded after 36 hours is noticeably more textured, indicating the 
appearance o f  larger crystallites. Such an observation is often characteristic o f a 
solvent-mediated phase transition in which one form dissolves and recrystallises into 
another form . Th is  is entirely possible since D M U  is very soluble in the 
methanohethanol m ixture.
F igure 4 .1 9 : 2 -D  d iffraction  im ages o f  D M U  at am bient pressure before (left) and after (right) 36  
hours.
4.3.5.3. Powder compression using Fluorinert-FC77 as pressure-transmitting 
medium
F igu re  4.20 shows the powder patterns for D M U  collected at incteasing 
pressure steps between ambient and 1.75 GPa. F luorineit-FC77 was used as pressure
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transm itting m edium  in this case. The pattern recorded at ambient pressure was 
indexed as fo rm  I. On increasing pressure to 0.1 GPa all peaks attributable to form I 
disappeared and new peaks appeared in the pattern, indicating a phase transition. The 
pattern at 0.1 G P a  was identified as a mixture o f forms II and III. Figure 4.21 shows 
a Le  B a il f it  o f  the experimental pattern at 0.1 GPa to the lattice parameters o f forms 
II and III. The pressure was then increased in small steps to 1.75 GPa. No further 
phase transition was observed and all the patterns were indexed as a mixture o f form 
II and III, show ing that both forms persist up to 1.75 GPa. However, broadening o f 
peaks w ith  pressure suggests either non-hydrostatic conditions associated with the 
pressure-transm itting medium  or strain in the sample, perhaps indicating the onset o f 
a phase transition. U n it ce ll parameters obtained with increasing pressures for form II 
and III are shown in  Tables 4.5 and 4.6, respectively. The derived lattice parameters 
for forms II and III are h igh ly  correlated and therefore show rather sim ilar values for 
volume/molecule.
F igure 4 .2 0 :  X -ray  p ow d er patterns o f  D M U  with Fluorinert FC -77 as pressure-transm itting m edium . 
Patterns w ere record ed  at pressures up to 1.75 GPa. Pow der diffraction patterns were co llec ted  with 
synchrotron  X -ray  radiation  (k  =  0 .4 8 5 A ) u sing  B eam line 115 at the D iam ond L ight Source, 
O xford sh ire.
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dmu f1 3  H is t  x
2 - T h e t a ,  d e g
Figure 4 .2 1 : L e B a il fit p ro file  for experim ental pattern at 0 .1 0  GPa. B lack and red ticks represent 
form s II and III r e sp e c tiv e ly . O bserved intensities (red), calculated pattern (green) and difference  
(pink).













Space group P 2 ,2 ,2 P 2,2,2 P 2|2 ,2 P2,2,2 P2,2,2 P 2|2 ,2
a (A) 5.1428(6) 5.0377(8) 4.9679(7) 4.9285(8) 4.8130(9) 4.7674(9)
b ( k ) 10.7074(10) 10.5689(15) 10.4903(16) 10.4400(18) 10.3117(20) 10.2113(26)
c (A) 4 .5893(4) 4.5762(6) 4.5562(5) 4.5477(4) 4.5239(6) 4.5066(8)
V (A3) 252.72(4) 243.65(6) 237.44(5) 234.00(6) 224.52(7) 218.46(8)
V /m olecule (A3) 126.36(2) 121.83(3) 118.72(2) 117.01(2) 110.48(1) 109.23(4)
Z 2 2 2 2 2
T (K ) 293(2) 293(2) 293(2) 293(2) 293(2) 293(2)
T able 4 .5 : L attice  param eters for form II at different pressures (pow der com pression  stud.es using  
Fluorinert F C -7 7  as pressure-transm itting m edium ).
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Pressure 0.10 G Pa 0.35 GPa 0.64 GPa 0.87 Gpa 1.27 GPa 1.75 GPa
Crystal System M onoclinic Monoclinic Monoclinic Monoclinic Monoclinic Monoclinic
Space group P2/c P2lc P2lc P2lc P2lc P2/c
a (A) 5.2559(5) 5.1659(6) 5.1153(7) 5.0751(8) 4.9742(8) 4.8691(11)
6 (A) 4.5873(32) 4.5654(5) 4.5391(8) 4.5229(8) 4.4925(8) 4.4630(10)
c (A) 10.5216(8) 10.4184(15) 10.3535(19) 10.2804(18) 10.1565(20) 10.0855(23)
PC) 96.948(6) 97.520(13) 97.985(15) 98.657(12) 98.912(18) 98.397(24)
V (AJ) 251.81(4) 243.60(5) 238.07(7) 233.29(5) 224.22(7) 216.82(9)
V /m olecule (AJ) 140.90(5) 121.65(3) 119.03(8) 116.64(7) 112.11(3) 108.26(4)
Z 2 2 2 2 2 2
T (K) 293(2) 293(2) 293(2) 293(2) 293(2) 293(2)
T ab le 4 .6 : L attice  param eters for form  III at different pressures (pow der com pression studies using  
Fluorinert F C -7 7  as p ressure-transm itting m edium ).
In the next step the sample was heated to 150 °C for 10 minutes in order to 
overcome any k ine tic  barriers to potential phase transitions. The powder pattern 
recorded after heating (Figure 4.22) was completely different and could be 
successfu lly  indexed to form  IV  (lattice parameters are shown in Table 4.7). The 
sharp peaks o f  the powder pattern combined w ith the excellent powder averaging 
(Figure 4.23) strongly suggest a reconstructive phase transition that has greatly 
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Figure 4 .2 2 : C o m p a riso n  o f  p ow d er patterns recorded before (low er) and after (upper) heating the 











T ab le  4 .7 : L attice parameters for form IV at 1.75 GPa.
Chapter 4: High-Pressure Studies of N,N'-dimethylurea
800 100 1200 1400 1600 1800 2000 2200 2400 2600 000 100 120 1400 160 180 2Q0 2200 2400 2600
Figure 4 .2 3 : C om p a riso n  o f  2 -D  d iffraction  im age for D M U  sam ples at 1.75 GPa before heating (left) 
and after h eating  (right).
F in a lly  the pressure was released to ambient and this resulted in a very poor 
quality powder pattern (F igure 4.24). The diffuse rings suggest that the sample has 
become amorphous, perhaps indicating a potential phase transition that is kinetically 
hindered. Fo r th is reason the sample was heated to 80 °C for 5 minutes in order to 
overcome any k ine tic  barrier, and this greatly improved the quality o f the powder 
pattern (F igure 4.24). F igure 4.25 shows the powder pattern recorded at ambient 
pressure after heating. It is evident from the comparison o f powder patterns (Figure 
4.25) that a ll the peaks attributed to form IV  have completely disappeared and the 
sample has transformed to a new form. The powder pattern does not correspond to 
forms I, II and III or any m ixture o f the three. Unfortunately all indexing attempts foi 
this form  were unsuccessfu l; perhaps suggesting it may be a mixed phase. The D A C  
was then left for 2 hours at ambient pressure. The powder pattern recorded aftei 2 
hours (Figure 4.14) shows partial transformation o f the sample to form I.
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Figure 4 .2 4 : C om p a riso n  o f  2 -D  d iffraction  im age for D M U  sam ples at ambient pressure before 
heating ( le ft) and after h ea tin g  (right).
Figure 4 .2 5 : X -ray  p ow d er d iffraction  patterns o f  D M U  recorded after releasing pressure to ambient 
(A. =  0 .4 8 5  A ).
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4.3.6. Stability and decompression studies
The transformations between the polymorphs o f N, N'-dimethylurea 
summarised in Scheme 4.1.
are
F o r m  II
Direct compression of powder sample to 0.1 GPa in Fluorinert FC-77
F orm  II + F orm  III
Heating to 150"C at 1.75 GPa
F o r m  III Crystallisation at 0.7 GPaCrystal dissolved and recrystallised to form I on decreasing pressure to ambient pressure
► F o r m  I < -
Crystallisation at 0.9 GPa
F o r m  III
Direct compression of powder sample to 0.15 GPa in methanobethanol(4:1)
Crystal dissolved and recrystallised to form I on decreasing pressure to ambient pressure
=► F orm  IV
Maintained at ambient pressure for 36 hours. Solvent mediated conversion to form I.
F o rm  III
Depressurise to ambient pressure + heating to 80 °C
N ew  form  (fo rm  V )
Maintained at ambient pressure for 2 hours
N ew  fo rm  + fo rm  I
S ch em e  4 .1 : T ransform ations o f  polym orphs o f  D M U
The question as to whether such high-pressure forms are sufficiently 
metastable that they can be recovered at ambient conditions is naturally o f great 
importance. A l l  the above experiments show that form I is the most stable polymorph 
under am bient conditions. Compression o f the powder samples o f form I using 
F luorinert FC -7 7  as a pressure-transmitting medium produced a mixture o f forms II 
and III at 0.1 GPa. Once produced, these forms were stable up to 1.75 GPa. Form III 
was rather persistent and was also produced by the compression o f the powdei 
samples o f  form  I at 0.15 G Pa  in methanol:ethanol mixture and through the 
crysta llisation from  methanohethanol solution at 0.7 GPa. Comparison o f the crystal
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structures o f form s I, II and III, suggests that direct compression o f form I is un likely 
to in itiate a transition to form  II or III, as this would involve the concerted 
reorientation o f D M U  molecules in  alternate chains. This would be expected to give 
rise to a s ign ifican t k ine tic  barrier, and so such phase transitions are like ly  to be 
solvent-mediated. These results appear to support this view.
A l l  the recrysta llis ion  experiments performed at ambient pressure have shown 
that form  II does not seem to be a low-temperature form (at least down to -5 °C) and 
the on ly  w ay to produce it is by using high pressure. However, the choice o f solvent 
for these high-pressure experiments is crucial and form II was only produced when 
using F luo rine rt FC -77 , a f lu id  in which D M U  has only a very low  solubility.
Bo th  form s II and III can be recovered at ambient conditions but are 
metastable compared to form  I. The elusive form II was transformed to the form I by 
simple grind ing. Sam ple preparation is crucial in identifying polymorphism 
especially in  the case o f X -ra y  powder diffraction, where it is normal routine to grind 
to im prove powder quality. How ever this type o f treatment can readily induce phase 
transitions as shown in  these studies, and there are several other examples in the 
literature where this has been reported [40, 41]. This might be one o f the reasons why 
form II has not been observed until recently. Decompression studies performed on 
the powder samples o f  form  III showed that form III was recoverable at ambient 
conditions, but converted back to form  I through a solvent-mediated phase tiansition 
w ithin 36 hours.
Fo rm  IV  was produced by heating a mixture o f forms II and III to 150 C  at
1.75 GPa. It was also produced through crystallisation o f a D M U  solution in 
methanol:ethanol at 0.9 GPa. Both these experiments strongly suggest that the 
transition to fo rm  IV  is reconstructive, heat or solvation energy is needed to 
overcome any k ine tic  barrier to a phase transition. This is also evident fiom  the 
crystal structure o f  fo rm  IV  where an entirely different packing arrangement is 
observed. O p tica l observation o f a single crystal during piogiessive decompiession 
from ca. 0.9 G P a  at 293 K , showed that the single crystal gradually dissolved.
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Decompression o f  the powder sample o f form IV  to ambient pressure resulted in an 
amorphous fo rm  w h ich  on heating converted to a new form, again suggesting a 
reconstructive phase transition. Th is new form was recovered to ambient conditions; 
but after 2 hours it pa rtia lly  converted to form I. The choice o f liqu id as pressure- 
transmitting f lu id  is also very important in high-pressure experiments, presumably 
reflecting the so lub ilit ie s o f the substrates in the respective media. In this case, 
compression using methanohethanol m ixture resulted in form III whilst compression 
using F luo rine rt FC -7 7  resulted in a m ixture o f forms II and III.
4 .4 .  C r y s t a l  s t r u c t u r e  p r e d i c t i o n  ( C S P )
4.4.1. Introduction
The studies on D M U  stimulated crystal structure prediction (CSP) 
calculations b y  D r. Graeme Day at the University o f Cambridge. D M U  is a small and 
fa irly  r ig id  m o lecu le  and so should be a very good candidate for such calculations. 
The aims o f  these studies were to discover whether C SP  methods were effective in 
identify ing the experim enta lly  observed forms and also to discover whether any o f 
the predicted form s cou ld  be accessed experimentally.
4.4.2. Result and Discussion
C rysta l structure predictions were performed assuming a rigid molecular 
geometry. In keep ing the predictions b lind from the experimental results, the only 
inform ation about the observed crystal known in advance o f computational w o ik  was 
that four po lym orphs had been isolated experimentally; two o f them were obtained at 
ambient cond itions w h ils t the other two were generated at high-piessuie. The 
structure o f  the D M U  molecule shows the possib ility o f conformational changes 
around the C -N  bond. Furthermore, a search o f the C SD  [42] on D M U  and sim ilai 
molecules ind icated that the conformation around one o f the nitrogen atoms may 
change. Therefore, ca lcu lations based on D FT  (density functional theory) were
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E-Z'_planar (+5.75 kJ/mol) E-Z'_nonplanar (+4.42 kJ/mol)
Figure 4 .2 6 : F our g eo m etr ie s  o f  D M U  m o lecu le  em p loyed  in CSP search. "Z-Z" represents the trans 
conform ation  o l  m eth y l grou p s w h ilst "E-Z" represents the cis conform ation o f  methyl group around 
C = 0  bond.
In itia l energy ca lcu lations showed that the Z-Z ' conformations were the two 
lowest energy m odifica tions. Furthermore, with the Z-Z ' conformation two sets o f 
predictions were performed; these differed only in the orientation o f the hydrogen 
atoms on the m ethyl groups. The two geometries that were considered had a C -H  
bond either eclipsed w ith the C = 0  or a C -H  eclipsed with the neighbouring N -H  
bond. These are related by a 60° rotation about the N -C  bond. The two geometries o f 
D M U  m olecules used in C S P  are shown in Figure 4.27.
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Figure 4 .2 7 : T w o  g eo m e tr ie s  o f  D M U  m o lecu le  used in CSP; one with C-H o f  methyl group eclipsed  
with C = 0  bond  (le ft )  and seco n d  with C -H  bond eclipsed  with N -H  bond (right)
Ca lcu la tions were performed using a model described by T. G. Cooper et al., 
[43], Structures obtained from all these geometries were then combined and 
duplicate structures were removed by the program PLATON [44], A l l  four 
polymorphs were found in the set o f low  energy structures. Polymorphs II, III and IV  
were in the low est five  structures in the lattice energy. The CSP  results are described 
in the fo llo w in g  paragraphs.
A pp rox im a te ly  100 crystal structures o f D M U  were predicted w ithin 5 kJ 
m ol"1 o f the g loba l m in im um  in lattice energy. A  plot o f the energies and densities o f 
the lowest energy calculated crystal structures, with the experimental structures 
highlighted, is shown in Figure 4.28. Un it ce ll parameters, space groups, volumes, 
densities and energies o f the 50 lowest energy predictions are given in Table 4.8. As 
expected, a ll o f  the lowest energy structures contain N -H .. .0  hydrogen bonds; the 
length o f th is bond (H ...O ) is w ith in the range o f 1.98-2.00 A . A lmost all o f the 50 
lowest energy structures show bifurcated hydrogen bonds to form infinite chains o f 
D M U  m olecu les that run parallel to one o f unit ce ll axes. However, only two o f these 
(nos. 4 and 11) form  different arrangements o f D M U  molecule; structure no. 4 shows 
hydrogen bond ing as depicted in one o f the high-pressure forms o f D M U  (form IV) 
whilst structure no. 1 1  shows an unusual packing o f molecules and can be excluded 
from the list. In a ll these predicted structures, D M U  molecules are planar and adopt 
the Z -Z ’ conform ation.
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Figure 4 .2 8 : P lo t o f  la ttice  en erg y  against volum e for the predicted structures o f  D M U  within 5 kJ/mol 
ol the g lo b a l m in im u m . E xp erim en ta l structures are highlighted as forms I, II, III and IV.
Rank on Energy E lattice (kJ/mol) SpaceGroup a (Ä) b(k) c(Ä) «(“) f O 7 0 Volume(AJ) Densityg/cm3 notes
1 -82.06 P2lc 5.415 4.629 10.249 90 96.29 90 255 1.146 form III
2 -81.77 P2,/c 4.632 5.415 20.352 90 90.45 90 510 1.147
3 -81.70 P2Jc 8.457 7.119 8.645 90 105.95 90 500 1.170
4 -81.69 Pbcn 4.624 8.383 12.614 90 90 90 489 1.197 form IV
5 -81.66 P2{2\2 5.427 10.142 4.635 90 90 90 255 1.147 form I
6 -81.63 P2/c 10.962 4.63 10.582 90 106.71 90 514 1.138
7 -81.55 C2Jc 4.639 9.826 22.536 90 95.57 90 1022 1.145
8 -81.49 C2Jc 14.106 4.634 15.707 90 92.86 90 1025 1.142
9 -81.48 Pmmn 6.45 8.646 4.633 90 90 90.01 258 1.133
10 -81.23 P2\/c 4.652 11.681 8.951 90 91.28 90 486 1.204
11 -81.16 P2i/c 4.899 11.314 9.042 90 97.96 90 496 1.179
12 -81.15 Pnma 12.904 8.644 4.64 90 90 90 518 1.131
13 -81.07 C2/c 10.338 4.637 10.8 90.03 96.05 90.02 515 1.137
14 -81.06 C2Jc 22.957 4.632 10.272 90 110 90 1026 1.140
15 -81.03 C2ic 21.474 4.634 10.575 90 101.6 90 1031 1.136
Table 4 .8 : S u m m ary  o f  the 5 0  lo w est energy structures generated by CSP calculations. C iystal 
structures w ere  gen erated  w ith  each  o f  the 4 m olecular geom etries and then lattice energy m inim ised. 
The Is1, 4 lh ,5 th and 4 1 st ranked structures are a reasonable reproduction ot lorms III, IV, II and I ol 
the D M U .
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Rank on Energy E lattice (kj/mol) SpaceGroup a (A) 6(A) c(A) « 0 fiO 70 Volume(Ah Densityg/cm3 notes
16 -81.00 CUc 21.201 4.636 10.797 90 102.54 90 1036 1.130
17 -80.95 Pcdl\ 10.619 4.633 10.478 90 90 90 515 1.135
18 -80.93 Pl\tc 5.418 4.635 20.583 90 96.43 90 514 1.139
19 -80.84 Pile 7.88 4.631 15.349 90 118.12 90 494 1.185
20 -80.82 P-\ 4.637 5.487 11.04 82.74 85.67 68.2 259 1.132
21 -80.77 P2\/c 4.635 20.365 7.113 90 130.16 90 513 1.140
22 -80.72 Itmn2 6.457 8.645 4.649 90 90 90 259 1.128
23 -80.66 P2¡2¡2¡ 4.638 5.418 20.434 90 90 90 513 1.140
24 -80.65 Pna2\ 20.317 4.637 5.446 90 90 90 513 1.141
25 -80.64 P-1 4.639 5.78 10.98474.87 78.1 66.54 259 1.130
26 -80.64 P-1 4.638 5.797 10.94795.46 102.1 113.48 259 1.131
27 -80.64 P2Jc 11.108 4.636 10.848 90 112.78 90 515 1.136
28 -80.63 C2Jc 10.63 4.643 21.373 90 101.36 90 1034 1.132
29 -80.62 P-1 4.638 5.796 10.94795.47 102.09 113.44 259 1.131
30 -80.60 C2/c 21.468 4.634 10.609 90 101.62 90 1034 1.132
31 -80.50 CUc 10.812 4.645 21.19 90 102.63 90 1038 1.127
32 -80.50 P2\tc 4.639 8.685 12.55 90 90.33 90 506 1.158
33 -80.46 PA 4.639 7 8.42 67.79 89.96 89.54 253 1.156
34 -80.46 Pbca 7.524 8.616 15.942 90 90 90 1033 1.133
35 -80.44 P2Jc 8.331 7.421 8.447 90 103.72 90 507 1.154
36 -80.39 CUc 10.823 4.641 10.803 90 106.75 90 520 1.127
37 -80.34 Pna2¡ 4.639 10.167 10.908 90 90 90 514 1.138
38 -80.28 C2 10.613 4.644 10.972 90 106.66 90 518 1.130
39 -80.28 CUc 10.093 4.602 11.30190.16101.23 90.04 515 1.137
40 -80.21 CUc 10.51 4.601 10.86190.02 101.3 90.49 515 1.137
41 -80.21 Fdd2 21.785 10.292 4.604 90.01 90 90 1032 1.134 form I (NUHUJ01)
42 -80.15 P2\lc 4.626 15.674 7.45 90 105.68 90 520 1.125
43 -80.11 CUc 10.695 4.603 10.65689.16 101.21 89.83 514 1.138
44 -80.08 P2Jc 4.648 9.644 11.106 90 90.05 90 498 1.176
45 -80.06 P2,/c 13.325 4.564 8.344 90 104.16 90 492 1.190
46 -80.06 CUc 15.508 4.619 15.743 90 118.4 90 992 1.180
47 -80.05 CUc 15.805 4.638 14.099 90 93.12 90 1032 1.134
48 -80.03 P2, 4.641 10.493 5.792 90 113.23 90 259 1.129
49 -80.03 CUc 15.379 4.64 15.928 90 118.67 90 997 1.174
50 -80.02 P2\lc 10.984 4.637 10.612 90 106.55 90 518 1.130
T able 4 .8  (con tin u ed ): S u m m ary  o f  the 5 0  low est energy structures generated by C SP calculations.
To  account fo r the lack o f kinetic considerations in the structure prediction, as 
well as im perfections in  the model potential, some obseivations fiom  the Cambride 
Structural Database (C SD ) can be used to highlight some o f the low eneigy 
predictions that are less like ly . Fo r example, some o f the predicted polymorphs have
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very long un it ce ll axes ranging up to 42.3 A . A  search o f the CSD  has shown that 
unit ce ll axes w ith  d im ensions over 30 A  are rare, even with two molecules in the 
asymmetric unit. The rarity o f such structures in the CSD  could reflect a kinetic 
disadvantage fo r such an elongated unit ce ll axis, perhaps because this can lead to 
extreme m orpholog ies and uncompetitive overall growth rate. Five structures were 
therefore considered to be un like ly, though not impossible, based upon their unit cell 
axes. One o f the useful parameters to evaluate predicted crystal structures is the 
frequency o f space groups w h ich occur in the CSD . A  search o f the CSD  has shown 
that some space groups e.g. P2\/c, are more common whilst some are very rare. In 
the 50 lowest energy predicted structure the most frequent space group was C2/c, 
with about 40% o f  structures show ing this space group. A  second common space 
group is P2\lc, w ith  about 20% o f the structures belonging to this space group. 
Interestingly a ll o f  the four known polymorphs o f D M U  show different space groups. 
This m ight suggest that there are more D M U  polymorphs which have not been 
experimentally observed yet. In our lowest energy predicted structure list, 4 out o f 50 
structures belonged to uncommon space groups and therefore were considered to be 
un likely, though not im possib le, and could be excluded from the list. Predicted 
structures were also v iew ed w ith MERCURY [21] and PLATON [44] in order to 
exclude any structures that have unusual intermolecular interactions.
The structure corresponding to a global m inimum at -82.06 kJ mol is a 
reasonable reproduction o f  the observed form III structure. This structure is denser 
than most o f the predicted structures which is in agreement with the expeiimental 
observation that fo rm  III was obtained at high pressure (0.7 GPa).
The crysta l structure w ith  the second lowest lattice energy has a space group 
P2\/c. It is just 0.29 kJ m o l ' 1 above the global minimum. There are four molecules in 
the unit ce ll, and it shows a s im ila r hydrogen bonding pattern to that found in foims 
I, II and III. How ever, in  th is case the D M U  molecules are non-planar which results
o
in slightly d ifferent hydrogen bond lengths from one anothei, one at 1.97 A  an 
second at 1.99 A . The difference in the two hydrogen bond lengths results in a 
different graph-set notation (N\ = in comparison to forms I, II
and III. C rysta l structure no. 3 is 0.29 kJ mol ' 1 higher in energy than the global 
m inimum. Th is  is  also a P2x/c structure w ith four molecules in the unit cell, but the
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density o f th is structure is sign ificantly higher (-15%) than the previous one. 
However, the crysta l structure shows corrugated chains o f D M U  molecules. This is 
rather unusual as a ll the reported disubstituted ureas with Z -Z ’ configurations show 
linear chains. O n th is basis, structure no. 3 can be excluded from this list.
The 4 th ranked structure is a reasonable reproduction o f the form IV  structure. 
It is on ly  0.37 kJ m o l above the global minimum. The crystal structure representing 
form I was also one o f the densest structures found in the CSP. The calculated 
density o f  th is structure is 1.197 g cm '3, ca. 4.5 % higher than for the global 
m in im um  structure. T h is  result is in good agreement w ith the experimental results, as 
form  IV  was obtained by  crysta llisation at high pressure (0.9 GPa).
The 5th structure in  the list o f lowest energy structures (Table 4.8) 
corresponds to the observed form  II structure. This crystal structure is 0.40 kJ m ol"1 
higher in  lattice energy than the global minimum. Form I (one o f the ambient 
pressure po lym orphs) was also predicted by the calculations. This structure occurs 
low  in  the lis t and is represented by structure no. 41 in Table 4.8. However, this 
order can be im proved, as some o f structures (e.g. 8 , 9 and 10) can be ruled out either 
by the presence o f  unreasonable packing or uncommon space group. This structure is 
only 2.39 kJ m o l"1 h igher in lattice energy than the global m inimum structure. 
Furthermore these ca lcu la tions were performed at 0 K , therefore stability o f these 
forms m ay change. Results from  these calculations show opportunities for 
experim entally obta in ing other polymorphs.
4 . 5 .  O v e r a l l  c o n c l u s i o n s
H igh-pressure crysta llisation o f D M U  solution in methanol.ethanol (4.1) 
m ixture contained in  a diam ond-anvil ce ll at pressure 0.7 and 0.9 GPa resulted in 
formation o f  two new high-pressure polymorphs designated as foims III and IV, 
respectively. C rysta l structures o f these forms have been reported here. The 
molecular pack ing arrangement o f the new forms is very diffeient fiom  forms I and
II. However, D M U  m olecules adopt the same (Z-Z') conformation in all these forms.
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Fo rm  II was f in a lly  produced at 0.1 GPa through compression o f form I using 
Fluorinert FC -77  as a pressure-transmitting medium. This result shows that high- 
pressure techniques can be used to obtain elusive polymorphs particularly when the 
elusive po lym orph is more dense. Form  III was also produced by compression o f 
powder samples o f fo rm  I using methanohethanol mixture. It is clear from the results 
o f this study that the role o f the pressure-transmitting medium is very important; 
different pressure transm itting medium may result in different forms depending on 
the so lu b ility  o f material. Decompression o f form III immersed in methanohethanol 
showed that fo rm  III can be recovered to ambient pressure, but it was converted back 
to form  I through a so lvent mediated phase transition.
Fo rm  IV  was produced by heating mixture of form II and III to 150 °C at 1.75 
GPa. Decom pression o f form  IV  to ambient pressure resulted in formation of 
amorphous material w h ich  on heating converted to a new form. This new form was 
recoverable at ambient pressure, but partia lly converted to form I.
It is  c lear from  this w ork that high-pressure techniques under a range o f 
conditions a llow  one to obtain different polymorphs. Therefore pressure has the 
potential to add another valuable dimension to polymorph screening. C iysta l 
structure pred iction ca lcu lations have generated all four forms, and point towaids 
more, as yet undiscovered, forms that may be accessible by experiment.
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Chapter 5: An Exploration of the Polymorphism of GSK Compound A
C h a p t e r  5  
A n  E x p l o r a t i o n  o f  t h e  P o l y m o r p h i s m  o f  G S K  C o m p o u n d  A
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C h a p t e r  5 :  A n  E x p l o r a t i o n  o f  t h e  P o l y m o r p h i s m  n f  C S K  
C o m p o u n d  A  
5 -1 . B a c k g r o u n d
Com pound A  was received from G laxoSm ithK line (GSK). It is a G S K  
developmental com pound known to have H M 7 4 A  (a protein-coupled receptor) 
agonist ac tiv ity  and has shown some potential to treat dyslipid im ia (a condition 
associated w ith  e levation o f lip ids in blood). The molecular structure o f compound A  
is shown in  F igu re  5.1.
Po lym orph  screening studies had previously been performed at G SK . Solid 
material used in  these experiments (denoted as group A  by G SK) was leceived aftei 
the first batch o f  synthesis and was identified as a mixture of two forms at ambient 
temperature. These form s were designated as unknowns 1 and 2. The D SC  
(Differential Scann ing  Ca lorim etry) plot obtained from group A  (Figure 5.2) showed 
three endotherms. The peak at ca. 155 °C was the predominant form with a small 
amount o f another fo rm  show ing a small endotherm at ca. 148 C. W ith increase in 
temperature the sample melted at ca. 156 °C and then recrystallised to give another 
form w ith a m elting po in t o f ca. 164 °C. The highei melting form was
F ig u re 5 .1 : M olecu lar structure o f  com pound A
designated as fo rm  I.
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Figure 5 .2 : D S C  p lo t o f  sam p le  from  group A . * represents temperatures at w hich X-ray powder 
diffraction  patterns w ere recorded as show n in Figure 5.3.
From  the screening work, two groups o f materials, designated as B and C, 
were isolated. Samples which showed sim ilar Raman, D SC  and X R P D  (X-ray 
powder d iffraction) were designated as a group.
F igu re  5.3 shows the D S C  plot obtained from samples from group B. It 
showed a sing le  endotherm ic melting event, which indicates the presence o f a single 
form w ith  a m elting po in t o f ca. 164 °C. This form was designated as fo im  I. It was 
produced from  a s lu rry  o f sample A  maintained at > 5 C  for 24 houis. The X R P D  
pattern o f  form  I is shown in Figure 5.7.
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F ig u re  5 .3 : D S C  p lo t o f  group B , in d icating o n ly  a s in g le  en d oderm ic peak  at 164 °C.
F rom  the samples o f group C , another new form  was identified by X R P D  and 
was designated as form  II. The X R P D  pattern o f form  II is shown in F igure 5.7. It 
was produced from  a slurry o f sample A  maintained at < 5 °C for more than 24 
hours. Fo rm  II was also produced from  a slurry o f form  I in 3 % aqueous acetone 
so lu tion maintained at 0 °C for more than one week. The D S C  plot obtained from 
form  II (F igure 5.4) showed three endotherms. The first sm all peak at ca. 127 °C 
represents a so lid  to so lid  phase transition to a new form  w ith melting point at ca. 
149 °C, w h ich  u ltim ate ly converted to form  I after melting and recrysta llis ing events. 
The new form  was identified as the same unknown 2 found for group A . X R P D  
patterns recorded before and after these events (highlighted by " * " in Figure 5.5) are 
shown in F igu re  5.6. The X R P D  pattern at ambient temperature (25 °C) represents 
pure form  II, w h ich  converted to unknown 2 at ca. 135 °C.
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Figure 5 .5 : D S C  p lo t o f  group  C. * represents points where X-ray powder patterns w ere recorded as 
shown in F igure 5 .6 .
Figure 5 .6: X -ray  p o w d er  d iffraction  patterns for group C obtained at room temperature (green). 110 
C (pink), 135 °C  (b row n ) and 152 °C (blue).
F rom  the screening studies it can be summarised that compound A  had four 
polymorphs; two o f them (forms I and II) were identified from screening
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expeiim ents, w h ils t the othei two (unknowns 1 and 2 ) were identified in in itia l 
samples from  group A . Form  I has the highest melting point (at ca. 164 °C) and for 
this reason is the most stable form. Form  II is metastable w ith respect to form I and 
these form s are enantiotropically related. The transition temperature to produce form 
II from  form  I is ca. 5 C. The polymorphism  o f compound A  is summarised in 
Figure 5.8. Pow der patterns (supplied by G S K ) for forms I, II and unknown 2 are 
compared in F igure 5.7. No  single crystal structure data were available for any o f 
these forms.
The aims o f  the current investigation were therefore to obtain structural 
in form ation fo r these polymorphs, to explore whether other polymorphs can be 
obtained at ambient pressure, and to explore whether high-pressure methods can be 
used to obtain new polymorphs.
F igure 5 .7 : E xp erim en ta l p ow d er patterns o f  G SK  form I, II and unknown 2 (k  1 .5418 A )
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M e ltin g  and  
recrysta llisa tion
Form I
(m p t 164 °C )
Sample from group A
U nknow n 1 (m pt 154 °C) +  
sm all am ount o f  unknow n 2
S o lv en t
slurry
Slurry >  5 °C




(m pt 151 °C)
M e ltin g  and  
recrysta llisa tion
Unknown 2
(m pt 148 °C)
Heat 140 °C  
'(so lid -so lid  transition  
at 126 °C)
F igure 5 .8 : Polym orphism  o f  com pound A.
5 . 2 .  E x p e r i m e n t a l
5.2.1. Material
A  pow der sample o f compound A  was received from G S K . The supplied 
form  was iden tified  as form  II by X -ray powder diffraction (XRPD ). It was used 
w ithout further m od ifica tion  for high-pressure X -ray  powder compression studies. 
For the recrysta llisation experiments analytical grade solvents were used. To  obtain 
samples o f  fo rm  I, form  II was heated to 160 °C for 12 hours.
A l l  high-pressure experiments were carried out using a M errill-Bassett 
d iam ond-anv il ce ll (D A C )  (half-opening angle 40 ), equipped with a pre-indented 
tungsten gasket o f  thickness 250 pm and a 300 pm diameter hole [1]. Fot high- 
pressure crysta llisa tion  experiments, a D A C  w ith tungsten caibide backing discs was 
used [2 ],
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5.2.2. Methods
5.2.2.1. Variable temperature X-rav powder diffraction
V a iia b le  tempeiature X -ray  powder diffraction (XRPD ) experiments were 
performed, using an An ton  Parr TTK450  heating and cooling stage over the 
temperature range 20-160 °C. 1 g o f sample was presented as a flat pressed powder 
in a sample stage. X R P D  data were collected on a Bruker A X S  D 8  diffractometer 
operating at 40 k V  and 40 m A , using C u X a  radiation (k = 1.5418 A ) and equipped 
w ith a P S D  detector. Each  sample was analysed between 29 = 2-40° w ith a step size 
o f 0 .0 2 °.
5.2.2.2. Recrvstallisation at high pressure
A  ca. 0.1 M  so lu tion o f compound A  was prepared in methanol:ethanol (4:1) 
mixture. The so lu tion was then loaded together w ith a few crystallites o f the supplied 
form at 293 K  into a D A C . A  small piece o f ruby was also added in order to allow  
the determ ination o f  the pressure [3]. A fter sealing the cell, it was then subjected to 
gentle heating to d isso lve  a ll o f the so lid material. The pressure was then applied by 
tightening the screws o f  the D A C  to induce precipitation. Crystallisation was 
achieved at ca. 0.7 GPa. The temperature was then cycled near 353 K  in order to 
dissolve a ll but one o f the crystallites. Coo ling to ambient temperature at this 
pressure a lw ays resulted in  the formation o f multiple crystallites. The pressure was 
then reduced to 0.4 G P a  to facilitate growing o f single crystal material. A l l  Oi the 
crystallites except one were dissolved by gentle heating. A  single crystal grew on 
slow coo ling  to 298 K .
5.2.2.3. Recrvstallisation at ambient pressure
A l l  recrysta llisations were performed using the analytical giade solvents 
listed in Tab le  5.2. Saturated solutions were prepared by dissolving the supplied 
powder sample o f fo rm  II and crystallisation was achieved by slow coolin& 
ambient temperature. E ither powder or single crystal samples weie obtained by
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crysta llisations. Pow der samples were analysed by X R PD . Single crystal data were 
collected at 298 and 150 K  by using Bruker A P E X  C C D  diffractometer using Mo-Ka 
radiation (k = 0.71073 A ). Further details are given in the subsequent sections.
S o lv e n t S o lu b ility  (m g /m l)a a t 20  °C
A c e tic  acid 66
A c e tic  acid : w ater (50%  v:v) 33
A c e to n e 66
A ce to n e : w ater (50%  v:v) 33
CH C13 200
C y c lo h e x a n e 33
D M F 300
D M S O 133
E tO A c 66
E th anol -
IP A 33
M e C N 33
M eO H 33
N itro m eth a n e 33
T H F 100
1-b u tan ol 100
W a ter 13
Table 5 .2 : R ec ry sta llisa t io n  o f  co m p ou n d  A  at am bient p ressu re .a Solubility  data w ere provided by 
GSK.
5.2.2.4. Structure determination of form II from powder X-ray diffraction
A  pow der sam ple o f form  II (as supplied) was loaded into a 0.7 mm 
borosilicate glass cap illa ry  and mounted on a B ruker-AXS D 8  diffiactometer (at the 
University o f  S trathclyde, G lasgow). The diffractometer was equipped with a Bruker 
Lynxeye PSD . Data were co llected at room temperature (298 K) in the range 26 = 2- 
4 5 ° (6 s per step, 0.016° step size; for indexing and structure determination) and 26 = 
2 -70° (variab le count tim e scheme, 0.016° step size for Rietveld refinement [4, 5]). 
Indexing o f the pow der pattern was performed using DICVOL-04 [6 ]. Structuie 
solution was perform ed using the global optimisation piogiam DASH [7]. Da 
analysis was perform ed by  the R ie tve ld  method as implemented in Topas A  
V  4.1 [8 ], All structure refinements were carried out at The University of Strathclyde
by Prof. Alastair Florence.
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5.2.2.S. X-ray powder diffraction at high press»™
H igh -p iessu ie  powder diffraction experiments were performed using a D A C . 
A  pre-indented tungsten gasket o f thickness 250 pm  and a 300 pm diameter hole was 
used. To  im p iove  the un ifo rm ity  o f polycrystalline material, the powder was gently 
ground using a mortar and pestle prior to loading into the cell. The powder was 
loaded w ith  a sm all ruby chip to measure the pressure. Methanokethanol m ixture 
(4:1) was used as the pressure-transmitting medium in these experiments.
Pow der d iffraction  patterns were collected with high flux synchrotron X -ray  
radiation (X = 0.444 A )  using Beam line 115 at the Diamond L igh t Source, 
Oxfordsh ire. T o  im prove the un iform ity o f the cones o f diffracted radiation, the 
sample was continuously  rastered over a range o f ± 1 0 0  pm  transverse to the incident 
X -ray  beam in  order to illum inate as many individual crystallites as possible. The 
scattered rad iation was then collected on an image-plate area detector (Mar345). A n y  
intense d iffra ction  peaks due to diamonds were masked and the remaining two- 
d im ensional pattern was then integrated to obtain a one dimensional powder- 
d iffraction pattern using the program FIT2D [9].
5 .3 .  R e s u l t s
5.3.1. Variable temperature X-ray powder diffraction experiments
F igu re  5.9 shows the X -ray  powder diffraction patterns collected at increasing 
temperature, starting from  25 °C up to 160 °C. The powder pattern at 25 C  
represents pure fo rm  II.
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Figure 5.9: X -ray  p o w d er  d iffra c t io n  patterns o f  com pound A  recorded in the temperature ranges 25- 
160 °C (A.= 1 .5 41 8  A ).
It is evident from  F igure  5.9 that the starting form II persisted up to 120 °C. 
On raising the temperature to 130 °C new peaks were observed to grow (26 = 9.4, 
12.7 and 13.7°) in the pattern. A t  150 °C, the Bragg peaks at 26 - 10.4 and 13.3° 
associated w ith  form  II com plete ly  disappeared. The pattern at 150 °C therefore 
represents a pure phase and was identified as form I by comparison with the powder 
pattern obtained fo r fo rm  I (F igure 5.10). No further changes in the patterns were 
observed up to the m e lting  point at 163 °C. On cooling, the sequence of patterns 
shown in F igure 5.11 was obtained. There were no significant changes observed in 
the patterns down to -5 °C, ind icating that form II is metastable and form I does not 
convert back to form  II in  the absence o f a solvent. No evidence was obseived for the 
formation o f unknow n 2 at 126 °C. This might be due to difference o f purity o f 
sample used in th is experim ent as compared to that used by GSK.
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Figure 5 .1 0 : C o m p a riso n  o f  X R P D  pattern for form II at 150 °C (red) with experimental pattern o f  
form I (b lu e ) ( X =  1 .5 4 1 8  A ). Patterns w ere co llec ted  on different instruments.
2-theta
Figure 5 .1 1 : X -ray  p o w d er  d iffraction  patterns recorded on cooling down to -5 °C (1 =  1.5418 A).
5.3.2. Crystallisation from solution at high pressure
Pressure-induced crysta llisa tion o f a solution o f compound A  in 
methanokethanol m ixture  (4:1) was achieved at 0.7 GPa. Methanokethanol was 
selected as a so lvent system because the compound is relatively soluble in this
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mature and it serves as a good pressure-transmitting medium. All of the crystallites 
except one were dissolved by gentle heating of the cell. Cooling to ambient 
temperature at this pressure always resulted in the formation of multiple crystallites 
The pressure was then reduced to 0.4 GPa to facilitate growing of single crystal 
samples. All of the crystallites except one were dissolved by gentle heating. The 
sample was then allowed to cool until a single crystal had fully grown. Single crystal 
X-ray diffraction data were then collected. Data indexing was performed using the 
program CELL_NOW [10]. This gave a monoclinic unit cell, space group P2,/„ with 
lattice parameters a = 5.111(3) A, b = 16.399(11) Ac = 23.215(14) Â, /?= 91.79(3)°, 
and V = 1945.2(2) Â3. Comparison of the simulated peak positions (with arbitrary 
intensity) obtained from these lattice parameters with powder patterns of the known 
forms is shown in Figure 5.12. Peak positions with arbitrary intensity were generated 
by putting a hydrogen atom into unit cell using program POWDER CELL [11], It is 
evident in Figure 5.12 that this form does not correspond to any of the known 
polymorphs observed by GSK, and so this new form was designated as form III.
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2 -theta
Figure 5 .1 2  : C o m p a riso n  o f  sim u lated  peak positions (represented by tick marks) o f  form III (top) 
with ex p er im en ta l p o w d er  patterns o f  form  I (red), form II (green) and unknown II (b lue)(k =  1.5418
A).
Unfortunate ly  the poor quality o f the diffraction data caused by small sample 
size and low  completeness o f this dataset made it d ifficu lt to solve the structure from 
this data. Furthermore, optical observation o f the crystal showed gradual growth o f 
powder inside the D A C  over a period o f time (<10 minutes). Progressive 
decompression from  0.4 G Pa  at 298 K  to ambient pressure allowed these crystallites 
to be recovered. These crysta llites were then removed from the gasket and used as 
seeds to grow  sing le  crysta ls at ambient pressure from a saturated ethanol solution. 
This resulted in  the production o f needle-shaped crystals. These crystals proved to be 
highly metastable and optical observation showed that they started to tiansform to 
po lycrysta lline  powder w ith in  10 minutes. This powder was identified as form II by 
X R PD . These results prompted recrystallisation experiments at ambient pressure to 
see whether fo rm  III (obtained by high-pressure crystallisation) could be obtained at 
ambient pressure.
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5.3.4. Recrystallisation at ambient pressure
Recrysta llisa tion  experiments at ambient pressure were performed in order to 
iden tify  possib le  polym orphs o f compound A  and to obtain single crystals suitable 
foi s ing le-crysta l d iffraction studies. Saturated solutions were prepared by using 
com m on solvents shown in Table 5.2. Recrystallisation was achieved by slow  
coo ling  to ambient temperature. For all the solvents except ethanol and IPA , 
po lycrysta lline  material was produced. Ana lysis o f X R P D  patterns showed that all o f 
these powders comprised form  II. Single crystals obtained from ethanol and P A  
so lu tion were subjected to single crystal X -ray  diffraction. Results from these studies 
are described in  the fo llow ing  sections.
5.3.4.1. Recrystallisation from ethanol solution
A  saturated solution o f compound A  was prepared by disso lv ing ca. 0.5 g o f 
material in  10 m l o f hot ethanol. A fte r 20 m in o f slow cooling to room temperature, 
needle shaped crystals started to grow along the walls o f crystallisation vial. These 
needle-shaped crystals were h igh ly  metastable and optical observation showed that 
they started to transform  to powder w ith in 5-10 minutes. This powder was identified 
as form  II b y  X R P D . To  avoid this conversion, some crystals were isolated from 
so lution at an early stage. S ingle crystal x-ray diffraction data were then collected. 
Data index ing  was performed using the indexing programme CELL_NOW [10], and 
was successfu lly  indexed in a m onoclin ic unit ce ll w ith lattice parameters shown in 
Table 5.3. Integration o f data sets and global ce ll refinement were carried out using 
the program  SAINT [12] and an absorption correction for the crystal was applied 
using SADABS [13]. The structure was solved in space group P2\ln using direct
I I ̂
methods (S IR  97) [14]. Fu ll-m atrix  least-squares structure refinement against | F  | " 
was then performed using CRYSTALS [15]. Hydrogen atoms were placed in 
ca lcu lated positions and allowed to ride on their paient atom. Fu ll stmctural 
refinement details are tabulated in appendix A . Crystallographic data in C IF  format 
are ava ilab le  on the attached CD .
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Crystal System M onoclin ic M onoc lin ic
Space group P2\/n P2\!n
«(A) 5.2361(17) 5.111(3)
6(A) 16.877(5) 16.399(11)
c (A) 24.218(7) 23.215(14)
o(°) 90 90
P O 94.432(6) 91.79(3)
Y(°) 90 90
V ( A J) 2133.7(11) 1945.2(2)
Z 4 4
P(GPa) 0 . 0 0.40(5)
T(K) 293(2) 293(2)
T ab le  5 .3 : U n it  c e ll  param eters for com pound A  form  III obtained from  ethanol and high pressure 
cry sta llisa tion .
Tab le  5.3 shows the close relationship between the lattice parameters for 
form  III iden tified  at h igh pressure and the form crystallised from ethanol at ambient 
pressure. T h is  confirm s that form  III is distinct and is not the same as any o f the 
unknown form s identified  by G S K  (Figure 5.13).
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2 -theta
F igure 5 .1 3  : C om p a riso n  o f  sim ulated  pow der pattern o f  form  III (orange) with experim ental pow der  
patterns o f  form  I (red ), form  II (b lue), unknown I (brow n) and unknown II (pink) ( X -  1 .5418 A ).
5.3.4.2. Recrystallisation from IPA (isopropyl alcohol) solution
A  saturated solution o f compound A  was prepared by disso lv ing ca. 0.5 g o f 
so lid  material in 10 m l o f hot IPA. On slow cooling over a period o f 20 minutes 
b lock-shaped crysta ls were produced, which were then subjected to single crystal X -  
ray analysis. D iffraction  data were collected at both 298 and 150 K . Data indexing 
was perform ed using the indexing programme CELL_NOW [10] and gave a tric lin ic  
unit ce ll w ith  space group P-1. Lattice parameters at both temperatures are shown in 
Table 5.4. Integration o f data sets and global ce ll refinements were performed using 
the program  SAINT [12] and an absorption correction for the crystal was applied 
using SADABS [13]. The structure was solved in P- 1 using direct methods (SIR  97) 
[14]. Fu ll-m a tr ix  least-squares structure refinement against | f | "  was then 
performed using CRYSTALS [15]. Hydrogen atoms were placed in calculated 
positions and a llow ed to ride on their parent atoms. Fu ll structural lefinement details
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are tabulated in  appendix A . Crystallographic data in C IF  format are available on the 
attached C D .
Form IV Form IV
Crystal System T ric lin ic T ric lin ic
Space ̂ roup P - l P - l
«(A) 8.667(5) 8.9117(13)
b( A) 10.2340(6) 10.2523(14)
c (A) 13.2989(8) 13.3658(19)
a (°) 109.258(3) 108.744(7)
P(°) 98.285(3) 99.604(7)
Y (°) 107.830(3) 108.028(7)
y (Â'\ 1021.15(11) 1050.6(3)
Z 2 2
Dc (g cm'3) 1.44 1.40
T(K) 150(2) 298(2)
T a b le  5 .4 : U n it c e ll param eters for form  IV o f  com pound A  at 150 and 298  K.
F igu re  5.14 shows the comparison between simulated powder pattern 
(calculated from  sing le  crysta l structure) w ith all the other known forms. It is evident 
that th is fo rm  does not correspond to any o f the known forms and is therefore 
designated as fo rm  IV .
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F igure 5 .1 4 : C om p a riso n  o f  X -ray pow der diffraction patterns o f  polym orphs o f  com pound A  ( k  =  
1 .5 41 8  A ).
5.3.5. Structure determination of form II
The crystal structure o f form  II was solved ab initio from powder diffraction 
data. F ixed  count time powder data sets were used for indexing attempts using 
DICVOL-04 [6 ] and resulted a tric lin ic  unit cell, space group P-1 w ith lattice 
parameter a = 4.4956 A , b = 13.9295 A , c = 17.4897 A , a = 77.9990°, /?= 83.2950°, 
7  = 81.2290° and V = 1054.665 A 3.
The background was subtracted from the data prior to Paw ley fitting (Pawley 
% 2 = 6.39). The sim ulated annealing (SA) component o f DASH [7] (0.02 coo ling rate, 
1.5 x 107 moves per run, 500 runs) was used to solve the crystal structure o f form  II. 
The internal coordinate description o f the molecule was derived fiom  the single­
crysta l structure o f form  IV. 292/500 S A  runs returned a profile % / Paw ley % latio  
o f less than 10, w ith  the lowest profile  value being 17.11 (Figuie 5.15).
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F igu re 5 .1 5 : O b serv ed  (b lu e), calcu lated  (red) and d ifferen ce (pink) p rofiles from  D A S H  for the best 
S A  run for form  II.
Inspection o f the best 10 S A  runs shows the excellent consistency o f the 
g lobal m in im um  returned by the search, w ith the position, orientation and 
conform ation o f the molecules essentially identical (Figure 5.16). A  pre lim inary tig id  
body refinement in D A S H  confirmed a lack o f significant prefeired orientation 
effects in  the data.
F igure 5 .1 6 : O verlay  o f  the m o lecu le  taken from the top 10 solu tions returned by the 5 0 0  D A S H  runs. 
T h e e x c e lle n t  rep rod u cib ility  sh o w s that the structure has been su ccessfu lly  so lved , with no ev id en ce
o f  d isord er or su p erp osition  of equal scattering groups.
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The structure was refined against data in the range 20 = 3.0-70° using a 
restrained R ie tve ld  method as implemented in TOP AS Academ ic v 4 . 1  [8 ], All 
structure refinements were carried out at the University of Strathclyde by Prof 
Alastair Florence. A scale and background on ly refinement o f the structure yielded 
an /?wp o f 0.0564 w hich fe ll to 0.0403 during the refinement. Overlay o f observed 
and ca lcu lated patterns w ith the difference profile  is shown in  Figure 5.17. A l l  
atom ic positions (includ ing H-atoms) for the structure were refined, subject to a 
series o f  restia ints on bond lengths, bond angles and planarity. Isotropic temperature 
factors (i/iso) fo r non-H-atoms were constrained to be equal whilst the Uiso values o f 
H -atom s constrained to be 1.2 times that for the parent atoms. Refined lattice 
parameters fo r the structure o f form  II are shown in Table 5.5
1 6 0 0 0
1 4 0 0 0
-o<0 Qfl “ 0 
iS  - 3 0-o
4 0
T w o  t h e t a  /  d e g r e e s
F igure 5 .1 7 :  F inal o b served  (p o in ts), calculated  (line) and d ifferen ce [(yobs - y ca lc ) /c (y o b s)]  p ro liles  
for the R ie tv e ld  re fin em en t o f  form  II.
149
Chapter 5: An Exploration of the Polymorphism of GSK Compound A
Form II










Dc (g c m 3) 1.398
T(K) 298(2)
T ab le  5 .5 : U n it c e ll parameters o f  G S K  com pound A  form  II.
5 . 4 .  D i s c u s s i o n
C rysta llog raph ic  data for a ll o f the structurally characterised forms (II, III and 
IV ) are summarised in Table 5.6. In the case o f form IV , both low  temperature (150 
K ) and ambient-temperature ce ll parameters are reported. The molecular structure o f 
com pound A  w ith  numbering scheme used in this work is shown in Figure 5.18. The 
conform ation o f the molecule can be described by four torsional angles; 0X (C3-N4- 
C 1 0 -C 1 1) i.e. tw isting o f the term inal butyl chain w ith respect to the diazine ring B , 
62 (C 5 -N 6 -C 17 -C 18 ) i.e. tw isting o f the second butyl chain (chain B) w ith respect to 
the ring  B , 03 (C19-C20-C21-N25) i.e. tw isting o f ring C  (oxadiazole ring) w ith 
respect to chain B , and 6 4  (024-C23-C26-C27) i.e. tw isting o f the terminal pyrid ine 
ring w ith  respect to the ring C. These torsional angles are shown by arrows in the 
F igure 5.18 and calculated by using the program MERCURY [16].
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F o r m  II F orm  III F o r m  IV F o r m  IV
C r y s ta l  s y s te m T riclin ic M onoclin ic Triclinic T riclinic
S p a c e  g r o u p P -\ P 2 |/n P - 1 P - l
a (À ) 4 .4 9 5 1 9 (6 ) 5 .2 3 6 1 (1 7 ) 8 .6 67 (5 ) 8 .9 1 1 7 (1 3 )
b (Â ) 1 3 .9 2 8 4 (2 ) 16 .877(5) 10.2340(6) 10 .25 23 (1 4 )
c (A ) 1 7 .4 8 9 5 (3 ) 2 4 .2 1 8 (7 ) 1 3 .2989(8 ) 1 3 .3658(19)
a  (°) 7 7 .9 6 6 0 (1 6 ) 9 0 .0 0 1 09 .258(3 ) 1 08 .744(7 )
13 O 8 3 .3 2 3 3 (1 1 ) 9 4 .4 3 2 (6 ) 9 8 .28 5(3 ) 9 9 .6 0 4 (7 )
Y (°) 8 1 .2 2 5 7 (1 6 ) 9 0 .0 0 107 .830(3) 108 .028(7 )
V  (k * ) 1 0 5 4 .4 9 (3 ) 2 1 3 3 .7 (1 1 ) 1021 .15 (11) 1050.6(3)
z 2 4 2 2
D r (g  c m  ') 1 .398 1.38 1.44 1.40
T (K ) 2 9 3 (2 ) 2 9 3 (2 ) 150(2) 2 93 (2 )
T ab le  5 .6 : C om p arison  o f  unit ce ll parameters for form s II, III and IV o f  com pound A.
F igure 5 .1 8 :  T h e  m olecu lar structure o f  G S K  com pound A  with num bering sch em e em p loyed  in this  
w ork. T h e  m o lec u le  is  d iv id ed  into four rings designated  A -D  and tw o four carbon chains A and B. 
T orsion a l a n g le s  are sh ow n  by red arrows.
5.4.1. Description of crystal structure of form II
The crysta l packing diagram for form II is shown in Figure 5.19. There are 
two m olecu les in the unit ce ll which form dimer units by making two hydrogen 
bonds between 0 1 5 -H .. .N 9  o f each molecule. The 015...N9 distance is cm 2.75 A.
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F igure 5 .1 9 : C rystal p ack in g  diagram  o f  form  II v iew ed  dow n the a -a x is  (left) and the hydrogen  
b on d ed  d im er unit (right).
The conform ation o f the molecules w ith respect to the four torsional angles is 
illustrated in Table 5.7.
5.4.2. Description of crystal structure of form III
The crysta l packing diagram for form III is shown in Figure 5.20. There are 
four m olecu les in the unit cell. S im ila r to the crystal structure o f form II, molecules 
pack as d im er units by making two hydrogen bonds between 0 1 5 -H ...N 9  o f each 
m olecule. H ow ever the 015...N9 distance is ca. 2.66 A , shorter than in form II 
(015 ...N 9  = 2.75 A ). The crystal structure shows disorder in the terminal butyl chain 
(Cha in A )  and the atoms o f two sites at distribution with ca. 60:40 % occupancy. 
Th is is to be expected as the terminal chain is not involved in any inteim olecular 
contacts and can move freely. Due to deterioration o f crystals on cooling, diffraction 
data were not co llected at lower temperatures.
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F ig u r e  5 .2 0 :  C rysta l p a c k in g  d iagram  o f  form  III v ie w e d  d o w n  th e a -a x is  (to p ) and h y d r o g en  b o n d ed  
d im er  u n it (b o tto m ).
The  conform ations o f m olecu les in the crysta l structure o f  fo rm  III are 
en tire ly  d iffe ren t com pared to form s II and IV  (see Tab le  5.7). The con fo rm ation  o f 
m o lecu les in  fo rm  III a llow s m o lecu les to get c lose  together through hydrogen 
bonding.
T o r s io n a l  a n g le F o r m  II F o r m  I I I F o r m  IV
0 . 0 9 7 .6 7 8 .7  &  109 .1 -9 8 .7
02 C ) -7 4 .3 9 5 .2 8 3 .7
03 0 0 .4 3 .6 -3 .6
04 0 -1 2 .8 1 7 9 .8 1 7 7 .6
T a b le  5 .7 : C o m p a r iso n  o f  torsio n al a n g le s  fo r  fo rm s II, III and IV . T h e  tw o  v a lu e s  o f  9\ fo r  fo rm  III 
a rise  b e c a u s e  o f  d iso rd er  in  th e term ina l b u ty l ch a in .
153
Chapter 5: An Exploration of the Polymorphism of OSK Compound A
5.4.3. Description of crystal structure of form TV
C rysta l pack ing diagram for form IV  is shown in Figure 5.21. There are four 
molecules in the unit eell. S im ila r to forms II and III, molecules are packed as dimer 
units by m aking two hydrogen bonds between 015 -H ...N 9  o f each molecule. The 
015 ...N 9  distance is ca. 2.77 Ä , comparable to form II (015-N9 = 2.75 Ä ) and 
longer than form  III (Q15-N9 = 2.66 Á).
Figure 5 .2 1 : C rystal p ack in g  diagram  o f  form IV v iew ed  dow n the a-axis (top) and hydrogen bonded  
dim er unit b otto m )
The conform ation o f molecules in the crystal structure of form IV  is different 
from  form s II and III (see Table 5.7). A l l three forms show differences in these 
torsional angles, ind icating a high degree torsional flex ib ility  of the molecule. The
154
Chapter 5: An Exploration of the Polymorphism of GSK Compound A
difference in conform ation among these forms is strikingly illustrated in the overlay 
diagram (F igure  5.22).
F igure 5 .2 2 : O v erlay  o f  com p ou n d  A  m olecu les as they pack in Forms II (red), III (b lue) and IV  
(p ink).
5 . 5 .  H i g h - p r e s s u r e  p o w d e r  d i f f r a c t i o n  e x p e r im e n t s
X -ra y  powder patterns were collected at increasing pressure steps between 
ambient and 3.5 G P a  (Figure 5.21). The pattern recorded at ambient pressure was 
indexed as fo rm  II. It is evident from Figure 5.21 that the starting form persisted up 
to 0.6 GPa. The on ly  change observed was the movement o f peaks towards higher 26 
values; th is is more prominent at higher angles. In the next step pressuie was 
increased to 0.9 GPa. A t this pressure new peaks were observed to g iow  in the 
pattern e.g. at ca. 3.1° and 5.7° (indicated by arrows in Figure 5.21). F igu ie  5.22 
shows that the powder pattern at 0.9 GPa does not correspond to any o f the known 
forms even taking into account the possible effects o f pressure on the patterns, and 
was therefore designated as form V. On further increase in pressure to 1.4 GPa more
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new peaks emerged in the pattern. However, these peaks were at entire ly different 29 
values and were not associated w ith either form  V  or form  II and for this reason this 
new torm  was designated as form  VI. F igure 5.22 shows the powder pattern o f form  
V I  compared w ith  the other forms. However, the powder pattern at 1.4 G Pa 
represents a m ixed phase as Bragg peaks associated w ith form V  were present in the 
pattern. A l l  the indexing attempts were unsuccessful. On further increase in pressure 
up to 2.5 G Pa  the powder pattern sim p lifies somewhat, but not a ll the peaks 
attributed to form  V  disappeared. No  further changes were observed in powder 
pattern by increasing pressure to 3.5 GPa.
F igu re 5 .2 1 : X -ray  p ow d er patterns o f  G SK  com pound A  recorded at pressure up to 3 .5  G P a (X -  
0 .4 4 4  A ).
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F ig u re 5 .2 2 : C om p a riso n  o f  polym orphs o f  com pound A  (A, =  1 .5418  A).
In an attempt to recover these high-pressure polymorphs, the pressure was 
gradua lly  released. Powder patterns obtained by decreasing pressure in steps down to 
am bient are shown in Figure 5.23. In the first step the pressure was released to 1.0 
GPa. F rom  the powder pattern at 1.0 GPa it is evident that form  V I persists down to 
th is pressure, and the on ly  change observed was movement o f peaks towards lower 
29 values. On decreasing the pressure to 0.7 GPa peaks attributable to form  V  
emerged in the pattern, indicating a reversible phase transition back to form  V . On 
further decrease in pressure to ambient, the sample converted back to form  II.
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F ig u re 5 .2 3 : X -ray  p ow d er patterns o f  G S K  com pound A  recorded after re leasin g  pressure d ow n  to 
0 .2  G P a  (A, =  0 .4 4 4  A ).
5 . 6 .  C o n c l u s i o n s  a n d  f u t u r e  d i r e c t i o n s
The transformations between the polymorphs o f compound A  are summarised 
in  Schem e 5.1.
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G r o u p  A
U n kn ow n  1 +  sm all 
am ount o f  unknow n 2
F o r m  III
F o r m  I -  ► Form  II * ------
Sln rrv <r* S °r* n , ^  F o r m  III
F o r m V  -+■ *  F o r m  V I F o r m  IVDecompression at 1.0 GPa
S ch em e 5 .1 : T ransform ations o f  p olym orp h s o f  co m p ou n d  A .
The high-pressure recrystallisation o f compound A  in a methanol:ethanol 
(4:1) m ixture contained in a diamond-anvil ce ll at a pressure o f 0.4 G Pa  resulted in 
the form ation o f  a new high-pressure polymorph designated as form  III. A lthough it 
was not possib le  to obtain the crystal structure at high pressure, it was possib le to 
recover th is form  to ambient pressure. The recovered sample was used as a seed to 
obta in sing le  crystals o f form  III from  ethanol solution at ambient pressure and the 
structure o f  form  III was obtained by single crystal X -ra y  diffraction. Form  III turns 
out to be h igh ly  metastable at ambient pressure and converted to form  II w ith in  10 
m inutes.
Another new polym orph (designated as form  IV ) was also obtained from  
crysta llisa tion  from  IP A  solution o f form II at ambient condition and its crystal 
structure has been reported here. The crystal structure o f form  II was obtained for the 
firs t tim e from  X -ray  powder diffraction data. A l l  these forms show s im ila r hydrogen 
bond ing m otifs as m olecules pack as dimer units through the formation o f two 
hydrogen bonds. However, the main difference in the packing arrangement arises 
from  the conform ationa l fle x ib ility  o f the molecule.
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Two new high-pressure forms designated as forms V and VI were identified 
at 0.9 and 1.4 GPa respectively, from the compression studies performed on the 
powder samples of form II. Decompression studies have shown a reversible 
transformation of these forms to form II.
These studies show the importance of the starting form in polymorph 
scieening experiments. Samples from group A (mixture of unknowns 1 and 2) were 
used as starting material in the screening experiments performed at GSK, but our 
studies were carried out using form II as starting material and resulted in two new 
forms (form III and IV), neither of which were produced in GSK screening 
experiments. On the other hand unknowns 1 and 2, found in the initial samples 
(group A), were not produced in our experiments. These forms might be examples of 
"disappearing" or elusive polymorphs where a polymorph may only be observed 
once before a new, more thermodynamically stable polymorph is crystallised. The 
crystallisation of the second form results in the ‘disappearance’ of the previous 
polymorph. Several examples of ‘disappearing’ polymorphs given in the literature 
have illustrated the importance of seed crystallites in the formation of the stable 
polymorph; once seed crystallites of the more stable form were present in the 
laboratory it proved impossible to obtain the other polymorphs [17],
Future work on this compound would focus on structural characterisation of 
form I and the high-pressure forms V and VI. It would also be of interest to 
investigate compression of forms I, III and IV.
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C h a p t e r  6  
A n  E x p l o r a t i o n  o f  t h e  P o l y m o r p h i s m  o f  G S K  C o m p o u n d  B
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C h a p t e r  6 : A n  E x p l o r a t i o n  o f  t h e  P o l y m o r p h i s m  o f  G S K  
C o m p o u n d  B
6 . 1 .  B a c k g r o u n d
Com pound B  was received from  G laxoSm ithK line  (G SK ), Stevenage, U K . It 
is  a G S K  developmental compound known to have pharm acological activ ity, but the 
deta ils have not been disclosed by G S K . The m olecular structure o f compound B  
w ith  the numbering scheme used in this w ork is shown in F igure 6.1.
F igure 6 .1: M o lecu lar structure o f  com p ou n d  B w ith  num bering sch em e.
Po lym orph screening studies had previously been performed at G S K . Form  I 
was the firs t form  to be identified. Figure 6.2 shows the D S C  p lot obtained from  a 
sample o f  fo rm  I, w h ich shows on ly one endothermic event, representing melting o f 
fo rm  I at ca. 188 °C.
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Exo Do'm Temperature (°C) uiivwsai V3.es ta ireiiunems
F igure 6 .2 : D S C  p lot obtained  from  form I sam ple. A  s in g le  endotherm ic p eak  sh o w s m eltin g  o f  form  
I at ca. 188 °C.
The po lym orph screening experiments showed the existence o f form  I along 
w ith  three solvates formed w ith D C M  (dichloromethane), T F E  (trifluoroethane) and 
CHCI3 (chloroform ). However, on heating almost a ll o f the solvated samples showed 
add itiona l thermal events after de-solvation and subsequent m elting o f form  I. The 
D S C  p lot obtained from  the D C M  solvate is shown in Figure 6.3. It showed three 
endotherms representing three forms. The first peak at ca. 188 °C represents melting 
o f fo rm  I w h ich  after recrystallisation resulted in a new form w ith a melting point o f 
ca. 212 °C. On further increase in temperature this new form  recrystallised into 
another form  w ith a melting point o f ca. 218 °C.




213 30 C 
23 92JJ
F igu re 6 .3 : D S C  p lo t o f  D C M  so lvate, sh o w in g  three endotherm s representing three forms.
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A  series o f experiments was then performed at G S K  in an attempt to isolate 
the suspected additional forms o f compound B. In total, four additional anhydrous 
(unsolvated) forms (designated as form  II-V) were obtained and characterised from 
th is w ork. The preparation o f these forms is described in the fo llow ing  section.
Form II
Form  II was generated in a hot stage m icroscopy experiment performed on a 
sample o f the solvate formed w ith CHC13. The sample was heated at 10 °C/m in until 
it melted at 200 °C. On cooling, needle-shaped crystals started to grow from  the melt 
(F igu re 6.4). These crystals were then used to seed a slurry o f form  I held at 60 °C in 
ethyl acetate fo r 24 hours. The so lid obtained was analysed by  Raman spectroscopy, 
X R P D  and D S C  and identified as a new anhydrous form. Th is form  was designated 
as fo rm  II. The D S C  plot obtained from  a sample o f form  II is shown in F igure 6.5.
F ig u re 6 .4 : Im a g e taken from  hot stage m icroscop e sh ow in g  grow th o f  n eed le  shaped  crystal from  
m elt o f  form  II on  c o o lin g .
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F igure 6 .5 : D S C  p lo t obtained  from  sam p les o f  form  II. S in g le  endotherm  represents m eltin g  o f  form  
II at ca. 2 0 3  °C.
Form III
Fo rm  III was generated in a D S C  temperature cyc ling  experiment performed 
on a sam ple o f the C H C I 3 solvate. The sample was heated to 204 °C at 10 °C/min, 
coo led  to ambient temperature and then heated to 250 °C at 10 °C/min. The resulting 
D S C  p lo t (F igure 6 .6 ) indicates the conversion o f form I to a new form  w ith a 
m elting po in t at ca. 208 °C and is designated as form  III. A  second sample was also 
prepared in  a s im ila r manner, heated to 204 °C and then cooled to ambient to obtain 
samples fo r X R P D  analysis. IR  and Raman spectra were also recorded, and these 
data were deemed suffic ient to designate this form  as anhydrous form  III. Numbers 
o f  experim ents were performed in solution using the sample o f form  III produced in 
the D S C  experim ent as seeds. These were unsuccessful in producing form  III, but 
instead generated form  II and form  IV  (see below).
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F ig u re 6 .6 : D S C  p lo t obtained  from  sam p les o f  CHC13 solvate. T he sam ple w as first heated to 2 04  °C  
in ord er to the m elt sam p le  (first endotherm  at ca. 188 °C represents m eltin g  o f  form  I). T he sam p le  
w a s then c o o le d  to 5 0  °C and this resulted in recrystallisation  o f  the m elt to form  III. A  seco n d  
en d o th erm  at ca. 2 0 8  °C represents m elting o f  form  III. On further heating, form  III con verted  to a 
n ew  fo rm  w ith  a m eltin g  poin t o f  ca. 2 19  °C (exp lain ed  b elow ).
Form IV
Fo rm  IV  was produced from  recrystallisation o f compound A  using form  III 
as seeds. A  th in slu rry o f form  I was formed at 60 °C in E tO Ac . Th is was heated to 
70 °C, fo rm ing  a clear solution and held at this temperature for 10 minutes. The 
so lu tion  was then cooled to 50 °C, and seeded w ith form III material obtained from  
thermal c y c lin g  experiments. The solution was then cooled to 30 °C. The resulting 
so lid  was then isolated by filtration and analysed by IR and Raman spectroscopy and 
X R P D . These data were deemed sufficient to designate this form  as anhydrous form  
IV . The X R P D  pattern o f form IV  is shown in Figure 6 .8 .
Form V
Fo rm  V  was generated in D S C  temperature cyc ling experiments performed 
on fo rm  IV . A  sample o f form IV  was heated to 217 °C at 10 °C/mm, cooled to 50 °C 
and then heated to 250 °C. The resulting D S C  plot (Figure 6.7) shows the conversion
o f fo rm  IV  into form  V .
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F igu re 6 .7 : D S C  p lo t obtained  from sam p les o f  form  IV. T he sam ple w as first heated to 2 17  °C in 
order to m elt all form  IV  (first endotherm  at ca. 213  °C represents m eltin g  o f  form  IV ) then c o o led  to 
0 0  C  and th is resu lt in crysta llisa tion  to form V. S econ d  endotherm  at ca. 219  °C represents m eltin g  
o f  form  V .
A  second sample o f form V  was also prepared in a similar' manner and was 
used as seed to try to generate form  V  from saturated solution o f compound B. 
How ever, this was unsuccessful, and form II was generated every time. S tab ility  
studies perform ed at G S K  on all o f the forms have shown that form II is the most 
stable form  at ambient conditions and for this reason was the developmental form  for 
further studies.
From  a ll the above polymorph screening results it can be summarised that 
com pound B  has five  anhydrous polymorphs. There are no single crystal data 
ava ilab le fo r any o f  these forms. X -ray  powder diffraction patterns o f all these forms 
are com pared in F igure 6 . 8  and the melting points for these forms are tabulated in 
Tab le 6 . 1 .
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F ig u re 6 .8 : C om p arison  o f  experim ental X-ray pow der pattern o f  p olym orphs o f  com p ou n d  B (A. =
1.544 A ).






T ab le 6.1: M elting points o f  polym orphs o f  com pound B.
The high-pressure studies described in this chapter aimed to identify whether 
(a) any o f  the five  forms could be obtained under pressure, and (b) any further 
po lym orphs cou ld  be obtained at high pressure.
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6 .2 . E x p e r i m e n t a l
6.2.1. Material
G S K  compound B  was received from G S K  Stevenage, U K . The supplied 
fo im  was identified as form  II on the basis o f X -ray  powder d iffraction 
measurements. Fo r the recrystallisation experiments analytica l grade solvents were 
used.
A l l  high-pressure experiments were carried out using a M errill-Basse tt 
d iam ond anv il ce ll (D A C )  (half-opening angle 40°) [1] and a pre-indented tungsten 
gasket o f th ickness 250 pm  w ith 300 pm  diameter hole.
6 . 3 .  R e s u l t s  a n d  d i s c u s s i o n
6.3.1. Recrystallisation from solution at ambient pressure (crystal 
structure of form II)
S ing le  crystals o f G S K  compound B  were obtained from  slow  coo ling  o f a 
saturated so lution (ca. 0.5 M ) in  ethanol. S ingle crystal X -ray  d iffraction data were 
co llected  at 150(2) K  on a Bruker Smart C C D  diffractometer em ploy ing M o -K a  
rad iation (k = 0.71073). Indexing was performed using the indexing programme 
CELL_NOW [2] and identified a tr ic lin ic  unit ce ll, space group P- 1 w ith lattice 
parameters shown in  Table 6.2. Integration o f the data sets and g lobal ce ll 
refinem ents were carried out using the program SAINT [3]. The intensity data were 
corrected fo r absorption by SADABS [4]. The structure was solved in  P-1 using direct 
methods (S IR  97) [5]. Fu ll-m atrix  least-squares structure refinement against | F |2 
was then performed using CRYSTALS [6 ]. Hydrogen atoms were placed in  calculated 
pos itions and a llow ed to ride on their parent atom. F u ll structural refinement details 
are tabulated in appendix A . Crystallographic data in C IF  format are availab le on the 
attached C D .
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D c (g cm 3) 1.30
T (K) 150(2)
Table 6.2: Unit cell parameters for form II of compound B.
6.3.2. Description of crystal structure of form II
The crystal packing in form II, together with a space-filling diagram, is 
shown in Figure 6.9. There are two molecules in the unit cell which form dimer units 
via two hydrogen bonds between N6-H...024 of each molecule (Figure 6.10). These 
dimer units are further linked with neighbouring dimer units by secondary hydrogen 
bonds formed between N25-H...N1 atoms. This results in infinite chains of dimer 
units parallel to the è-axis of the unit cell. Hydrogen bonding in form II can be best 
described with the aid of graph-set analysis. The graph-set notations are assigned by 
the method described by Bernstein et al. [7] and confirmed by P L U T O  [8] and 
M E R C U R Y  [9]. The description of the hydrogen-bond pattern in form II according to 
the graph-set notation at the first level graph set is N\ = C(4)R22(24). The C(4) motif 
represents chain arrangements of dimer unit as shown in Figure 6.10, whilst the R i 
motif represents ring of atoms formed by dimer unit, n -n interactions (shown by red 
arrows in Figure 6.10) are also present in molecules of the dimer unit. Distances 
between the molecules involved in these interactions are shown in Table 6.3.
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Figure 6.9: Crystal packing diagram viewed down c-axis (left) (hanging red contacts show hydrogen 
bonds) and space-filling diagram (right) for form II.
Figure 6.10: Hydrogen bonded chains of dimer units in form II. Red arrows show n-n interaction 
between aromatic rings of the molecules.
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Table 6.3. Distance between molecules involved in hydrogen bonding and k-k interaction for form II.
The conformation of the molecule in the crystal structure can be described by 
thiee totsional angles (Figure 6.11); 6\ (C14-C9-C7-N6) i.e. twisting of the terminal 
azole ring with respect to the phenyl ring, 02 (C14-C13-C17-C22) i.e. twisting of 
pyridine ring with respect to the phenyl ring and 03 (C19-C20-C23-O24) i.e. twisting 
of the terminal chain with respect to the pyridine group. These torsional angles are 
calculated using the program M E R C U R Y  [9] and are shown in Table 6.4.
Figure 6.11: Compound B molecule with description of torsional angles, 9\ = C14-C9-C7-N6, 02 = 
C 14-C13-C17-C22 and 03 = C 19-C20-C23-O24.
Torsional angle
0, (C14-C9-C7-N6) 31.2°
(C14-C 13-C 17-C22) 46.2°
03 (C19-C20-C23-O24) 23.1°
Table 6.4: Description of torsional angles for form II.
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6.3.3. Direct compression of single crystal of form II
High pressures for single-crystal X-ray diffraction studies were generated 
using a Merrill-Bassett diamond anvil cell (DAC) [1] equipped with 600 pm culet 
diamonds and a tungsten gasket. A single-crystal of form II and a small ruby chip 
were loaded into the DAC (Figure 6.12), together with Fluorinert-FC77 as a 
pressure-transmitting medium. The pressure applied to the sample was determined by 
the ruby fluorescence method [10] using the 632.8 nm excitation line from a He-Ne 
laser. The fluorescence was detected by a Jobin-Yvon FabRam 300. High-pressure 
data sets were collected on a Bruker A P E X  I I CCD diffractometer by using co-scans 
in 12 settings of 20 and cp with step size 0.3° for 40 s [11]. The first data set was 
collected at ambient pressure. Indexing of the reflections confirmed the known 
triclinic form II of compound B. Diffraction data were then collected at incremental 
steps of pressure up to 3.82 GPa. Data indexing from all the data sets were performed 
using the indexing programme C E L L _ N O W  [2], Fattice parameters at pressures up to
3.8 GPa are compared in Table 6.5. On raising the pressure to 4.2 GPa the crystal 








Figure 6.12: Single crystal of form II loaded with ruby and Fuorinert-FC77 as pressure-transmitting
medium (PTM).
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All single-crystal data sets up to 3.8 GPa were processed according to the 
procedure described by Dawson et al. [12]. Integration of data sets and global cell 
refinement were carried out using the program S A IN T [3], in which ‘dynamic masks’ 
were used in order to prevent integration of areas of the detector shaded by the body 
of the DAC. An analytical correction for the absorption by the D A C  component was 
then applied using S H A D E [13] and an absorption correction for the crystal was 
applied using S A D A B S [4], Known fractional coordinates were taken from the form 
II crystal structure and a full-matrix least-squares-refinement against |F| was 
performed using the program C R YS T A LS [6]. Isotropic refinement of non-H atoms 
was used to ensure a high data:parameter ratio. Hydrogen atoms were placed in 
calculated positions and fixed during refinement. Because of high /?-factor, the 
crystal structure at 3.8 GPa is not reported. Crystallographic data for all the other 
structures in CIF format are available on the attached CD.
Figure 6.13 illustrates the variation of unit cell parameters with increasing 
pressure. There is a continuous decrease in cell lengths a, b and c; the a-angle 
increases, whilst the /?- and y- angles decrease with increasing pressure. Figure 6.14 
shows the variation of unit cell volume with increasing pressure. The unit cell 
volume decreases by ca. 20 % between ambient pressure and 3.8 GPa. This large 
decrease in volume suggests a high compressibility for form II. A  continuous 
decrease in the volume also shows that there is no 1st or 2 order phase transition 
associated with compression.
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Figure 6.14: Variation of unit cell volume of form II with increasing pressure.
Compression studies were also performed on the powder samples of form II. 
Finely ground powder samples of form II along with a ruby chip were loaded into a 
DAC. Fluorinert-FC77 was used as the pressure transmitting medium. Raman 
spectroscopy was used to identify any structural transition with pressure.
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Scans with acquisition times of 15 minutes were collected at incremental 
pressure steps between ambient pressure and 2.5 GPa. Figure 6.15 shows the Raman 
spectra plotted at selected pressures. From ambient pressure to 2.5 GPa, no 
significant changes were observed in the spectra, thus confirming that no pressure- 
induced phase tiansition occurs under these conditions.
Figure 6.15: Raman spectra of form II with increasing pressure.
Over the studied pressure range, no significant changes were observed in the 
molecular conformation or in any of the primary bond lengths and angles of the 
molecule. The hydrogen bonding interactions N6...024 and N25...N1 both become 
shorter, although rather surprisingly it is the shorter of the two that is the more 
compressible. It appears to be approaching a limiting value of 2.56 A (at 3.2 GPa) 
which from our past experience indicates an onset of a phase transition. The n -n  
interactions also become shorter over this pressure range (see Table 6.6).
D i s t a n c e  (A) 0 .0 0 .3 0 .5 1 .4 2 .0 2 .5 3 .2
G P a G P a G P a G P a G P a G P a G P a
N6...024 2.88 2.86 2.69 2.66 2.63 2.60 2.56
N25...N 1 3.07 3.05 3.03 2.98 2.96 2.94 2.93
jt-7t interaction 3.91 3.69 3.57 3.35 3.29 3.25 3.18
Table 6.6: Variation of intermolecular distances for form II with increasing pressure.
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Figure 6.16 shows the structural overlay of molecules at ambient and 3.2 
GPa. The only changes observed were a ca. 8° twist in d\ and a ca. 5° twist in 02. The 
vaiiation ol the thiee torsional angles, 6\, 02and #3 with pressure are shown in Table 
6.7.

















0i (°) 34.6 33.8 32.1 31.3 30.2 28.7 26.8
02 O 46.1 43.9 42.9 42.3 42.8 41.8 40.9
03 0 19.6 21.4 19.2 18.1 17.4 18.2 17.8
Table 6.7: Variation of torsional angles for form II with increasing pressure.
The apparent stability of form II structure with respect to pressure is 
presumably a result of the particular crystal structure of form II in which the 
molecules pack as dimer units by making two hydrogen bonds, locking the molecules 
into a specific conformation. This conformation is also stabilised by the 71-Ji 
interaction between the pyridine rings of the two molecules involved in dimei 
formation. Application of pressure results in more dense packing, with loss of voids 
in the structure (as depicted in Figure 6.17) without a change in the geometiy i.e. the 
barrier to molecular rearrangement is presumably high and cannot be achieved 
simply by compression. These observations therefore piompted a study using 
recrystallisation from solution at high pressure.
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Figure 6.17: Comparison of space-filling diagrams for form II at ambient pressure (left) and 3.2 GPa 
(right).
6.3.4. Crystallisation from solution at high pressure
A  ca. 1M solution of compound B was prepared in methanol:ethanol (4:1) 
mixture. The solution was then loaded along with a few crystallites of compound B 
(form II) at 293(2) K into a DAC. A small piece of ruby was also added in order to 
allow the determination of the pressure by laser fluorescence spectroscopy 10 The 
pressure was increased to a minimum in order to form a sealed system and the cell 
was then subjected to gentle heating to dissolve all of the solid material. Pressure was 
then applied by tightening the screws of the DAC to induce precipitation. 
Crystallisation was achieved at ca. 0.6 GPa. The pressure was then reduced to 0.4 
GPa in order to facilitate growth of a single crystal. The temperature was then cycled 
near 353(2) K in order to dissolve all but one of the crystallites. On slow cooling to 
293(2) K  a single crystal grew (Figure 6.18). The pressure within the gasket hole was 
determined to be ca. 0.4 GPa. Diffraction data were collected on a Biuker A P E X  I I  
C C D  diffractometer by using co-scans in 12 settings of 20 and cp with step size 0.3 
for 40 s. Data indexing was performed using the indexing programme C E L L _ N O W  
[2], This gave a monoclinic unit cell with space group P2\hi. Lattice parameters are
shown in Table 6.8.
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grown at 0.4 GPA
Figure 6.18: Optical image of single crystal of compound B in diamond-anvil cell grown at 0.4 GPa.
0.4 GPa (form VI)
Crystal System Monoclinic









D c (g cmJ) 1.32
P (CPa) 0.40(5)
T (K) 293(2)
Table 6.8: Unit cell parameters for form VI of compound B.
Data processing was performed according to the procedure described by 
Dawson et al. (2004) [12]. Integration of data sets and global cell refinement were 
carried out using the program S A IN T [3], in which ‘dynamic masks’ were used in 
order to prevent integration of areas of the detector shaded by the body of the DAC. 
An analytical correction for the absorption by the D A C  component was then applied 
using S H A D E  [13] and an absorption correction for the crystal was applied using 
S A D A B S [4]. The structure was solved in space group P2\ln using direct methods 
(S H E L X ) [14]. Full-matrix least-squares structure refinement was then performed 
using C R Y S T A L S [6]. Isotropic refinement of non-H atoms was used to ensure a high 
data:parameter ratio. Hydrogen atoms were placed in calculated positions and
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allowed to ride on their parent atom. Full structural refinement details are shown in 
Appendix C. Crystallographic data in CIF format are available in the attached CD.
Figure 6.19 shows the comparison between the calculated powder pattern 
horn single crystal data for the high-pressure form with the experimental powder 
patterns of all the known forms of compound B. It is evident that the new high- 
piessure loim does not correspond to any of the known form and so this new form is 
designated as form VI.
Figure 6.19: Comparison of simulated X-ray powder diffraction pattern calculated from single crystal 
data for high-pressure form (top) with the experimental X-ray powder patterns of all known 
polymorphs of compound B (k -  1.544 Â).
6.3.5. Description of crystal structure of high-pressure form (form 
Y u
Figure 6.20 shows the packing and space-filling diagrams for form VI. There 
are four molecules in the unit cell. It shows different airangements of molecules 
compared to form II. There is no dimer formation in the structure. In form VI, 
molecules are linked together by forming two hydrogen bonds between N25 and 024 
atoms (N25-H...024), with a N25...024 distance = 2.93 Â. This results in infinite
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chains of hydrogen-bonded molecules running parallel to the b-axis (Figure 6.21). 
These hydrogen-bonded chains adopt alternating orientations with respect to 
neighbouring chains. Molecules in the form VI crystal structure show different 
conformations compared to form II; the three torsional angles are compared in Table 
6.9. All three torsional angles are different between these forms, indicating a high 
degree of torsional flexibility for the molecules. The differences in conformations for 
these forms can best be seen in the overlay diagram (Figure 6.22).
Figure 6.20: Crystal packing diagram viewed down c-axis (left) and space-tilling diagram (right) of 
form VI.
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Figure 6.22: Comparison of molecular conformations for form II (blue) and VI (red).




Table 6.9: Comparison of torsional angles between form II and VI.
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6.3.6. Decompression studies
The question as to whether this high-pressure form can be recovered to 
ambient conditions was naturally of great importance. Pressure was gradually 
released from 0.4 GPa to ambient pressure at 293(2) K. Optical observation showed 
that the single crystal of form VI survived on decompression (Figure 6.23) showing 
no reconstructive phase transition. However, optical observation of the crystal does 
not rule out a non-reconstructive phase transition. Figure 6.24 shows the comparison 
between Raman spectra recorded at 0.4 GPa and ambient pressure. It is evident from 
the comparison that there is no phase transition; both spectra are identical and form 
VI has been recovered. This was confirmed by recording single crystal X-ray 
diffraction data of the recovered crystal at ambient pressure. A  unit cell of a -  
10.0199(6), b = 9.9211(4), c = 21.4471(9) and ¡3 = 102.939(4) was obtained, 
consistent with that of form VI.
Figure 6.23: Optical image of form VI at ambient (left) and 0.4 GPa (right).
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Raman Shift (crrf1)
Figure 6.24: Comparison of Raman spectra of form VI collected at 0.4 GPa and ambient pressure. 
Raman spectrum for form II (top) is also shown for comparison.
6.4. Conclusions a n d  future w o r k
The polymorphism in compound B is summarised in scheme 6.1. Compound 
B has shown rich polymorph behaviour. This could probably have been predicted on 
the basis of its molecular structure, where conformational flexibility can result in 
different polymorphs. Six polymorphs along with three solvates of compound B have 
been identified; transformation between these forms is shown in scheme 6.1.









Heated to 50 °C (de-soivation) Form I -(m.p 186 °C)
Heated to 200 °C and then cooled to 50 °C. (Recrystallisation from melt)
------------ ► Form II
Recrystallisation of saturated solution in EtOAc
Heated to 204 °C and then cooled to 50 "C.
Form IV < -(m.p 212 °C) Form III(m.p 208 °C)
(m.p 203 °C)
Crystallisation at high pressure (0.4 GPa)
Form VI
Heated to 210 °C and then cooled to 50 °C.
Form V(m.p 219 °C)
Scheme 4.1: Transformations of polymorphs of compound B.
The work presented in this chapter has demonstrated that high-pressure 
crystallisation can be used to prepare a new polymorph, designated as form VI. A  
single crystal was grown at 0.4 GPa and the structure was successfully solved.
The crystal structure of most stable form (form II) has been obtained for the 
first time. Direct compression of a single crystal of form II has shown an unusually 
high compressibility for the structure with no phase transition up to 3.8 GPa. By 
increasing pressure to 4.2 GPa the crystal disintegrated, suggesting a reconstructive 
phase transition. Form II is an example of a structure where molecules are locked 
into a specific conformation. This conformation is stabilised by hydrogen bonding 
and n-iz interactions and suggests a high kinetic barrier towards molecular
Heated to 217 °C and then cooled 50 °C.
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rearrangement in the solid. It shows a good example where recrystallistion from 
solution has been successfully used to lower the kinetic barrier for molecular 
rearrangement to obtain a new polymorph (form VI) at high pressure.
Decompression studies have shown that the high-pressure form (form VI) can 
be recovered to ambient conditions. Recovery of form VI at ambient pressure is of 
significant importance as it is a good example of a high-pressure form being 
recovered to ambient pressure. Further work to investigate the stability of form VI 
with respect to other forms is of particular interest and will very likely lead to 
interesting results. Bulk preparation of the high-pressure forms at ambient pressure is 
another area of interest. Further work is envisaged in this respect e.g. recrystallisation 
at ambient pressure using seeds of form VI for bulk preparation of this form.
It is clear from this work that high-pressure techniques, especially high- 
pressure crystallisation, allow one to obtain different polymorphs. In particular 
compound B shows an example of a pharmaceutical substance where not only a new 
form is obtained, but can also recovered to ambient pressure. Therefore pressure has 
the potential to add another valuable dimension to polymorph screening of 
pharmaceuticals.
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C h a p t e r  7: Conclusions. General R e m a r k s  a n d  Future 
Directions
7.1. Conclusions
The high-pressure techniques described in this thesis have been shown to be 
very successful means for the preparation of both new and elusive polymorphs of 
complex molecular compounds e.g. pharmaceuticals. Structural information has been 
obtained at elevated pressures, including structure solution and refinement of a 
variety of new high-pressure forms. A  key factor contributing to this success has 
been the combination of techniques that include single-crystal X-ray diffraction, X- 
ray powder diffraction, and Raman spectroscopy.
An elusive polymorph of a potent analgesic drug substance, mefenamic acid, 
has been obtained from crystallisation of ethanol solution at 0.6 GPa and dry milling 
of powder samples. Two new polymorphs of mefenamic acid designated as form III 
and form IV have been obtained from compression studies on powder samples using 
methanolrethanol and Fluorinert-FC77, respectively. Two new high-pressure 
polymorphs, designated as form III and form IV of N,N'-dimethylurea (DMU) have 
been obtained using the high-pressure recrystallisation technique at 0.7 and 0.9 GPa, 
respectively. These forms were also produced by compression of powder samples of 
D M U  using methanokethanol mixture as pressure-transmitting medium. 
Decompression studies have shown that form III can be recovered to ambient 
pressure, but is metastable with respect to form I. Decompression of powder samples 
of form IV resulted in the formation of another new form. Powder compression 
studies using Fluorinert-FC77 as pressure-transmitting medium also revealed that the 
elusive form II of D M U  could also be produced through high-pressure techniques, 
particularly when the elusive polymorph is more dense. These studies show that the 
choice of liquid as pressure-transmitting fluid is also very important in high-pressure 
experiments, reflecting the importance of solvent-mediated transitions.
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High-pressure techniques have been shown to be an excellent tool for probing 
polymorphism in more complex pharmaceutical compounds. This is underlined by 
the high pressure studies of G S K  developmental compounds A  and B. New 
polymorphs for these compounds have been obtained at high pressure. Of particular 
importance are form III and form VI of compounds A  and B, respectively, where 
these high-pressure forms were obtained through high-pressure crystallisation and 
can be recovered to ambient pressure. From the compression studies performed on 
the powder samples of compound A, two new high-pressure forms designated as 
forms V  and VI were also identified. New polymorphs of these compounds were also 
produced from recrystallisation at ambient pressure. These studies show the 
importance of the starting form in polymorph screening experiments as these new 
forms were not produced in G S K  screening experiments, where different starting 
polymorphic forms were used. In contrast, some of the forms obtained at G S K  were 
not found during the course of the high pressure experiments, thus emphasising that 
high-pressure techniques are complementary rather than a direct replacement for 
conventional screening methods.
7.2. General r e m a r k s  a n d  future directions
There are several reasons why pressure is effective in the discovery of new 
polymorphs, particularly when combined with recrystallisation from solution. High- 
pressure conditions encourage structures in which molecules pack together more 
efficiently, leading to closure of voids in the structure. This means that changes in 
the relative orientations of molecules in a solid are very likely to occur, thereby 
giving rise to different motifs of intermolecular interactions. These interactions are 
themselves sensitive to distance, and hence to the effects of pressure. The strengths 
of these intermolecular interactions are susceptible to the relatively modest pressures 
used in these studies.
High-pressure crystallisation from solution removes the need for excessively 
high temperatures and overcomes the barrier to molecular rearrangement in the solid 
since the lattice energy is now overcome by solvation energy. Furthermore, the
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interaction between solute and solvent molecules are also modified by pressure 
thereby changing the solubility of given polymorph. In some cases the solubility 
difference between two or more forms might also be expected to change, thereby 
encouraging recrystallisation of one polymorph at the expense of another. The 
changes in the solvent properties under pressure are still poorly understood, but 
clearly play a significant role in the high-pressure crystallisation process.
Further work to investigate the high-pressure behaviour of pharmaceutical 
materials will very likely lead to improvements in the scope of polymorph screening. 
Of particular interest could be recovery and bulk preparation of high-pressure 
polymorphs.
The work presented in this thesis also highlights the challenges associated 
with high-pressure single-crystal X-ray diffraction and powder X-ray diffraction, one 
of the most important being the restricted reciprocal space caused by the diamond- 
anvil cells. The design of high-pressure cells that will improve the access of X-ray to 
the sample chamber is therefore an area of current interest. New strategies for the 
collection of single-crystal high-pressure data are also expected to attract 
considerable attention e.g. data collection of multiple crystals within the cell to 
improve data completeness and the use of shorter X-ray wavelengths to improve 
coverage of reciprocal space.
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A p p e n d i x  A :  Crystallographic D a t a
Crystallographic Information Files for the structures described in Chapters 3, 4, 5 and 
6 are on the attached CD.
Chapter 3: Mefenamic acid form II
F o r m  I I
C r y s t a l  d a t a
Chemical formula c I5h 15n o 2
Mr 241.29
Cell setting, space group Triclinic, P-l
a, b, c (Ä) 7.7900(15), 9.1890(18), 9.4120(19)





No. of reflections for cell parameters 418




Crystal form, colour Block, colourless
Crystal size ( m m ) 0.1 x 0.1 xO.15
D a t a  c o l l e c t i o n
Diffractometer Bruker SMART
Data collection method ca scans
Absorption correction multi-scan (SADABS)
7min 0.630
7max 1.000
No. of measured, independent and observed 
reflection
4003, 1210
Criterion for observed reflection I > 2a(i)
Rint 0.0269
0max (°) 20.87
Range of h, k, 1 -7 h -* 7 
-9 -* k 9 
-9 —»/ —>• 9
R e f i n e m e n t
Refinement on F
R factor, wR factor, S 0.0953,0.0942, 1.23
No. of reflection 418
No. of parameters 73
H-atom treatment Riding
Weighting scheme w' x [ 1 - (AFobs / 6 x AFest)2]2 
w' =[P„T0'(x) + P,T,'(x) + ...P ^ T ^ 'M r1,
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where P, are the coefficients of a Chebychev 
series in t;(x), and x = Fcalc/Fcalcmax.
P0 - P„-i = 3.28 -0.337 1.88
(̂ tt)max <0.0001
P̂max> APmin (eA3) 0.50, -0.46
Extinction method none
Table 1: Crystal, collection and refinement details for M A  form III at 0.3 GPa
Chapter 4: N, N-dimethylurea (form III and form IV)
' Form III Form IV
Crystal data
Chemical formula c3h8n2o c 3h8n2o
Mr 88.10 86.10
Cell setting, space group Monoclinic, Pile Orthorhombic, Pbcn
a, b, c (Ä) 5.0888(10), 4.5563(3), 
10.2891(7)
4.3178(12), 8.490(6), 11.757(4)
«, Â y (°) 90, 98.081(10), 90 90, 90, 90
V(À3) 236.20(5) 430.7(4)
z 2 4
Dx(M g m'3) 1.24 1.36
Radiation type MoKa Mo/fa
No. of reflections for cell 
parameters
137 and 140 385 and 159
9 range (°) 4.001-23.053 3-23
ß (mm'1) 0.094 0.103
Temperature (K) 298(2) 298(2)
Pressure (GPa) 0.70(5) 0.90(5)
Crystal form, colour Block, colourless Block, colourless
Crystal size (mm) 0.12x0.16x0.30 0.10x0.10x0.15
Data collection
Diffractometer Bruker SMART Bruker SMART
Data collection method co scans co scans
Absorption correction Empirical & multi-scan 
(,SADABS)
Empirical & multi-scan 
(SADABS)
T ■1  min 0.87 0.76
T1  max 0.99 0.99
No. of measured and 
independent reflections
150, 137 200, 200
Criterion for observed 
reflection
/ > 2(3(1) / > 2c(l)
înt 0.000 0.0359
9m ax O 23.05 23.3457
Range of h, k, 1 -2 -► h - »  1 
0 -> k-> 5  
0 -*/-*  11
-4 —► h ->4 
-6 —> k —> 6 
-12 12
Refinement
Refinement on F F
/?-factor, vvR-factor, S 0.050, 0.055, 1.20 0.05,0.049, 1.10
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No. of reflection 111 124
No. of parameters 29 29
H-atom treatment Riding Riding
Weighting scheme w' x [1 - (AFobs / 6 x AFest)2]2 
w'=[PoTo'(x) + P,T,'(x) + ...Pn. 
iT„.,'(x)]-',
where P, are the coefficients of a 
Chebychev series in t,(x), and x =
f ca!c/fca|cmax*
P0 - P„.i = 6.46 -2.45 4.37
w' x [1 - (AFobs / 6 x AFest)2]2 
W'=[P0T0'(x) + PIT1'(x) + ...Pn. 
.Tn.,'(x)r‘,
where P; are the coefficients of a 
Chebychev series in ti(x), and x =
Tcalĉf calcmax-
P0 - P„., = 6.42 -3.77 3.79
(A/o)max <0.0001 <0.0001
P̂maxi ̂ Pmin (cA ) -0.12,-0.14 -0.19, -0.19
Extinction method none none
Table 2: Crystal, collection and refinement details for D M U  form III and form IV
Chapter 5: GSK Compound A
GSK Compound A (form III)
Crystal data
Chemical formula C20 H22 C,i N7 O3
Mr 443.89
Cell setting, space group Monoclinic, P2 ¡/n
a, b, c (À) 5.2361(17), 16.877(5), 24.218(7)
a, (3,y (°) 90, 94.432(6), 90
V(À3) 2133.7(11)
Z 4
D t(Mg m 5) 1.38
Radiation type MoKa (0.71073 À)
No. of reflections for cell parameters 425




Crystal form, colour Needles, colourless
Crystal size (mm) 0.10x0.10x0.5
Data Collection
Diffractometer Bruker SMART
Data collection method (p and co scans
Absorption correction Empirical & multi-scan (SADABS)
T 0.6651
T 0.7449
No. of measured and independent reflections 6142, 3056
Criterion for observed reflections I > 2 o(I)
0.0394
0m:1V (°) 23.53
Range of h, k, 1 -5 —  h -»5 -15 —> k—» 18 




/?-factor, w/?-factor, S 0.0063,0.025, 1.20
No. of reflection 805
No. of parameters 276
H-atom treatment Riding
Weighting scheme w' x [ 1 - (AFobs / 6 x AFest)2]2 
w' =[P0T 0'(x) + P ,T|'(x) + ...Pn.,Tn.1'(x)]-1, 
where Pi are the coefficients of a Chebychev 
series in ti(x), and x = Fcalc/Fcalcmax.
Po-Pn.,= 2.73-2.91 1.97
(A/o)max <0.0001
P̂maxi P̂min (eA" ) 0.29, -0.26
Extinction method none
Table 3: Crystal, collection and refinement details for GSK compound A form III
GSK Compound A 
form IV (298 K)
GSK Compound A 
form IV (150 K)
Crystal data
Chemical formula C20 H22 Cl, n7 o3 C20 H22 Cl, n 7 o 3
Mr 443.89 443.98
Cell setting, space group Triclinic P-1 Triclinic P-l










Dr(Mg m 3) 1.40 1.44
Radiation type MoKu. MoA'a
No. of reflections for cell parameters 1944 1944
8 range (°) 3-22 3-22
ß (mm‘ ) 0.220 0.226
Temperature (K) 298(2) 150(2)
Crystal form, colour Block, colourless Block, colourless
Crystal size (mm) 0.11 x 0.21 x 0.24 0.11 x 0.21 x 0.24
Data collection
Diffractometer Bruker SMART Bruker SMART
Data collection method cp and co scans co scans
Absorption correction Empirical & multi-scan 
(.SADABS)




No. of measured and independent 
reflections
13900, 4291 12433,4155
Criterion for observed reflections I > 2o(/) / > 2o(I)
Rint 0.0400 0.0442
a™ n 26.4889 26.3867
Range of h, k, I - l l -* A ->  11 
-12 12 
-15 —>/-> 16
-10 —> h —>10 
-12 —► fc—*• 12 
-16 - W —  16
Refinement
Refinement on F F2
R-factor, wR- factor, S 0.056, 0.167, 1.01 0.047, 0.127, 1.000
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No. of reflection 4021 4155
No. of parameters 280 280
H-atom treatment Riding Riding
Weighting scheme w' x [1 - (AFobs / 6 x AFest)2]2 
w' =[P0T 0'(x) + P|T|'(x) + ...Pn. 
iTn-lXx)]1,
where Pj are the coefficients of 
a Chebychev series in ti(x), and 
x Fca]c/Fcaicmax.
P0 - P„.i = 0.280 0.294 0.963E- 
01
Calculated = l/[a2(F02) + 
(0.072P)2 + 0.650P] 
where P = (F02 + Fc2)/3
(A/o)max <0.0001 <0.0001
APmax> ^PminjtV) 0.36, -0.27 -0.25,0.51
Extinction method none none
Table 4: Crystal, collection and refinement details for GSK compound A form IV
Chapter 6: GSK compound B
F o r m  I I F o r m  V I  
( h i g h - p r e s s u r e  f o r m )
C r y s t a l  d a t a
Chemical formula C22H23F1N4O3 O3211-1 ■ 1N4O3
Mr 410.45 410.45
Cell setting, space group Triclinic, P-l Monoclinic, P2)/n




«, ß, y n 92.7920(10), 102.9880(10), 
106.1160(10)
90, 102.987(8), 90
V (A ) 1048.94(5) 2060.5(4)
z 2 4
DA Ms mJ) 1.30 1.32
Radiation type MoKa MoA'a
No. of reflections for cell 
parameters
9176 1766
6 range (°) 5-61 3-20
p (mm1) 0.094 0.096
Temperature (K) 150(2) 298(2)
Pressure (GPa) 0.00 0.40(5)
Crystal form, colour Block, colourless Block, colourless
Crystal size (mm) 0.12x0.27 x 0.55 0.10x0.10x0.15
D a t a  c o l l e c t i o n
Diffractometer Bruker SMART Bruker SMART
Data collection method co scans co scans






No. of measured, independent 
and observed reflection
16977,5854 1357,1294
Criterion for observed 
reflection




0ma* (°) 30.5242 26.487
Range of h, k, 1 -12 —> A —> 12 
-14 13 
-15—W —  16
-5 — /i —» 5 
-11 -^ k -*  11 
-25 —*■ / —» 25
Refinement
Refinement on F F
R-factor, w/?-factor, S 0.0502, 0.0523, 1.10 0.0871,0.0891,0.98
No. of reflection 5040 686
No. of parameters 271 121
H-atom treatment Riding Riding
Weighting scheme w' x [ 1 - (AFobs / 6 x AFest)2]2 
w' =[P0T 0'(x) + P |T,'(x) + ...Pn.
iTn-l'(x)]1,
where P, are the coefficients of a 
Chebychev series in t,(x), and x
— Pcaic/Pcalcmax-
P0 - Pn_, = 0.870 0.640 0.534 3
w’ x [1 - (AFobs / 6 x AFest)2]2 
w' =[P0T 0'(x) + P,T,'(x) + ...P„-
iTn-.'fx)]1,
where Pj are the coefficients of a 
Chebychev series in ti(x), and x 
— Fcaic/Fcaicrnax.
P0 - P„-i = 7.68 -3.21 3.92
(A/o)max 0.0006 0.0001
Apmax> APminl i F T 0.41,-0.26 0.24, -0.25
Extinction method none none
Table 5: Crystal, collection and refinement details for GSK compound B form II and form VI.
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A p p e n d i x  B:
Chapter 4: Polymorph Screening of N.N'-dimethvlurea
No. Solvent Drug substance (mg) Solvent (ml)
1 1,4-Dioxane 100 0.75
2 1-Butnol 75 0.75
3 1-Propanalol 75 0.75
4 Acetic acid 100 0.75
5 AcOH: Water (50 %) 100 0.75
6 Acetone 100 0.75
7 Acetone:Water (1%) 75 0.75
8 Acetone:Water (50%) 100 0.75
9 Benzonitrile 75 0.75
10 Trichloromethane 75 0.75
11 Chlorobenzene 50 0.75
12 Cyclohexane 50 0.75
13 Cyclohexanone 75 0.75
14 Dichloromethane 100 0.75
15 DEGDME 50 0.75
16 Dimethycarbonate 50 0.75
17 Dioxane:Water (1%) 50 0.75
18 DMSO 175 0.75
19 Ethylacetate 75 0.75
20 Ethylacetate:Cyclohexane (1:2) 50 0.75
21 Ethylacetate:Toluene (1:2) 75 0.75
22 Heptane 35 0.75
23 Isopropylalcohol 50 0.75
24 IsopropylalcohohiPrOAc (1:2) 75 0.75
25 IsopropylalcohohWater (1%) 50 0.75
26 Isopropylether 50 0.75
27 Isopropyl acetate 75 0.75
28 Acetonitrile 50 0.75
29 Acetonitrile:Water (1%) 50 0.75
30 MEK 50 0.75
31 Methylacetate 75 0.75
32 Methanol 75 0.75
33 Methanol:Water (1%) 75 0.75
34 MethanohWater (20%) 75 0.75
35 MethanohWater (50%) 75 0.75
36 MIBK 50 0.75
37 Nitromethane 50 0.75
38 NMP 175 0.75
39 Polyethyleneglycol 100 0.75
40 TBME 50 0.75
41 Trifluoroethanol 100 0.75
42 Tetrahydrofuran 75 0.75
43 Tetrahydrofuran:Water (1%) 75 0.75
44 Toluene 75 0.75
45 Water 100 0.75
46 Ethanol 100 0.75
47 MethanohEthanol (4:1) 100 0.75
48 DMF 75 0.75
Table 6: Solvent used in automated polymorph screening of N,N'-dimethylurea.
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A p p e n d i x  C: Conferences a n d  Lecture Courses Attended
Year 1
P os ter  presentations:
Nasir Abbas, Iain D. H. Oswald, Colin R. Pulham, Clare Anderton, Alistair Lennie, 
and Timothy J. Prior. Exploring polymorphism and solvate formation of urea 
using high pressure. British Crystallographic Association Spring Meeting. 
Canterbury, UK, April 2007.
L ectu re  courses:
11th BCA-CCG Intensive Course on X-ray Structural Analysis, Durham, UK, March
2007. Organised by the British Crystallographic Association.
Science Communication in Action and Presentations Skills. Organised by the 
University of Edinburgh.
Participated in Summer Science Exhibition 2007, The Big Squeeze. Organised by 
The Royal Society, UK.
Year 2
O ra l presentations:
Nasir Abbas, Colin R. Pulham and Clare Anderton. Exploring polymorphism in 
pharmaceuticals using high-pressure techniques. GlaxoSmithKline, Stevenage 
UK, March 2008.
P oster  presentations:
Nasir Abbas, Iain D. H. Oswald, Colin R. Pulham, Clare L. Anderton, Alistair Lennie, 
and John E Warren. Exploring polymorphism and solvate formation in 
pharmaceuticals using high pressure techniques. British Crystallographic 
Association Spring Meeting. York, UK, April 2008.
Nasir Abbas, Iain D. H. Oswald, Colin R. Pulham, Clare L. Anderton, Alistair Lennie, 
and John E Warren. Exploring polymorphism and solvate Formation in 
pharmaceuticals using high pressure. Erskine Williamson day. CSEC, Edinburgh,
2008.
Lectu re  courses:
Summer school on Application of Synchrotron techniques. Oxford, August 2008. 




O ra l p resen ta tion s:
Nasir Abbas, Colin R. Pulham and Clare Anderton. Exploring polymorphism in 
pharmaceuticals using high-pressure techniques. GlaxoSmithKline, Stevenage, 
UK, October, 2009.
Nasir Abbas, Colin R. Pulham, Clare Anderton, Graeme Day, Alistair Lennie, 
Timothy J. Prior and Annette Kleppe. Exploring polymorphism and solvate 
formation using high pressure. Edinburgh University Postgraduate Meeting, 
Firbush, Scotland, March 2009.
P o s te r  p resen ta tion :
Nasir Abbas, Iain D. H. Oswald, Graeme Day, Colin R. Pulham, Clare L. Anderton, 
Alistair Lennie, and John E Warren. Exploring polymorphism of N,N'- 
dimethylurea using high pressure techniques. CPOSS open day, University 
College London, UK, March 2009.
Nasir Abbas, Iain D. H. Oswald, Graeme Day, Colin R. Pulham, Clare L. Anderton, 
Alistair Lennie, and John E Warren. Exploring polymorphism and solvate 
formation in N,N'-dimethylurea using high pressure techniques. British 
Crystallographic Association Spring Meeting, Loughborough, UK, April 2009.
Nasir Abbas, Iain D. H. Oswald, Graeme Day, Colin R. Pulham, Clare L. Anderton, 
Alistair Lennie, and John E Warren. Exploring Polymorphism using High Pressure 
(a case study of N,N'-dimethylurea). Erice Summer School on High-pressure 
crystallography, Erice, Italy, June 2009.
L ec tu re  cou rse :
Erice Summer School on High-pressure crystallography, Erice, Italy, June 2009
Publications
D. M. S. Martins, C. K. Spanswick, D. S. Middlemiss, N. Abbas, C. R. Pulham and C. 
A. Morrison, J. Phys. Chem . A , 2009, 113, 5998-6003.
N. Abbas, I. D. H. Oswald, M. G. Day, C. R. Pulham, C. Anderton, A. Lennie and A. 
Kleppe, M anuscrip t in Prepara tion . High-Pressure Studies of N,N,-dimethylurea.
-203 -
Appendix
A p p e n d i x  D: Abbreviations
CSD Cambridge Structural Database
CIF Crystallographic Information File
DSC Differential Scanning Calorimetry
D M U N,N' -dimethylurea
D...A Hydrogen-bond Donor...Hydrogen-bond Acceptor
FD A Food and Drug Administration
IR Infrared
M A Mefenamic acid
N M R Nuclear Magnetic Resonance
2-D Two-Dimensional
3-D Three-Dimensional
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